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Immunity to Salmonella enterica serovar Typhimurium (STm) is complex and requires both cell 
mediated and humoral immunity at different stages of infection. In infants in sub-Saharan Africa infection 
with non-typhoidal Salmonella (NTS), such as STm, can commonly cause fatal invasive disease. 
Evidence indicates that disease may be preventable by antibody, which makes vaccine development 
against these devastating infections a promising option. 
 
This work has explored the cell-mediated and humoral response to STm and its component antigens, 
their intrinsic properties, and capacity to act as protective immunogens in a mouse model. In particular, 
responses to surface exposed structures such as the outer membrane proteins (Omps) and the flagellar 
protein FliC, which are potent, immunodominant antigens and frequent targets of antibody, that may 
offer potential as vaccine candidates have been examined. Immunisation with soluble flagellin (sFliC) 
induces a potent Th2 response. Despite this, immunisation with sFliC results in accelerated clearance of 
STm after the first week of infection in an antibody independent, but T-bet-regulated manner. This 
suggests that the Th2 responses to flagellin are flexible since they can promote Th1 mediated clearance 
of STm. This moderate protection conferred by sFliC contrasts with the potent benefit conferred by 
porins. These proteins induce, and can mediate protection through a T-independent B1b cell population. 
In particular, antibody to OmpD is key for this protection. These results suggest that vaccines that 
induce protective antibody to STm may be more effective than vaccines that induce T cell-mediated 
protection, since they reduce bacterial numbers at the earliest stages of infection. Lastly, experiments 
using N. brasiliensis show that infectious history can impact on the host’s ability to control primary STm 
infection and the efficacy of antibody-mediated protection against infection. These projects further our 
understanding of the relationship between host and pathogen and the mechanisms used to control 
infection, but also identify the need to consider the impact of infectious history on the host’s capacity to 
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1.1 The Immune System 
The immune system is divided into two categories: innate and adaptive immunity, which are 
complementary and work in a co-ordinated manner. It can respond to a broad range of antigens 
throughout the body with responses which are both general and tailored to the antigen encountered. 
This requires interplay between these two components of the immune system to orchestrate an effective 
response through cellular contacts and the secretion of soluble mediators, known as cytokines produced 
by various cell types.  
 
1.2 The Innate Immune Response 
Innate immunity is the first line of defence against invading pathogens, and critical for immediate and 
rapid control. It is the same on the first encounter with a pathogen and upon subsequent encounter. It is 
efficient at either preventing an infection or greatly reducing the pathogenic load, and many invading 
pathogens are effectively eliminated by innate effectors (Janeway and Medzhitov, 2002). Innate 
immunity can be considered as consisting of a number of cell types that recognise foreign antigens 
through a series of receptors.  
 
1.2.1 Cellular Components of Innate Immunity 
1.2.1.1 Neutrophils 
Neutrophils are one of the first immune effectors to enter sites of inflammation in response to 
chemotactic signals, such as IL-8 (Peveri et al., 1988). Although short-lived, they are indispensable for 
defence against invading pathogens, through secreting chemokines which promote the recruitment 
and/or activation of other innate immune effectors, including dendritic cells and macrophages 
(Bennouna et al., 2003; Chertov et al., 1997; Wittamer et al., 2005). Neutrophils kill micro-organisms 
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upon phagocytosis through exposure to microbicidal agents liberated from granules and secretory 
vesicles, such as hydrolytic enzymes (cathelicidins, defensins and lysozymes) or antimicrobial peptides 
(lactoferrin), which destroy bacterial cell wall integrity or antagonise bacterial growth, respectively 
(Masson et al., 1969). Additionally, they kill many microbes upon internalisation through oxygen 
consumption in the phagocytic vacuole, in a reaction termed the respiratory burst (Segal, 2005). 
 
1.2.1.2 Dendritic Cells 
DC are professional antigen presenting cells which form a bridge between innate and adaptive 
immunity. As immature cells, they reside in non-lymphoid tissues where they are likely to encounter 
antigen which they recognise through pattern recognition receptors. Upon pathogen recognition by Toll 
like receptors, DC undergo maturation and differentiation to become antigen presenting cells, 
characterised by increased expression of MHC and up-regulation of co-stimulatory molecules such as 
CD40, CD80 and CD86. Thus, they acquire the capacity to migrate to the T zones of secondary 
lymphoid tissues, where they present processed antigens to naïve re-circulating T cells in the context of 
MHC (Banchereau and Steinman, 1998). This enables DC to stimulate primary immune responses by 
inducing activation and differentiation of naïve T-helper cells (Banchereau and Steinman, 1998; 
Jankovic et al., 2001; Mizel et al., 2003). Distinct DC populations exist and can be resident in lymphoid 
or non-lymphoid tissues. 
 
1.2.1.3 Macrophages Populations 
Macrophages are tissue-resident mononuclear phagocytes that contribute to the effector phase of the 
immune response, and have anti-microbial functions as well as other roles. Activation of macrophages 
during Th1 responses induces development of classically activated macrophages (CAM) (Aderem and 
Underhill, 1999), which promote phagocytic internalisation and intracellular bacterial killing through 
induction of cytotoxic reactive nitrogen species, such as iNOS and nitric oxide. In the presence of IL-4 
and IL-13, key Th2 cytokines produced during allergy and parasite infections, a distinct population of 
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non-phagocytic macrophages are induced, known as alternatively activated macrophages (AAM) 
(Goerdt and Orfanos, 1999; Stein et al., 1992). AAMs play an important role in moderating inflammation 
and promoting tissue repair (Goerdt and Orfanos, 1999; Loke et al., 2007; Loke et al., 2000). 
Furthermore, AAMs can enhance the host defence against parasites. Due to these diverse activities 
proposed for AAMs their functional significance in vivo remains controversial.  
 
1.2.2 Pattern Recognition Receptors 
Innate cells recognise conserved signature molecules on the invading pathogens, called Pathogen 
Associated Molecular Patterns (PAMP) through germline encoded Pattern Recognition Receptors 
(PRR) (Janeway and Medzhitov, 2002). PRR enable the host to distinguish between different types of 
pathogens and initiate a robust and rapid defence, and include Nucleotide Binding and Oligomerisation 
Domain (NOD)-Like Receptors (NLR) and Toll-Like Receptors (TLR) amongst others. Induction of 
innate immunity may involve the activation of multiple PRR and their collaboration (Underhill, 2007).  
 
1.2.2.1 Toll-Like Receptors 
Many bacterial PAMP signal through Toll-Like Receptors (TLR), which are a family of at least twelve 
conserved germline-encoded transmembrane glycoprotein receptors expressed on antigen presenting 
cells. TLR recognise a broad range of microbe derived ligands in the extracellular milieu or in the lumen 
of endocytic vesicles (Table 1.1). Each member of the TLR family detects a unique or limited set of 
microbial PAMP which collectively allows the host to efficiently sense most microbes. TLR are thought 
to be largely responsible for recognition and activation of innate responses (Mizel et al., 2003; Underhill, 
2007).  
 
1.2.2.2 Nod-Like Receptors  
Nucleotide Binding and Oligomerisation Domain (NOD)-Like Receptors (NLR) are a family of innate 
pattern recognition cytoplasmic receptors. They contain a central nucleotide binding and oligomerisation 
7 
 
domain, an N-terminal signal domain and a C-terminal leucine-rich repeat domain involved in 
recognition. The stimuli activating NLR receptors are not clear, and unlike TLR, NLR recognise 
pathogen derived molecules that gain access to intracellular compartments, or detect products that are 
released into the cytoplasm by processes such as phagocytosis (Strober et al., 2006; Underhill, 2007). 
The NLR-family comprises more than 20 members and includes: ICE protease-activating factor (Ipaf) 
(also known as CARD12, CLAN or NLRC4), which can recognise flagellin when intracellularly localised 
after phagocytosis (Franchi et al., 2006; Miao et al., 2006). 
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1.3 The Adaptive Immune Response 
For infections not controlled by innate responses, effective resolution requires the induction of adaptive 
immunity. Adaptive responses are characterised by their specificity and immunological memory 
necessary for rapid induction upon antigen re-encounter. Adaptive immunity is central to the concept of 
vaccination. There are two main cell types which are the effectors of the adaptive response: 
lymphocytes derived from the thymus (T cells) and bone marrow (B cells). The key difference between 
innate and adaptive effectors is that each T or B cell is mono-specific. The adaptive response may 
encompass T cell-induced cell-mediated immunity, B cell-driven humoral-immunity, or a combination of 
both of these for successful eradication. 
 
1.3.1 Principles of Cell-Mediated Immunity 
Cell-mediated immunity involves T cells, recruited after antigen recognition of peptides presented 
through MHC (Major Histocompatibility Complex) on the surface of antigen presenting cells by their T 
cell receptor (TCR) (Fig. 1.1). MHC class I molecules are expressed on most nucleated cells, whilst 
MHC class II expression is restricted to professional antigen presenting cells (DC, macrophages and B 
cells). There are many classes of T cells, but the better characterised effector cells include CD8 
cytotoxic T-lymphocytes (CTL) and CD4 T-helper lymphocytes which are MHC-class I and MHC-class II 
restricted, respectively (Germain, 1994). As the role of CD8 T cells is not important for infections with 
Salmonella, they will not be discussed in detail in this thesis. 
 
1.3.1.1 Priming of Naïve T Lymphocytes by APC 
Activation of naïve antigen-specific T cells requires at least two signals (Fig. 1.1). The first signal is 
delivered through the TCR after its interaction with the peptide-MHC complex on the antigen presenting 
cell. The second signal is generated through engagement of co-stimulatory molecules expressed by 
antigen presenting cells with receptors expressed by T cells, such as CD28 on T cells with B7-1 (CD80) 
9 
 
or B7-2 (CD86) on antigen presenting cells for CD4 T cells (Shahinian et al., 1993), and 4-IBBL 
(CD137L) on DC by CD137 on T cells for CD8 T cells (Shuford et al., 1997). After priming, CD4 T cells 
start to proliferate and acquire effector characteristics. Primed CD4 T cells differentiate down one or 
more functionally distinct subsets, and acquire the capacity to interact with B cells at this time (Toellner 
et al., 1998). Amongst other outcomes, primed CD4 T cells can migrate to the tissues to execute their 
function, enter follicles where they are involved in the Germinal Centre (GC) reaction (Fuller et al., 
1993), or develop into central and effector memory cells which reside in secondary lymphoid organs and 
tissues, respectively (Sallusto et al., 1999). 
 
 
A      B 
  
 













Figure 1.1: T cell activation requires two signals: (A) CD4 and CD8 T cells recognise antigens through their T 
cell-receptor (TCR) as peptide fragments displayed on antigen-presenting cells by MHC Class II or MHC Class I 
molecules, respectively (Germain, 2002). (B) Simultaneous recognition between the TCR and peptide-MHC, and 
engagement of co-receptors on naïve CD4 T cells (CD28) with their ligands on antigen presenting cells (CD80 or 
CD86) stimulates priming of naïve T CD4 cells, resulting in proliferation and differentiation. In the absence of 
CD28 co-stimulation, T cells undergo apoptosis or become anergic (Alegre et al., 2001). 
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1.3.1.2 Lineage Decisions of CD4 T-helper Cells 
Primed CD4 T cells were originally shown to differentiate into two functionally distinct subsets, 
designated T helper 1 (Th1) and (Th2) (Mosmann et al., 1986; Mosmann and Coffman, 1989) (Fig 1.2). 
Phenotypically, Th1 and Th2 cells can be distinguished by their specific function, through the selective 
cytokines they secrete, and in mice, the switched antibody isotype they induce in B cells. Furthermore, 
although less prominent, several other CD4 T cell subsets exist alongside these conventional CD4 T 
cells, such as Th17 (Harrington et al., 2005; Park et al., 2005) and regulatory T cells (Tregs) (Chen et 
al., 2003) each of which have distinct functions and cytokine profiles.  
 
1.3.1.2.1 CD4 T-helper 1 Responses 
Th1 responses are induced after co-culture of naïve CD4 T cells with Interferon-gamma (IFNγ) (Hsieh et 
al., 1992) and interleukin-12 (IL-12) (Hsieh et al., 1993; Manetti et al., 1993). IFNγ is the hallmark 
cytokine associated with Th1 immunity as is the secretion of Tumour Necrosis Factor (TNFα) and 
Lymphotoxin-α (LTα) (Zhu et al., 2010). IFNγ signals through STAT-1, and together with TCR signalling 
drives Th1 differentiation by inducing T-bet (T-box expressed in T cells) in naïve T cells (Lighvani et al., 
2001). T-bet is a member of the T-box family of transcription factors and is a key Th1 transcription factor 
(Szabo et al., 2000). Its expression enables remodelling of the gene encoding IFNγ to facilitate its 
secretion (Kobayashi et al., 1989), and expression of T-bet correlates with expression of IFNγ. In 
addition to initiating Th1 lineage commitment, T-bet simultaneously represses opposing Th2 programs 
in early developing, and fully committed Th2 cells (Szabo et al., 2000). 
 
In mice, during cognate interaction between Th1 cells and antigen-specific naïve B-cells, IFNγ secretion 
promotes T-dependent immunoglobulin class-switching to IgG2a (DeKruyff et al., 1989; Mosmann et al., 
1986). Th1 lymphocytes are important for cell-mediated and inflammatory immunity, and delayed type 
hypersensitivity reactions. Typically, Th1 responses are associated with the resolution of viral, 
intracellular bacterial and protozoan infections. Indeed, IFNγ is a potent activator of the intrinsic 
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antimicrobial functions of CAMs and other professional phagocytes, having the inherent ability to induce 
bactericidal activity of Salmonella-infected macrophages through increased phagosome-lysosome 
fusion, and enhanced secretion of reactive oxygen intermediates (ROI) (Kagaya et al., 1989). Certainly, 
defects in the IFNγ pathway are characterised by the increased susceptibility to severe infections with 































Figure 1.2: CD4 T cell subsets and the factors reported to induce them and their effector profile: During 
CD4 T cell activation in response to a particular cytokine environment, naive CD4 T cells may differentiate into 
one of several functionally distinct lineages, including the classically-recognised CD4 T cells, Th1 and Th2. Other 
effector populations of CD4 T cells, including: Th17 cells, regulatory T cells and follicular (Tfh) T cells represent 
additional CD4 T cell fates. They are defined by their function, expression of specific transcription factors, and 
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1.3.1.2.2 CD4 T-helper 2 Responses 
Th2 responses are classically associated with humoral immunity, necessary for resolution of 
extracellular pathogens such as helminths (discussed in detail elsewhere) (Arthur and Mason, 1986; 
Urban et al., 1991), the induction of allergic reactions (Holgate, 1999), and antibody responses to alum-
precipitated proteins. The antibody isotypes associated with Th2 responses are IgE, and in mice IgG1 
as well (Mosmann et al., 1986; Vitetta et al., 1985). Th2 responses are also associated with promotion 
of AAM development, activation of mast-cells, as well as tissue infiltration by both basophils and 
eosinophils, and goblet cell hyperplasia (Madden et al., 1991). Together, these processes mediate 
physiological changes such as airway hyper-responsiveness, airway mucus hypersecretion and 
inflammation (Kuperman et al., 1998), important in allergic type responses such as asthma. 
 
The signature cytokines of Th2 cells are IL-4 and IL-13 (Hsieh et al., 1992). IL-4 is largely produced by 
Th2 lymphocytes but basophils, mast cells, NK T cells (Yoshimoto and Paul, 1994), eosinophils (Moqbel 
et al., 1995) and δT cells (Abbas et al., 1996), have also been demonstrated to produce IL-4. IL-13 can 
be produced by the same cells which secrete IL-4 (Hershey, 2003) and their biological activities have 
been found to overlap. The Th2 defining transcription factors are: signal transducer and activator of 
transcription 6 (STAT-6) (Andrews et al., 2002) and GATA-binding protein 3 (GATA-3), which promote 
secretion of the Th2 selective cytokines: IL-4, IL-5, IL-9 and IL-13 (Banchereau and Steinman, 1998; 
Lanzavecchia and Sallusto, 2000; Le Gros et al., 1990; Paul and Seder, 1994). Other cytokines have 
also been associated with Th2 polarisation, particularly IL-6 (Diehl and Rincon, 2002) and IL-10 
(Mosmann, 1994). GATA-3 is important for the development and maintenance of Th2 responses (Pai et 
al., 2004; Zhu et al., 2004) through inducing Th2 activity and terminating the opposing Th1 genetic 
programs (Ouyang et al., 2000). 
 
Although IL-4 and IL-13 are important for directing the development of Th2 characteristics in vitro (Kuhn 
et al., 1991; Mohrs et al., 2000), their importance is dispensable in vivo, as Th2 development can occur 
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independently of both these cytokines (Brewer et al., 1996; Kopf et al., 1993). Indeed, the induction of 
IL-4 and IgG1 switching is maintained to wild-type levels in the absence of IL-4 signalling, or upon the 
dual loss of IL-4 and IL-13 signalling through the IL-4 receptor alpha pathway (Cunningham et al., 2002; 
Kuhn et al., 1991) (Fig 1.3). These studies suggest in vivo CD4 T cell IL-4Rα independent pathway(s) 
for IL-4 and IL-13 production exist (Cunningham et al., 2002; Mohrs et al., 2000; Noben-Trauth et al., 
1997). Despite Th2 priming being IL-4 independent in vivo, IL-4 production is necessary for confirming 
the induced Th2 state, and supporting its subsequent development through selectively expanding Th2 
clones (Cunningham et al., 2002). 
 
Figure 1.3: IL-4 and IL-13 receptor signalling complexes: Th2 immune effector responses are characterised 
by IL-4 and IL-13 dependent signalling through heterodimeric transmembrane receptors containing an IL-4 
receptor alpha (IL-4Rα) subunit (Mohrs et al., 1999). IL-4 signals through both the type 1 and type 2 receptor 
complexes, whilst IL-13 signals via the type 2 complex. Both type 1 and 2 receptors share a common IL-4Rα 
chain which dimerises with either the γc chain to form a type 1 receptor or the IL-13Rα1 to form a type 2 receptor. 
Ligand binding of these complexes results in initiation of the signal cascade and activation of STAT-6 
transcription factor which upregulates transcription of Th2 associated genes. IL-13Rα2 (not shown) does not 
dimerise with IL-4Rα, is only bound by IL-13 and does not initiate activation of STAT-6 (Image taken from 
((Hershey, 2003)).  
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1.3.1.2.3 Other CD4 T cell subsets 
A major function of CD4 T cells is to help B cells produce antibody in response to T-dependent antigens. 
CD4 T cells that specifically enter GC to mediate their helper function for antibody production are 
designated T follicular helper (Tfh) cells. They reside in GC (Reinhardt et al., 2009) and produce lL-4 
and IFNγ, but no other signature cytokines (Zaretsky et al., 2009). Although not fully characterised, they 
can express Programmed-Death Receptor-1 (PD1) and B cell lymphoma 6 protein (BCL-6) (Yu et al., 
2009).  
 
CD4 regulatory T cells (Tregs) are both promoted by and differentiated into producers of Transforming 
growth factor-β (TGF-1), utilising the transcriptional regulator Forkhead box p3 (Foxp3) for 
differentiation (Chen et al., 2003). They play an important role in regulating and preventing over-activity 
of the immune system, and their deficiency results in a lethal multi-organ autoimmune syndrome, and 
hyper-reactivity to commensal microbes (Groux and Powrie, 1999; Powrie and Mason, 1990). T cells 
can also differentiate to become Th17 cells after IL-6 and TGF-1, and this requires the transcriptional 
factor STAT-3. Their signature cytokines are IL-17, IL-22 and IL-23 (Harrington et al., 2005; Park et al., 
2005). They are found in the gut, in particular, the lamina propria where specific commensal bacteria 
can promote their differentiation (Ivanov et al., 2008; Ivanov et al., 2006). Th17 cells are potent effectors 
of inflammation, thus key mediators of autoimmune diseases. Moreover, they also play critical roles in 
protecting the host from pathogenic yeast, fungi and extracellular bacteria, particularly at mucosal 
surfaces (Aujla et al., 2008; Bettelli et al., 2006).  
 
1.3.2 B Cell-Mediated Immunity 
B cells can differentiate into plasma cells to secrete antibody or into memory B cells. Antibody is 
important against extracellular pathogens. Unlike T cells, antigen recognition by B cells does not require 
antigen processing and presentation through MHC. B cells recognise and interact with soluble antigens 
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in their native form through their B Cell Receptor (BCR). The principal function of B cells is to synthesise 
and secrete antibodies which contribute to immunity in multiple ways. Firstly, antibody can neutralise the 
effect of a pathogen or toxin through binding to its surface and thereby blocking its interaction or effect 
with its target. Indeed, immunisation with modified bacterial toxins, called toxoids, induce protective 
neutralising antibody against the potential pathogenicity of Diphtheria and Tetanus toxins (Robbins and 
Robbins, 1986). Alternatively, antibodies can opsonise pathogens to facilitate their destruction by 
phagocytic cells or thirdly, antibodies can activate complement to enable lysis of certain pathogens. A 
further mechanism, Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), which is probably less 
pronounced in mice, works by targeting and destroying antibody-coated cells by NK T cells (Takai, 
1996). This latter mechanism is important for the action of therapeutic monoclonal antibodies utilised in 
anti-cancer therapy (Clynes et al., 2000).  
 
1.3.2.1 B Cell Subsets and their Antigenic Targets 
The nature of the antigen influences antibody production by B cells. Nearly all protein antigens 
assessed require cognate interaction between T and B cells in order to initiate antibody responses, and 
are called Thymus-dependent (TD) antigens. However, protective antibody responses to some bacterial 
antigens, such as capsular polysaccharides can arise in the absence of T cells and CD40 ligation (Fikrig 
et al., 1996; McKisic and Barthold, 2000), and are termed Thymus-independent (TI) antigens. TI 
antigens have been sub-classified into: Type-I (TI-1 antigens) and Type-II (TI-2 antigens) which activate 
B cells by different mechanisms (Fagarasan and Honjo, 2000; Noelle and Snow, 1991).  
 
Mature B cells can be divided into distinct subsets which respond to TD and TI antigens and are 
designated: Follicular (FO), Marginal Zone (MZ), B1a and B1b B cells (Fig 1.4). Each subset has a 
distinct function in the immune system and can be further distinguished by their anatomical location, and 







Figure 1.4: Distinct B cell populations respond to TD and TI antigens: B2 cells represent the greatest 
proportion of the adult B cell population and are subdivided into Follicular (FO) and Marginal Zone (MZ) B cells, 
which secrete antibodies towards TD and TI-2 antigens, respectively. Although, FO B cells may respond to TI-1 
antigens if they express the appropriate accessory receptor. A smaller subset of B cells, B1 B cells are 
distinguished from B2 cells by their anatomical location (Herzenberg and Tung, 2006; Kantor et al., 1992). They 
were originally defined by CD5 surface expression and high IgM expression compared to FO B cells (Hayakawa 
et al., 1983). B1 B cells can be subdivided into B1a and B1b cells which are CD5-positive and CD5-negative, 
respectively. B1a cells respond to TI-1 antigens, but the role of B1b cells is not clear, although they are important 
in the TI response to relapsing fever caused by Borrelia hermsii (Alugupalli et al., 2004). B cells do not respond in 
isolation as pathogens present various antigens which has the capacity to invoke a range of responses. 
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1.3.2.1.1 T-Dependent (TD) Antibody Responses 
Naïve FO B2 cells represent the largest proportion of the adult B cell population. They are in a constant 
state of migration between the follicles of secondary lymphoid organs (MacLennan et al., 2003). This 
process ceases if B cells are recruited into the antibody response. Activation of FO B cells requires two 
signals, the first signal is provided by antigen recognition through the BCR during which the antigen is 
internalised, processed and presented to naïve antigen specific CD4 T cells through MHC II, where it 
can be recognised by T cells (Renshaw et al., 1994). The second co-stimulatory signal is provided 
through interaction between CD154 (CD40L) on T cells and CD40 on B cells which is central in the 
control of both humoral and cellular immunity (Grewal et al., 1995). Unlike TD antigens, TI antigens can 
directly induce B cell proliferation (Cambier et al., 1982) as the second signal can be provided by the 
antigen itself. 
 
The T cells involved in TD antibody responses have previously been primed by DC in the T-zone (Fig 
1.5). As a result of this priming, T cells acquire the capacity to interact with B cells, whereupon they 
promote proliferation of B cells and their induction of switched germ-line transcripts, influenced by type-
specific cytokines produced by T cells. Activated FO B2 cells can either proliferate within follicles where 
they form GC, or differentiate into proliferating antibody secreting cells called plasmablasts, and then 
into non-proliferating antibody secreting cells called plasma cells in the extra follicular (EF) response 
(MacLennan et al., 2003). GC induction is required for memory and high affinity antibody production. 
This is achieved through affinity maturation by somatic hypermutation (SHM) of the immunoglobulin 
variable region genes, and changes in immunoglobulin isotype by class switch recombination, giving 
rise to different subclasses of B cells. The resulting B cells are subjected to careful screening for their 
reactivity to self-antigens and self-reactive B cells are eliminated by apoptosis. A proportion of 
positively-selected GC B cells differentiate into plasma cells that can be long-lived and some become 
memory B cells. Long-lived plasma cells migrate into specialised compartments in the bone marrow or 
splenic red pulp, where contact with the surrounding tissue may be instrumental for their survival (Manz 
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                                           (Image adapted from Ian MacLennan) 
 
Figure 1.5: Development of TD Antibody Responses: DC primed by antigen in the periphery migrate to the T 
zones of secondary lymphoid tissues where they prime naïve CD4 T cells. Primed T cells acquire the capacity to 
interact with B cells. Activated FO B2 cells can either proliferate within follicles where they form GC, or as 
plasmablasts, before differentiating into plasma cells in the extra follicular (EF) response (MacLennan et al., 
2003). EF plasma cells reside in the medullary cords of lymph nodes or the red pulp of the spleen (Jacob et al., 
1991). EF plasma cells secrete antibodies that show no evidence of affinity maturation, and are of modest affinity. 
Despite this, the EF response provides a rapid first line of defence against invading pathogens (Cunningham et 
al., 2007). Induction of TD EF responses requires T cells and CD154, but once established, continue in the 
absence of further T cell help (Cunningham et al., 2004b; Toellner et al., 1996). Follicular DC and T cells are 
critical for GC B cell responses. They provide crucial interactions necessary for screening the resulting 
immunoglobulin to eliminate low-affinity or self-reactive B cells (Toellner et al., 2002). Without this selection, GC 
collapse by mass apoptosis (Vinuesa et al., 2000). Upon selection, FO B cells exit GC and differentiate into 
plasma cells which secrete high-affinity antibodies, or they differentiate into memory B cells.  
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1.3.2.1.2 T-Independent (TI) Antibody Responses 
B1 and MZ B cells respond to antigen in the absence of T cell help (Fig. 1.4). Such responses are 
characterised by the absence of GC (MacLennan et al., 2003; Toellner et al., 1998) and the production 
of low-affinity germ-line encoded antibodies. Nevertheless, TI-antibody responses offer the capacity to 
respond to specific foreign antigens rapidly, thereby providing immediate protection through secretion of 
antibodies with a broad-specificity against ubiquitous micro-organisms, before the establishment of 
adaptive immunity. Despite their importance in infection, little is known about how they are recruited for 
antigenic clearance, and the mechanisms by which they are activated and regulated. 
 
B1 B cells can develop during the foetal and neonatal period (Hayakawa et al., 1983) and are the major 
population of B cells in infancy. They are notable for their capacity to proliferate and self-renew, a 
property that FO and MZ B cells do not have. They are found in the peritoneal and pleural cavities 
(Hayakawa et al., 1983) but can migrate to other tissues, including the mesenteric lymph nodes (MLN), 
spleen, and gut associated lymphoid tissue where they can differentiate into plasma cells (Bos et al., 
1996). B1a B cells constitutively produce natural antibody (Baumgarth et al., 1999) and respond to TI-1 
antigens which trigger innate signalling receptors on B cells. The most obvious example is LPS 
(Fagarasan and Honjo, 2000). The role of B1b cells in immunity remains to be fully elucidated, but they 
can protect against infection with the relapsing fever bacterium Borrelia hermsii (Alugupalli et al., 2004). 
Furthermore, transfer of purified B1b cells from B. hermsii immune mice into Rag-deficient mice can 
provide long-lasting immunity through the rapid induction of IgM, suggesting they may invoke a memory 
response (Alugupalli et al., 2004). 
 
MZ B cells are non-recirculating B2 cells that localise to the marginal sinus, at the border of the splenic 
white and red pulp. There is evidence that they may arise from the differentiation of re-circulating FO B 
cells (Kumararatne and MacLennan, 1981; Vinuesa et al., 2003). MZ B cells can respond to TI-II 
antigens, which typically, but not exclusively, are antigens that contain polysaccharide chains 
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comprising repetitive sequences, such as the capsular polysaccharides of pneumococci. These 
antigens can extensively crosslink many BCRs on the same B cell to induce a proliferative antibody 
response (Guinamard et al., 2000). Antibody responses to certain capsular bacteria, such as 
Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae are not generated in 
the early years of life, and vaccines against these pathogens are ineffective in infants therefore, MZ B 
cells are crucial for immunity against this important group of pathogens. 
 
1.4 Salmonella enterica serovar Typhimurium 
1.4.1 The species Salmonella enterica 
Salmonella are non-spore forming, facultative intracellular, Gram-negative (GN) bacilli. Classification of 
Salmonella was initially based on clinical considerations, for example S. choleraesuis (swine cholera). 
However, nomenclature is now based on DNA sequences which has left only two species: S. enterica 
and S. bongori. These species are further divided into subspecies and serovars, which are defined by 
antigenic structure and biotype in accordance with the Kauffman-White classification scheme. 
 
S. enterica is clinically important and contains over 2000 serovars, including Salmonella enterica 
serovar Typhi (ST) and Salmonella enterica serovar Typhimurium (STm). Genetically, almost 98% of 
known DNA sequences between ST and STm are identical at the sequence level, highlighting the 
homology between the two serovars (Crosa et al., 1973; Zahrt and Maloy, 1997). However, 20% of their 
genes are different and unique to each species (Lan and Reeves, 1996; McClelland et al., 2001; Parkhill 
et al., 2001) which may contribute to their respective host specificity and infectivity (discussed in 1.4.2). 
The most striking structural difference between them is the absence of a capsular polysaccharide in 




1.4.2 Disease Burden of Salmonella Infection 
Salmonella are important human and animal pathogens. In particular, Salmonella enterica serovar Typhi 
(ST) and Salmonella enterica serovar Paratyphi A, B and C which are human specific, cause typhoid 
fever and paratyphoid fever, respectively. Typhoid is a serious systemic infection which can be fatal if 
left untreated. According to WHO figures, typhoid fever caused 21, 650 974 illnesses and 216, 510 
fatalities during 2000 (Crump et al., 2004). Typhoid is spread by the faecal-oral route by ingestion of 
food or water contaminated by excreta from patients or chronic carriers (Parry, 2004). It is closely 
associated with poor hygiene, lack of clean drinking water and inadequate sanitation. Typhoid is 
commonly characterised by abdominal pain, the sudden onset of sustained fever, severe headache and 
nausea. Furthermore, an asymptomatic carrier state may follow acute infection. Paratyphoid fever is 
clinically similar to typhoid fever but milder, and with a lower fatality rate.  
 
Non-Typhoidal Salmonella (NTS) serovars include, Salmonella enterica serovar Typhimurium (STm) 
and Salmonella enterica serovar Enteritidis. The serovar STm includes numerous pathovars some of 
which can infect different livestock hosts and humans, whereas others exhibit a restricted host range 
(Rabsch et al., 2002). In developed countries, in humans, NTS infection caused by STm is normally 
associated with a self-limiting gastroenteritis with symptoms resolving by a week (Zhang et al., 2003). 
Systemic disease with STm is rare in most parts of the world, although disease can be more severe in 
the young, elderly or immunocompromised. However, in sub-Saharan Africa (SSA) there has been a 
dramatic increase in NTS-associated invasive disease, frequently associated with STm isolates (Gilks et 
al., 1990; Graham et al., 2000; Vugia et al., 1993). Here, NTS infections show a dramatically more 
severe presentation and often in the complete absence of gastro-intestinal symptoms. These invasive 
NTS infections are a common cause of bacteraemia in infants between 6-24 months (MacLennan et al., 
2008). Furthermore, NTS infections are a major problem in people of all ages with HIV/AIDs, where it is 
often fatal, and mortality is largely associated with bacteraemia. This suggests that invasive NTS 
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infections in SSA may differ to classical NTS infections seen in the West where bacteraemia is a rare 
complication (Gordon, 2008; Hohmann, 2001). 
 
Interestingly, multilocus sequence analysis of invasive NTS strains in SSA recognised an isolate of STm 
which is rarely reported outside of Africa. Whole genome sequencing of this isolate identified a virulence 
associated plasmid encoding multiple drug resistance genes. Furthermore, sequencing found evidence 
of genome degradation, including the formation of pseudogenes and chromosomal deletions when 
compared to other STm genome sequences (Kingsley et al., 2009). This suggests that host-restriction 
and change of niche (gut to systemic disease) is linked to the accumulation of large numbers of 
pseudogenes and reduction in genome size. Therefore, STm isolates that cause invasive disease are 
phylogenetically distinct from STm isolates that cause gastroenteritis.  
 
1.4.3 Entry and Colonisation in the host 
Infections with ST are well characterised and our understanding of disease progression in Salmonella is 
based on ST infection, where ingestion and transit through the gastrointestinal (GI) tract forms the 
natural means of infection (Fig 1.6). After ingestion of contaminated food or water, the initial stages of 
infection involve bacterial survival within the acidic environment of the stomach, surviving bacteria 
spread rapidly along the GI tract. Ingested Salmonella must cross the intestinal epithelial barrier to 
initiate systemic infection. This is achieved by transit across the mucosal barrier, primarily through 
Membranous epithelial (M) cells (Jepson and Clark, 2001; Jones et al., 1994) in the specialised follicle-
associated epithelium (FAE) overlying organised mucosa-associated lymphoid tissues, such as the 
Peyer’s patches (PP). Salmonella can utilise M cell-independent routes of extraintestinal dissemination, 
including phagocytes and epithelial cells (Vazquez-Torres et al., 1999). 
 
Regardless of the route of entry, following penetration bacteria colonise the lamina propria and PP 
where Salmonella rapidly invade host cells within these sites. If local host defences fail to kill the 
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bacteria then bacteria can spread systemically. Initially, bacteria are translocated to the MLN through 
the lymphatics where they multiply, from here they can escape and enter the blood through the thoracic 
duct, leading to a transient bacteraemia. This primary bacteraemia is cleared by the reticuloendothelial 
system (RES), and intracellular replication in cells of the RES results in a secondary bacteraemia to the 
spleen and non-lymphoid organs, such as the liver, where bacteria replicate in macrophages (Richter-
Dahlfors et al., 1997; Salcedo et al., 2001). Colonisation of the liver results in spread to the biliary tract 
promoting colonisation of the gall bladder, and large numbers of bacteria in the small intestine, where 
necrosis and ulceration may occur. The key feature with typhoid and NTS is that severity requires 







Figure 1.6 Model of how ST infection is established: Ingested bacteria translocate across the mucosal barrier 
through M cells to induce a systemic infection. The apical membranes of M cells are relatively accessible to 
luminal bacteria, and their increased pinocytic activity is exploited by Salmonella (Jepson and Clark, 2001). 
Successful translocation enables bacteria to enter Peyer’s patches where bacteria can specifically target host 
cells, such as DCs and macrophages which enables dissemination through the lymphatics and circulation. 
Bacteria can persist in the MLN, bone marrow and gall bladder for life. (Image taken from (Monack et al., 2004)). 
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1.4.4 Structural Features STm 
The hallmark of GN bacteria is the composition of their cell envelope comprising three morphologically 
distinct layers (Fig 1.7). It is characterised by a double membrane (the cytoplasmic and the outer 
membrane (OM)) separated by a highly viscous compartment known as the periplasm. The OM has an 
array of different components involved in numerous bacterial processes that are also important potential 
immunological targets. 
 
1.4.4.1 Lipopolysaccharide (LPS) 
LPS consists of three components: Lipid A, the core and the O-antigen (Fig 1.7). Lipid A is a 
glucosamine disaccharide coated with multiple fatty acids which anchor LPS to the OM of the cell wall. 
The structure of lipid A is highly conserved among GN bacteria and it is largely responsible for much of 
the toxicity associated with LPS, including endotoxic shock (Raetz and Whitfield, 2002). The core is a 
surface-exposed negatively-charged oligosaccharide. The O-antigen or O-polysaccharide extends from 
the core and comprises the outermost domain of LPS. It is composed of heteropolysaccharide side 
chains of repeating oligosaccharide units. The composition of the sugars in the O-chain varies markedly 
between species and even different GN bacteria. Indeed, antigenic variation of the O-antigen enables 
the existence of multiple serotypes of a given bacterium and forms the basis of serotyping by antibody. 
Furthermore, variation in the repeating sugar units associated with the O-chain determines whether LPS 
is considered rough or smooth. Loss of the O specific region by mutation results in the strain becoming 
a "rough" strain (due to the appearance of the colony on agar) and such bacteria are designated LPS 
rough (Lerouge and Vanderleyden, 2002).  
 
1.4.4.2 Outer Membrane Proteins 
The GN cell envelope contains numerous highly organised β-barrel proteins called Outer Membrane 
Proteins (OMPs). They span the membrane with an even number of amphipathic β-strands with 
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antiparallel topology, connected by alternating short periplasmic turns and longer extracellular loops that 







Figure 1.7 Composition of the Gram-negative cell wall: The inner membrane (IM) is a symmetrical 
phospholipid bilayer. The outer membrane (OM) is a highly asymmetrical bilayer comprising phospholipids and 
lipopolysaccharides (LPS) in its inner and outer leaflets, respectively. The membranes are separated by an 
aqueous compartment known as the periplasm, which contains soluble proteins and a thin peptidoglycan layer 
(Ruiz et al., 2006). The peptidoglycan layer functions as an extracytoplasmic cytoskeleton which maintains 
cellular architecture (Bos and Tommassen, 2004). The cell wall is a dynamic structure containing several 
components necessary for bacterial function, including Outer membrane proteins (OMPs) and LPS. OMPs are 
cylindrical β-barrel proteins which largely function in the exchange of molecules across the cell wall (OMPs image 
taken from: (Nikaido, 2003)). LPS is composed of three regions: The Lipid A portion extends from the OM and is 
attached to the core antigen which is attached to the O-antigen. The O-antigen is a repeating unit (n) of specific 
sugar residues. LPS forms strong lateral interactions between neighbouring molecules which enables LPS to 






















A subset of these proteins, called porins, span the membrane as protein trimers forming water-filled 
channels which facilitate the transport of small hydrophilic molecules (Nikaido and Vaara, 1985). Porins 
have numerous surface-exposed epitopes and monoclonal antibodies raised against them have been 
used to characterise porins between different species (Singh et al., 1992). Porins are important 
antigenic determinants, and their importance in immunity to STm is discussed later. 
 
The OmpC, OmpD, and OmpF genes encode the three major porins of STm, which are 36 kDa, 34 kDa, 
and 35 kDa respectively. Expression of OmpC and OmpF expression is regulated by growth medium 
osmolarity and other factors. Under conditions of high osmolarity, OmpC expression is elevated and 
OmpF is repressed. Under conditions of low osmolarity, the reverse occurs (Hall and Silhavy, 1981; 
Jovanovich et al., 1988; Norioka et al., 1986). OmpR encodes a positive regulator which controls OmpC 
and OmpF expression, but control of OmpD expression is OmpR independent and less well understood 
(Head et al., 1998; Mizuno and Mizushima, 1990), but may be regulated by multiple environmental 
factors. Indeed, OmpD expression decreases in low pH and increases in anaerobic conditions. Changes 
in response to anaerobic conditions appears to be controlled post-transcriptionally by the global 
transcriptional regulator, Fnr. However, Fnr is not responsible for changes in OmpD expression in 
response to pH alterations (Santiviago et al., 2003). All Salmonella serovars, except ST express OmpD, 
and it is highly expressed in the OM (Santiviago et al., 2001). The OmpD primary amino acid sequence 
is more than 99% conserved between serovars. 
 
1.4.4.3 Flagellin  
STm is motile be means of peritrichous flagella which extend from the GN bacterial cell wall (Yoshikawa 
et al., 1980). Flagella filaments are composed of monomers of flagellin, which are exported through the 
type III secretion system (T3SS) to the cell wall where they polymerise to form long protofilaments. Each 
flagellum is composed of 11 flagella protofilaments, each with 30, 000 or more flagellin monomers 
(Yonekura et al., 2002, 2003) (Fig 1.8A).  
27 
 
STm expresses two antigenically distinct flagellin genes which are translated into FliC (Phase 1) and 
FljB (Phase 2) proteins. Only one of the two flagellin types is produced at any given time and a 
bacterium never naturally expresses both gene products simultaneously (Wyant et al., 1999), through a 
complex system of phase variation achieved by gene inversion (Fig 1.8B). No clear biological function 
for phase variation has been described, and the literature remains conflicting. Both proteins can signal 
through TLR5 similarly (Simon and Samuel, 2007), and can adhere and invade mouse epithelial cells to 
the same capacity (Ikeda et al., 2001). However, in vivo FliC-locked strains replicate faster and after oral 
infection of mice with WT STm, most invasive bacteria express FliC (Ikeda et al., 2001).  
 
The predicted amino acid sequences of the two flagellins are very similar. The fliC and fljB genes 
encode 495 and 506 amino acid sequences respectively which are highly conserved at the N and C-
terminus between different Salmonella species. Each flagellin monomer is composed of four globular 
domains: DO, D1, D2 and D3. The D0 and D1 domains of flagellin are formed from these conserved 
regions which are important for TLR5 recognition (Namba et al., 1989; Smith et al., 2003a) and flank a 
central more divergent region (D2 and D3) (Fig 1.8C). The D2 and D3 domains are dispensable for 
flagella function (Eaves-Pyles et al., 2001). They are surface exposed and confer antigenic differences 
to the flagella which forms part of the basis of STm serotyping (Brown and Hormaeche, 1989). Flagellin 
is an important target of the immune response to STm. Indeed, it is recognised by the innate receptors: 
TLR5 and Ipaf (Amer et al., 2006; Franchi et al., 2006; Hayashi et al., 2001). In addition, the adaptive 
immune system generates antibodies to the variable domains of the monomer (Frankel et al., 1989) and 
responds to MHC-II presented peptide derived from flagellin during infection (Cookson and Bevan, 
1997) (discussed in detail elsewhere). 
 
1.4.4.4 Virulence Genes associated with Salmonella 
Salmonella possess many virulence genes which largely have defensive functions against host 
immunity. Salmonella has also developed two complex virulence functions to actively interact with the 
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host and modify cellular functions. These virulence functions are linked to horizontally acquired regions 
of DNA called pathogenicity islands (PAIs), and are termed Salmonella Pathogenicity Islands (SPIs) 
(Marcus et al., 2000). There are several known SPIs. The better characterised, SPI1 and SPI2 each 

























Figure 1.8 Structure and properties of STm flagellin: (A) The bacterial flagellum consists of several 
components. The motor complex traverses both membranes where it joins a flexible hook structure at the cell 
surface. The hook is connected to the filament which can grow by self-assembly of as many as 30, 000 flagellin 
subunits forming long protofilaments. Filament growth occurs at the distal end where a cap protein is stably 
attached at its tip. Each flagellum is a tubular structure of 11 protofilaments. (Image from (Pallen and Matzke, 
2006)) (B) STm phase variation is achieved through alternative inversion of 1 kb of DNA containing the promoter 
region of fljB and fljA (an inhibitor of fliC) (Bonifield and Hughes, 2003; Zieg et al., 1977). In one orientation, the 
promoter is situated upstream of the fljBfljA operon (termed ON) enabling transcription of fljB (Phase 2) and fljA, 
whilst transcription of fliC, is repressed through fljA. In the opposite orientation (termed OFF), fljB and fljA are not 
transcribed, enabling fliC (Phase 1) expression. This invertible DNA segment is flanked by inverted repeats which 




T3SS-1 is encoded within SPI1, it is required for the initial stages of infection, the invasion of epithelial 
cells which is orchestrated through rearrangements of the actin cytoskeleton (Lostroh and Lee, 2001). 
SPI1 mutants are not attenuated for systemic virulence after intraperitoneal infection of mice (Galan and 
Curtiss, 1989a). T3SS-2 is encoded within SPI2, which is required for the secretion of effector proteins 
across the membrane of Salmonella-containing vacuoles (SCV). Thus, SPI2 is required for later stages 
of the infection to enable intracellular accumulation of STm and systemic dissemination (Waterman and 
Holden, 2003). The role of SPI2 for survival and replication in macrophages is important for this phase 
of pathogenesis, and SPI2 mutants are severely attenuated in virulence in mouse models of systemic 
infections (Cirillo et al., 1998; Shea et al., 1999; Shea et al., 1996). Interestingly, a great deal of 
attenuating mutations in STm are located within SPI1 and SPI2 (Carnell et al., 2007). 
 
1.4.5 Murine Model of STm 
STm infection in mice can resemble typhoid fever in many respects and is therefore, widely accepted as 
a good experimental system for studying human typhoid (Santos et al., 2001). Mice show varied levels 
of susceptibility to intracellular pathogens such as STm which is associated with a macrophage divalent 
cation transporter called Slc11a1 (formerly Nramp1) (Goswami et al., 2001). In mice a single mutation in 
Slc11a1 determines resistance (Gly169) or susceptibility (Asp169) to numerous intracellular pathogens 
(Vidal et al., 1995). Innately resistant mice can control low doses of virulent organisms which reach a 
plateau without T cell intervention (Hormaeche et al., 1990). In contrast, innately susceptible mice 
cannot control infection with virulent strains of STm. They succumb to overwhelming sepsis following 
parenteral injection of a very few microorganisms (the LD50 is less than 10 organisms) (Plant and Glynn, 
1976; Santos et al., 2001). STm infection in these animals results in rapid death (usually less than 1 
week) whereas death in human typhoid is rare, and if apparent, late in infection. Most laboratory mouse 
strains carry the susceptible Asp169 allele and to overcome this enhanced susceptibility live attenuated 
STm can be used, allowing infection of genetically modified strains, generally only available on the 
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highly susceptible C57BL6/J or BALB/c background. One advantage of using this system is that 
adaptive immunity is required for protection which enables immune responses to be followed from 
induction through to resolution of infection. 
 
Many routes of infection exist for STm in the mouse model. Intraperitoneal or intravenous infection of 
susceptible strains of mice with attenuated STm provides a model to study synchronised disseminated 
infection that resembles many features of disseminated infection in resistant mice, such as induction of 
a low grade bacteraemia. However, intravenous infection is not reduced by the presence of immune 
sera thus, intraperitoneal immunisation has the added benefit of enabling the role of antibody in 
protection to be assessed. This may be because complement is not effective at killing STm in cell-free 
systems in the mouse (Siggins et al., 2011). Ideally, oral infection would be a suitable route as it 
resembles the natural route of infection and would enable mucosal responses to be assessed. However, 
attenuated strains do not necessarily colonise effectively when orally administered and other factors, 
such as resistance to innate barriers, including gastric acid or bile can affect interpretation of results. 
 
1.4.6 Innate Immune Regulation of Salmonella Infection 
During the early phase of infection (the first week) of mice with STm numerous phagocytic cells, 
including neutrophils, macrophages, and natural killer (NK) cells rapidly increase in infected sites. These 
innate cells act to restrict bacterial growth and dissemination before establishment of adaptive immunity 
(Jepson and Clark, 2001; Johansson et al., 2006; Mastroeni and Sheppard, 2004). This is achieved 
through mechanisms such as intracellular killing and the actions of numerous soluble mediators, 
including cytokines and complement components. 
 
1.4.6.1 Role of Cytokines 
Early inflammation is orchestrated by these soluble innate effectors such as tumour-necrosis factor 
alpha (TNF-alpha), which is required for the formation and maintenance of macrophage-rich focal 
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lesions in the tissue called granulomas, which help contain infection (Mastroeni et al., 1999). The pro-
inflammatory cytokines, IL-12 and IL-18, produced by DC and activated inflammatory cells in response 
to pathogens (Janeway and Medzhitov, 2002) are crucial for immunity against virulent STm (Mastroeni 
et al., 1999; Mastroeni et al., 1996). The importance of IL-12 and IL-18 in immunity against STm has 
been attributed to their ability to promote release of IFNγ (Janeway and Medzhitov, 2002; Mastroeni et 
al., 1999; Mastroeni et al., 1996), which is instrumental in co-ordinating an effective immune response to 
STm through the activation of CAMs. Disruption of the IFNγ pathway impairs the ability to eliminate STm 
infection in mice (Hess et al., 1996; Mastroeni et al., 1996). The innate response initiated against STm is 
complex and requires both soluble mediators and innate effectors to act in a co-ordinated manner. This 
generates a potent response against invasive pathogens which breach basic immune mechanisms. The 
key function of innate immunity is to contain infection as innate immunity alone cannot resolve infection. 
Indeed, mice lacking functional T cells can contain STm infection for almost three weeks, after which 
uncontrollable bacterial growth occurs (Hess et al., 1996; Ravindran et al., 2005). 
 
1.4.6.2    Pattern Recognition Receptors in Innate Immunity to Salmonella  
1.4.6.2.1  Innate Recognition of Flagellin  
Flagellin is an important target of the innate and adaptive immune response to STm. Cytosolic flagellin 
is recognised by Ipaf and extracellular or endosomal flagellin, through TLR5. TLR5 recognises flagellin 
from both GN and Gram-positive bacteria (Hayashi et al., 2001; Means et al., 2003; Smith et al., 2003a). 
Amino acids residues 386-407 of TLR5 are necessary for recognition of flagellin, whilst the extracellular 
domain encompassing amino acids 1-386 appear important for signalling (Mizel et al., 2003). TLR5 is 
not expressed on conventional mouse DC or bone marrow derived macrophages (Means et al., 2003), 
but is expressed on the basolateral surfaces of murine CD11b+CD11c+ intestinal lamina propria DC 
(Jepson and Clark, 2001; Uematsu et al., 2006). TLR5 expression is not restricted to cells of the 
immune system as it is abundantly expressed on most types of epithelial cells as outlined in Table 1.2.  
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Mutating flagellin reveals that TLR5 recognises an evolutionary conserved site in flagellin which has 
been mapped to amino acids 89-96 of the N-terminal D1 domain (Andersen-Nissen et al., 2005; Smith 
et al., 2003a). This region is only exposed in monomeric flagellin, and during filament assembly contacts 
between adjacent flagellin monomers buries this site in the centre of the filament. Therefore, only 
monomeric flagellin induces TLR5 activity (Smith et al., 2003a). This TLR5 recognition site is also 
important for flagella motility, as mutations in this region compromise bacterial motility, as well as 
filament assembly (Andersen-Nissen et al., 2005). Interestingly, the α- and ε-Proteobacteria, including 
Campylobacter jejuni and Helicobacter pylori, which require flagella-mediated motility for colonisation 
and persistence in their hosts, synthesise flagellin molecules which circumvent recognition by TLR5, yet 
retain motility. This has been shown to be due to differences in this site that permit TRL5 evasion, but 
retain motility (Andersen-Nissen et al., 2005). 
 




Cell Type Host Reference 
 
Gastric Epithelial Cells 
 
Human Cell Lines 
 
(Smith et al., 2003b) 
 
Intestinal Epithelial Cells 
 
Mouse 
Human Cell Lines 
 
(Gewirtz et al., 2001) 
(Rhee et al., 2004) 
 
Lung Epithelial Cells 
 
Human Cell Lines 
 
(Blohmke et al., 2008) 
 
Uterine Epithelial Cells 
 
Human Cell Lines 
 




Human Cell Lines 
 




Human cell Lines 
 
(Jin and Kang, 2010) 
 

















(O'Mahony et al., 2008) 
33 
 
Upon flagellin binding, TLR5 dimerises enabling signalling through the adaptor molecule myeloid 
differentiation factor 88 (MyD88) and the serine kinase IRAK. This leads to the release of numerous pro-
inflammatory mediators including TNF-alpha, IL-1, IL-6 and iNOS, which depends on activation and 
translocation of the nuclear factor transcriptional factor NF-Κ into the nucleus (Eaves-Pyles et al., 
2001; Janeway and Medzhitov, 2002; Underhill, 2007).  
 
In addition to detection by TLR5, intracellular flagellin within the macrophage inflammasome is 
recognised through the cytoplasmic NLR Ipaf (Franchi et al., 2006; Miao et al., 2006). Ipaf is activated in 
response to flagellin delivered through the SPI1 T3SS. Therefore, Ipaf may respond to bacteria 
expressing both flagellin and virulence factors. Additionally, NAIP5 (NLR apoptosis-inhibitory protein 5) 
which forms hetero-oligomers with Ipaf (Damiano et al., 2004), has been proposed to be involved in 
sensing cytosolic flagellin (Molofsky et al., 2006) through the conserved carboxy-terminal domain of 
flagellin (Lightfield et al., 2008). Therefore, TLR5 and Ipaf both recognise different, but conserved 
domains of flagellin. Ipaf activation leads to processing of pro IL-1β by caspase 1 and release of pro-
inflammatory cytokines upon activation of the inflammasome (Franchi et al., 2006; Kanneganti et al., 
2007). Ultimately, the impact of flagellin on the innate immune system is profound. TLRs and NLRs work 
to activate pro-inflammatory transcription factors, trigger phagocytosis and promote bacterial killing 
(Vijay-Kumar et al., 2007).  
 
1.4.6.2.2 Innate Recognition of LPS  
LPS induces signalling through TLR4 (Poltorak et al., 1998). Recognition of LPS by TLR4 is complex 
and requires additional accessory molecules, including a soluble acute phase protein, LPS-binding 
protein (LBP) which recognises LPS and transfers it to the LPS co-receptor CD14 (Tobias et al., 1986). 
CD14 is a high affinity LPS receptor that can either be secreted into the serum, or expressed as a 
glycophospho-inositol linked protein on the surface of macrophages (Wright et al., 1990). Signalling also 
requires MD-2, which is physically associated with the extracellular region of TLR4. Activation of TLR4 
34 
 
can lead to MyD88-dependent or independent signalling to stimulate production of various pro-
inflammatory mediators (Kawai et al., 1999).  
 
TLR2 recognises a broad range of microbial products (Table 1.1) by forming heterodimers with either 
TLR1 or TLR6 (Janeway and Medzhitov, 2002). TLR2 has also been reported to recognise LPS 
preparations from non-enterobacteria (Smith et al., 2003b; Werts et al., 2001). These LPS structures 
differ from the typical LPS recognised by TLR4, in the number of acyl chains in Lipid A (Netea et al., 
2002). However, the recognition of LPS by TLR2 remains inconclusive (Hashimoto et al., 2004). Indeed, 
LPS preparations contain trace amounts of endotoxin protein contaminants, and TLR2 is extremely 
sensitive to these proteins which are difficult to separate when purifying LPS (Hirschfeld et al., 2000).  
 
1.4.7 Cell-Mediated Immune Regulation of Salmonella Infection 
In terms of enteric infections caused by STm, such infections in humans are entirely controlled by innate 
immune effectors. However, in relation to the mouse model of NTS infections caused by STm, the 
innate immune system restricts the initial growth of STm but is incapable of eliminating STm from the 
host. During infection STm transitions from an extracellular to an intracellular phase, predominantly 
residing in specialised Salmonella-containing vacuoles (SCVs). This enables evasion of host 
antimicrobial defences (Vazquez-Torres et al., 1999) by preventing phago-lysosomal fusion, and 
delaying vacuole acidification (Salcedo et al., 2001). The intracellular location of STm requires cell-
mediated immunity for control whilst the extracellular dissemination requires humoral control in terms of 
invasive STm infection. 
 
Clearance of STm in the mouse model requires Th1 CD4 T cells (Pie et al., 1997), but optimal immunity 
requires both cell mediated immunity and antibody (Mastroeni et al., 2000). T cell deficient mice or mice 
where total CD4 T cell responses are defective exhibit a persistent burden of infection, and become 
chronically ill as uncontrollable bacterial growth occurs and mice fail to clear the infection leading to a 
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progressive, usually fatal increase in bacterial numbers (Mastroeni et al., 1992; McSorley and Jenkins, 
2000). In contrast, mice deficient in MHC class-I restricted T cells or γδ T-cells resolve infection (Hess et 
al., 1996). This requirement for CD4 T cells has been attributed to the ability of CD4 Th1 cells to induce 
IFNγ, which activates CAMs to kill STm (Mittrucker et al., 2000).  
 
1.4.7.1 Target antigens of the CD4 T cell response  
Infection with STm generates substantial numbers of STm-specific CD4 T cells which expand rapidly 
following encounter, and these cells persist at high frequency for several weeks until bacteria are 
eliminated (McSorley et al., 2002a). Few T cell epitopes from STm have been characterised, and of 
these, flagellin is the one most consistently recognised. Flagellin is a major target of the CD4 T cell 
response to STm in both humans and mice infected with STm (Bergman et al., 2005; Cookson and 
Bevan, 1997; McSorley et al., 2000; Sztein et al., 1994). Indeed, some T cells isolated from STm 
infected mice can be detected in the memory population months after infection which remain 
responsive, and the predominant recall antigen for CD4 T cells from STm infected mice is flagellin 
(Cookson and Bevan, 1997; Srinivasan et al., 2004). 
 
CD4 T cells responding to flagellin produce IFNγ but not IL-4, reflective of a Th1 response, and this 
antigen-specific recall response to flagellin is sufficient to protect naïve mice against lethal challenge 
with a virulent strain of STm (McSorley et al., 2000). Interestingly, the CD4 T cell response to flagellin 
(or STm) is not identical in every site. It is highly dependent upon the initial site of infection where 
activation is first seen in the draining secondary lymphoid tissues. This was demonstrated using TCR 
transgenic FliC-specific CD4 T cells (SM1 T cells), which enables direct visualisation of CD4 T cell 
responses to STm flagellin in vivo (McSorley et al., 2002a). Following oral STm infection, adoptively 
transferred SM1 T cell proliferate rapidly in mucosal gut-associated lymphoid tissues (PP and MLN) 
(within 3 hours), whereas in the spleen and liver SM1 T cells are not activated, even by day 3, despite 
the presence of bacteria in both these sites (McSorley et al., 2002a). In contrast, after intravenous 
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infection SM1 T cells were activated in the spleen, but not in the MLN (Srinivasan et al., 2004), 
demonstrating a more complicated response in vivo. 
 
A number of epitopes have been recognised in flagellin (residues 339-350) as the minimal region 
capable of stimulating proliferation of CD4 T cells from STm-infected mice (Cookson and Bevan, 1997). 
Interestingly, these CD4 T cell epitopes within flagellin are localised within the conserved N and C-
terminal regions (D0 and D1 domain), the same domains recognised by TLR5 (Bergman et al., 2005). 
These epitopes are conserved between FliC and FljB and other flagellated gamma-proteobacteria 
(Alaniz et al., 2006; Bergman et al., 2005; McSorley et al., 2002a; McSorley et al., 2000). Therefore, 
STm infection generates innate and adaptive immune responses to multiple regions of flagellin, but 
predominantly targets the highly conserved domains (Bergman et al., 2005; McSorley et al., 2000).  
 
1.4.7.2  Properties of Flagellin 
1.4.7.2.1 Effects on the Immune System  
Not only is flagellin a target of the innate and adaptive immune system, but it is a powerful and effective 
adjuvant, as it is capable of enhancing antigen-specific CD4 T cell and B cell responses to itself and co-
administered antigen (Bergman et al., 2005; Cuadros et al., 2004; Cunningham et al., 2004a; Salazar-
Gonzalez et al., 2007; Uematsu et al., 2006). For instance, immunisation with flagellin-OVA fusion 
peptides can augment the total number of proliferating OVA specific CD4 T cells relative to 
immunisation with OVA alone (Bates et al., 2009; McSorley et al., 2002b). The ability of flagellin to 
modulate CD4 T cell responses is related to its capacity to induce maturation of DC (Huleatt et al., 2007; 
McSorley et al., 2002b; Sanders et al., 2006), in a TLR5 dependent manner (Bates et al., 2009). Indeed, 
incubation of splenic and bone marrow-derived murine DC with flagellin can induce up-regulation of 
MHC II and co-stimulatory markers (CD80 and CD86) (Didierlaurent et al., 2004) which can encourage 




1.4.7.2.2 Characteristics of the Immune Response to Flagellin 
The direction of B cell switching to flagellin when flagellin is presented in its native context, bound to live 
STm is predominantly to IgG2a, indicative of a Th1 response (Cunningham et al., 2004a). In contrast, 
when flagellin is presented as a recombinant soluble protein, sFliC, or a polymeric form purified from 
STm, it is to IgG1 (Cunningham et al., 2004a), which mirrors the response seen against haptenated-
protein antigens. Thus, the context in which flagellin is encountered by APC appears to influence the 
outcome of the immune response. This Th2-bias of responses to flagellin is supported by in vivo studies 
which demonstrate that activation of TLR5 by flagellin can induce MyD88-dependent OVA-specific CD4 
Th2 responses (Didierlaurent et al., 2004).  
 
1.4.7.2.3  Evasion of Cell Mediated Immunity 
Several reports have focussed on differential flagellin expression during infection. Although STm 
expresses flagellin when replicating in vitro (Cummings et al., 2006), once it establishes an intracellular 
state during infection it is not clear whether flagellin is still actively expressed. Indeed, during transition 
from an extracellular to an intracellular phase STm triggers changes in antigen expression (Cummings 
et al., 2006; Lucas and Lee, 2000). This was elegantly demonstrated in a study where FliC-specific CD4 
T cell proliferation was assessed ex-vivo, using antigens derived from bacteria grown in conditions 
which mimicked the extracellular or intracellular environments. This showed that T cell responses to 
extracellular phase bacterial antigens were greater compared to intracellular phase antigens, which 
were unable to support expansion of FliC-specific T cell populations in vitro (Cummings et al., 2005). 
This suggested that the antigen specificity of these T cells was directed against antigens which were 
only expressed by bacteria during their extracellular growth phase. 
 
During growth inside macrophages at systemic sites such as the spleen and liver (Cummings et al., 
2005), intracellular STm repress FliC transcription and its expression at the protein level below the 
threshold required to stimulate DCs in vitro (Bergman et al., 2005), thereby diminishing innate 
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recognition. Artificially introducing flagellin during infection enables STm-infected antigen-presenting 
cells to stimulate FliC-specific T cells (Cummings et al., 2005). This repression of flagellin by 
intracellular STm may be dependent on the PhoP-PhoQ two-component system (Cummings et al., 
2006; Galan and Curtiss, 1989b; Groisman, 2001). Additionally, during intracellular growth STm can 
reduce the ability of antigen-presenting cells to present FliC to CD4 T cells by confining its expression to 
SCVs, which are not accessible to antigen-presenting cells, thereby reducing its bioavailability (Alaniz et 
al., 2006). Thus, intracellular localisation of STm naturally compartmentalises FliC which directly affects 
DC mediated activation of FliC-specific T cells, which may limit activation of host immune responses. 
 
1.4.8 B Cell Mediated Control of STm Infection 
The role of antibody in immunity to STm is incompletely defined. There is an essential role for CD4 T 
cells (Hess et al., 1996) and a dispensable role for antibody for the effective resolution of primary 
infection with attenuated STm. Indeed, B cells are not necessary at all to control primary infection with 
attenuated STm, as mice lacking B cells do not succumb to infection (Mastroeni et al., 2000; McSorley 
and Jenkins, 2000; Mittrucker et al., 2000).  
 
Although antibody cannot prevent the progress of an established primary infection with attenuated STm 
in innately susceptible mice, or clear bacteria from the tissues, antibody can increase the efficiency of its 
clearance during secondary responses (McSorley and Jenkins, 2000). Furthermore, antibody induced 
during infection can help restrict bacteraemia during primary infection (Cunningham et al., 2007), whilst 
vaccination of adults against typhoid with purified polysaccharide Vi antigen from ST, a wholly TI antigen 
is sufficient to protect against invasive disease (Acharya et al., 1987; Guzman et al., 2006; Klugman et 
al., 1996). Additionally, passive transfer of serum protects genetically resistant mice to challenge with 





In SSA NTS infections can cause a progressive bacteraemia, killing around 50% of infected individuals. 
It has been hypothesised, that this bacteraemia may arise as cell-mediated effectors fail to control the 
intracellular infection, enabling rapid extracellular growth (MacLennan et al., 2008). Cell mediated 
immunity does not protect against bacteria in the blood, and antibody and complement become critical 
for controlling this extracellular growth. Indeed, the peak risk of disseminated infection where 
bacteraemia is pronounced occurs between the ages of 6 and 24 months, correlating with loss of 
maternal antibody and before acquisition of humoral immunity (MacLennan et al., 2008). Furthermore, 
although individuals who lack components of IL-12 or IL-23 signalling display more severe STm 
infections, and have greater disseminated infections in tissues compared to patients with a defect in 
IFNγ alone (MacLennan et al., 2004), these patients generate serum anti-STm IgG and do not die from 
NTS infections, suggesting a requirement for humoral immunity against NTS infections. 
 
Nevertheless, optimal immunity is seen when both cell-mediated and antibody are present (McSorley 
and Jenkins, 2000). Indeed, the simultaneous adoptive transfer of immune serum and cellular immune 
effectors is necessary to protect naïve innately susceptible mice from challenge with virulent STm. The 
transfer of immune cells or serum alone cannot confer protection (Mastroeni et al., 1993). Thus, unlike 
many other intracellular pathogens, both antibody and T cells are involved in resistance to challenge 
with STm (Mastroeni et al., 2000; Mastroeni et al., 1993; Mittrucker et al., 2000).  
 
1.4.8.1 Mechanism of action of antibody to STm 
In humans, both bactericidal and opsonising antibody are important in immunity to STm (Casadevall, 
1998; Siggins et al., 2011). Indeed, sera from healthy Malawian children containing anti-STm IgG and 
IgM antibody displays bactericidal activity against NTS (MacLennan et al., 2008). This study showed a 
correlation between complement deposition and antibody titre. This suggests that cell-free antibody-
dependent complement-mediated killing, through the induction of membrane attack complex, may be 
important against NTS bacteraemia in humans, but not mice (Siggins et al., 2011). Antibody in mice 
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probably contributes to protective immunity through opsonising the bacterial cell surface, and thereby 
facilitating uptake by macrophages (Hsu, 1989). 
 
1.4.8.2 Features of the antibody response to STm 
STm induces an atypical antibody response in mice which differs from classical TD antibody responses 
(Cunningham et al., 2007). It is characterised by a rapid and massive TD EF antibody response, which 
persists throughout infection and markedly reduces bacteraemia (Cunningham et al., 2007). In contrast, 
the onset of GC, and therefore high affinity antibodies are not apparent until the infection is almost 
resolved, which differs significantly from classical Th2 responses in terms of kinetics (Cunningham et 
al., 2007). This study showed that the key component of antibody protection was the presence of IgG, 
which augmented protection of IgM, but was independent of the affinity of IgG. 
 
1.4.8.3 Antibody Targets in STm infection 
Antibodies against STm target bacterial surface antigens such as LPS, flagellin and lipoproteins (Brown 
and Hormaeche, 1989) as well as other surface components. Antigenic targets of B cells which confer 
protection against STm are not clear, and their identification and characterisation is required to aid 
development of effective vaccines against systemic NTS infections. 
 
Porins 
Immunisation with porin preparations isolated from a rough mutant of STm proved to be an effective 
immunogen, and could induce protection against STm infection (Kuusi et al., 1979). The protection 
conferred by porins has been related to their ability to induce protective humoral responses. Indeed, 
serum from typhoid patients largely recognises these proteins (Calderon et al., 1986; Ortiz et al., 1989), 
whilst Secundino and colleagues elegantly demonstrated that purified porins isolated from ST promoted 
marked, persistent antibody responses in mice in the absence of exogenous adjuvants. This long-lasting 
antibody response demonstrated specific bactericidal activity (Secundino et al., 2006). Interestingly, 
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despite the high degree of homology among porins isolated from different Salmonella serovars, serum 
from mice immunised with ST porins did not cross protect against STm (Secundino et al., 2006), 
demonstrating the species specificity of this antibody response. This ability of porins to elicit an immune 
response which can protect the host against infection has led to studies on the potential of porins from 
ST as vaccine candidates against typhoid (Salazar-Gonzalez and McSorley, 2005; Singh et al., 1999).  
 
Other Targets 
Antibodies against flagellin and LPS are used in serotyping Salmonella species (Brown and Hormaeche, 
1989; Frankel et al., 1989). However, despite the immunogenicity of flagellin, whether antibody to 
flagella can provide immunity to Salmonella remains unresolved. Historically, antibody to LPS has been 
shown to be strongly induced in response to infection (Brown and Hormaeche, 1989), which can confer 
high levels of protection against virulent strains of STm. Furthermore, antibodies directed against the O-
antigen of STm LPS have been demonstrated to enhance opsonisation of STm (Jorbeck et al., 1981).  
 
1.4.9 Vaccines 
Three vaccines have been developed against ST. The heat-killed phenol-preserved vaccine consisting 
of whole cells is no longer licensed in the UK, but is still in use today in some countries in spite of its 
high reactogenicity (Engels et al., 1998). Two newer vaccines are currently licensed for use in humans 
against typhoid and are widely used today, they are well tolerated and effective. This includes the A 
subunit of the ST polysaccharide antigen (Vi) (Robbins and Robbins, 1986) and the oral attenuated live 
bacterial vaccine Ty21a (Clemens et al., 1999; Germanier and Fuer, 1975; Guzman et al., 2006; Levine 
et al., 1989). Both these vaccines fail to induce long-lasting immunity, the Vi vaccine is considered to be 
protective for at least three years, whilst Ty21a for 5-7 years. Furthermore, neither Vi nor Ty21a are 
effective in infants less than 3 years of age. Consequently, vaccines comprising Vi-conjugated to TD 
protein carriers have been developed (Kossaczka et al., 1999; Lin et al., 2001).  
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There is currently no available vaccine against NTS for use in humans, and current antibiotic treatments 
are being confounded by the widespread development of drug-resistant strains. Importantly, many NTS 
STm isolates causing invasive disease are multiply antibiotic resistant (Gordon et al., 2008). Vaccination 
is an essential requirement for controlling NTS infections in SSA. In the murine model protective 
immunity can be conferred by immunisation of susceptible mice with live attenuated STm, but it is not 
known which antigens are responsible for inducing resistance, and further characterisation of isolated 
antigens based on specific virulence features, and knowledge of the immune response to them may 
prove beneficial in vaccine design. Interestingly, despite the effectiveness of antibody-mediated 
protection to ST induced by vaccines it does not appear that there is much cross-reactivity between ST 
and NTS. Whilst some antigens such as the Vi antigen are not present in STm, it is less clear why 
attenuated ST vaccines, which are antigenically more complex, should not cross-react. 
 
1.5 Helminth Infections 
1.5.1 Incidence and Pathology 
Almost half of SSA’s population is affected by one or more soil-transmitted helminth (de Silva et al., 
2003) and although mortality is a rare outcome from infection, heavy parasitic helminth burdens are 
associated with serious morbidity. Indeed, hookworm infections are the leading cause of iron deficiency 
anaemia and malnutrition worldwide, infecting nearly 800 million people (Hotez et al., 2004) with 
children disproportionately affected (Brooker et al., 2006). Sequela in this group can include profound 
physical and mental deficits (Hotez et al., 2008). Moreover, it is common in areas with high prevalence 
of parasitic nematode infections for individuals to carry multiple infections of several nematode species. 
Therefore, such infections have a staggering economic impact in endemic areas (Hotez et al., 2008).  
 
Helminths can have immunomodulatory effects on the host which may influence the response to other 
pathogens or antigens, and these may be positive or negative for the host (Cooper et al., 2001; Su et 
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al., 2005). Indeed, helminth infections are associated with diminished responses to BCG and cholera 
vaccination (Elias et al., 2008; Harris et al., 2009). Furthermore, soluble immunomodulatory parasite 
antigens can cross the placenta and significantly affect responses to antigens included in childhood 
vaccinations years later (Christian et al., 2004). The effects of helminth infections on the host are not 
always negative. Interestingly, allergic diseases are lower in helminth endemic areas (Lynch et al., 
1993; Scrivener et al., 2001) supporting the notion that childhood exposure to chronic helminths can 
direct the maturing immune system to develop tolerance to environmental antigens (Yazdanbakhsh et 
al., 2002). Moreover, helminths may reduce inflammatory disease caused by infection (Fox et al., 2000; 
Nacher et al., 2001) and offer a potential method of treating both immune dysfunction and auto-immune 
diseases. 
 
1.5.2 Host Immune Responses to Helminth Infections 
1.5.2.1 The classical Th2 response 
Helminth immunity requires Th2 cell-mediated responses involving multiple cell types including CD4 T 
cells, eosinophils, basophils, mast cells, epithelial and smooth muscle cells, and IgE production by B 
cells whilst Th1 responses can inhibit immunity (Finkelman et al., 1997; Urban et al., 1991). In humans 
the production of IL-4 and IL-13 correlates with a protective immune response against helminths (Turner 
et al., 2003) and this is also supported by experimental murine models, which show key roles for these 
cytokines in effective worm expulsion (Barner et al., 1998; Dehlawi et al., 2006; Horsnell et al., 2007).  
 
1.5.2.2 Th2-induced changes in gut physiology 
Clearance of helminths from the intestine requires integrated physiological and immunological 
responses. In addition to immune cell recruitment, the response is characterised by changes in gut 
physiology to establish a hostile environment for the parasite (Bancroft et al., 1998; Finkelman et al., 
2004; Urban et al., 1992). This includes: enhanced gut motility through hyper-contractility of intestinal 
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smooth muscle cells (Zhao et al., 2003), increased luminal fluid secretions, enhanced epithelial cell 
permeability and accelerated cell turn-over, all of which are mediated by Th2 associated factors such as 
STAT-6 signalling (McKenzie et al., 1998; Zhao et al., 2003). Worm expulsion is facilitated by increased 
mucus production from goblet cells which affect worm viability by inhibiting parasite motility (Lee and 
Biggs, 1990) and their ability to feed (Rothwell, 1989). Goblet cell hyperplasia is dependent on IL-4 and 
IL-13 induced STAT-6 signalling (Hershey, 2003; Khan et al., 2001; McKenzie et al., 1998).  
 
1.5.2.3 Role of Antibody 
In humans, parasitic nematode infections fail to induce immunity to re-infection. Antibodies may protect 
against re-infection, as shown using maternal-derived antibodies in murine models (Harris et al., 2006). 
It has been proposed that antibodies may promote recruitment of effector cells to neutralise secretory 
products produced by helminths. Nevertheless, the importance of antibody in primary and secondary 
infections, and the potential mechanisms by which they may execute their function is largely unknown. 
 
1.5.3 Nippostrongylus brasiliensis 
The nematode, Nippostrongylus brasiliensis belongs to the phylum Nematoda which also includes 
whipworms, and filarial parasites (Camberis et al., 2003). N. brasiliensis is a natural parasite of rats and 
has been adapted for use in mice. It provides an acute model of gastrointestinal nematode parasite 
infection, and is used as a model of hookworm disease, as its lifecycle is analogous to the human 
hookworms N. americanus and A. duodenale, important parasitic pathogens that cause the most 
common neglected tropical disease in SSA (Bethony et al., 2006). 
 
The typical hookworm lifecycle consists of cutaneous invasion of the host by newly hatched infective 
third-stage (L3) larvae residing in the soil, or less commonly by oral ingestion (Fig 1.9). After infiltration, 
larvae migrate to the lungs through the vasculature where molting occurs to enable emergence of L4 
larvae. These migrate out from capillaries, through the alveoli and into the bronchi where they are 
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coughed and swallowed into the small intestine. Here worms complete their development into sexually 
mature adults (L5), which mate and produce eggs which are passed in the faeces (Camberis et al., 
2003). The lifecycle of N. brasiliensis is analogous to the human hookworm, as larvae reach the lung 
within hours of infection and establish a definitive adult stage in the proximal half of the small intestine 
by day 5-8 (Camberis et al., 2003). Pathology occurs in the intestine with considerable damage to the 
host intestinal architecture (Horsnell et al., 2007).  
 
                                                                                              
 
 
1.5.3.1 N. brasiliensis induced Immune Response 
N. brasiliensis infection results in potent systemic and mucosal Th2 responses required for parasite 
expulsion (Finkelman et al., 1997; Horsnell et al., 2007; Mearns et al., 2008). This Th2-response is host 
protective and can lead to rapid worm expulsion following primary immunisation. IL-4 is dispensable for 
N. brasiliensis expulsion, but clearance does require signalling of IL-13 through IL-4Rα and activation of 
the STAT6 pathway (Barner et al., 1998; Urban et al., 1998). The loss of IL-13 or impairment in IL-13 
signalling is characterised by the failure to expel N. brasiliensis, and infection is associated with higher 
fecundity (Barner et al., 1998; McKenzie et al., 1999).  
Figure 1.9 Expulsion of N. brasiliensis in BALB/c 
mice after s.c infection: Eggs are passed in the 
faeces and 500 infective third-stage (L3) Nb larvae are 
administered s.c. Larvae infiltrate through connective 
tissue and migrate through the vasculature to the lungs 
within hours of infection. Larvae migrate through the 
trachea and emerge in the proximal half of the small 
intestine by day 5-8 where worms complete their 
development and mate to produce eggs which are 
passed in the faeces. Larvae are absent from the lungs 
from day 4 of the infection despite a persistent Th2 
response. In an immune-competent mouse Nb is 
normally expelled by day 9-11 (Camberis et al., 2003). 
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1.6 Summary and Aims 
NTS infections are huge, yet poorly-recognised problems in SSA where such infections can be typified 
by invasive disease associated with high case-fatality rates. Antibiotic resistance is an increasing 
problem and the development of a vaccine is urgently required. Immunity to STm is complex, and during 
primary responses protective immunity is provided by CD4 Th1 cells through their ability to invoke 
macrophage activation. However, during secondary responses optimal protection also requires B cells. 
This highlights that effective resolution of STm infection encompasses aspects of innate, cell-mediated, 
and humoral immunity. Therefore, an integrated approach is required to understand how immunity is 
executed. In addition, helminth infections are endemic in SSA and the likelihood of co-infection with 
STm is reasonable. This can further complicate immunity to infection given the documented 
immunomodulatory influences of helminths on host immunity, demonstrating a highly complicated 
relationship between the host and pathogen.  
 
This study aims to examine the adaptive immune response to STm, and in particular, the individual 
contribution of component surface antigens in immunity, and to identify their influence on protective 
immunity during primary and secondary STm infections. Specifically, this study will focus on the cell 
mediated and humoral immune response to flagellin and OMPs. Furthermore, this thesis aims at 
identifying whether intestinal parasitic co-infection with STm, confounds the development of the 




2.0 Materials and Methods 
 
2.1 Animals Used 
For animal studies mice were age and sex-matched and between the ages of 6-12 weeks. Wild type 
(WT) C57BL6/J or BALB/c mice were obtained from HO Harlan OLAC Ltd. (Bicester, U.K) or from 
colonies maintained in the University of Birmingham Biomedical Services Unit (BMSU) for experiments 
performed in the UK. For experiments conducted in Cape Town WT mice were sourced from in-house 
colonies from the animal facility at The University of Cape Town (UCT). All genetically modified mice 
used were sourced from in-house colonies in the BMSU and the original source is provided in Table 2.1. 
All mice were bred and maintained under specific-pathogen free conditions.   
 
At indicated time points, mice were sacrificed by a schedule 1 method in accordance with Home Office 
guidelines (UK) or sacrificed by CO2 asphyxiation in accordance with UCT guidelines (Cape Town). 
Animal studies were performed with ethical approval from both the UK and UCT Research Animal 
Ethics Committees. 
 
2.2 Antigen Preparation for Immunisation 
2.2.1 Bacterial Antigens 
The attenuated Salmonella enterica serovar Typhimurium SL3261 (STm) strain was used throughout.  
SL3261 is a well-studied vaccine strain which confers protection to re-challenge with virulent STm 
(Hormaeche, 1991). All STm strains used and their sources have been identified in Table 2.2. Most of 
the strains used were provided by Dr. RA Kingsley (Wellcome Trust Sanger Institute, Cambridge) and 





Table 2.1: Genetically modified mouse strains used and their sources 
Table provides the source and phenotype of mice used throughout the study for experiments performed 














αβTCR transgenic specific for STm flagellin 
peptide residues 427-441 bred to Rag-2 deficient 
mice 
 
Source: Professor Paul Garside  
              University of Strathclyde. 





Disruption of Rag 1 gene causing early arrest of B 
and T cell development  
 
 
Source: Professor Peter Lane 
              University of Birmingham 
             (Mombaerts et al., 1992b)   
 
OTII Boy J 
(Cogenic  CD45.1) 
 
αβTCR transgenic specific for chicken ovalbumin 
peptide residues 323-339 in the context of H-2 I-Ab 
which has been crossed to CD45.1+ C57BL6/J 
cogenic mice 
 
Source:  Charles River  





Impaired IL4 and IL-13 signalling via deficiency of 
the IL-4 receptor alpha chain following Cre-
mediated recombination of the IL4-receptor alpha 
allele through the cre/loxP system. 
 
Source:  Professor James Alexander  
               University of Strathclyde 





Homologous recombination of IL-10 with a 
neomycin cassette 
Mice develop chronic enterocolitis 
 
Source:   Charles River 





Disruption of T-bet gene by homologous 
recombination 
 
Source:  Jackson Laboratory 





Absent δ and αβ T cells through targeted deletion 
of beta and delta TCR genes  
 
Source:  Jackson Laboratory 
              (Mombaerts et al., 1992a) 
 
IgH deficient  
 
B-cell deficient. Generated from breeding out the 
QM IgH transgene from QM mice, which have the 
other IgH locus inactivated. 
 
Source:  Dr Kai Toellner 
               University of Birmingham 
              (Cascalho et al., 1996) 
 
TLR5-deficient 
(C57BL/J x 129/Sv 
background) 
 
Targeted deletion of TLR5 
Reduction of serum cytokines in response to 
flagellin 
 
Source:  Professor Bernhard Ryffel; 
               Toulouse, France 




Table 2.2: Bacterial strains used 
Table lists all the STm strains used throughout the study. The methods used to generate specific strains 
are outlined in Appendix B. 
 






(Hoiseth and Stocker, 
1981) 
 
Attenuated Salmonella Typhimurium aroA--deficient strain 
Attenuated through insertional mutagenesis of aroA using aroA554::Tn10  






(Serre et al., 2008) 
 
Attenuated Salmonella Typhimurium aroA--deficient strain 
Constitutively expresses OVA under Tac promoter 







Attenuated Salmonella Typhimurium aroA--deficient strain 
Constitutively expresses GFP under Tac promoter 




(Hoiseth and Stocker, 
1981) 
 




Robert A. Kingsley 
 
Attenuated Salmonella Typhimurium aroA--deficient strain 
Phase-locked to express FljB only (termed locked-ON) 




Robert A. Kingsley 
 
Attenuated Salmonella Typhimurium aroA--deficient strain 
Phase-locked to express FliC only (termed locked-OFF) 
SL3261 aroA OFF          
 
SW  564 
 
Robert A. Kingsley 
 
Attenuated Salmonella Typhimurium aroA--deficient strain 
Does not produce FliC or FljB so does not make flagella– (termed Aflagellated)  




Robert A. Kingsley 
 
OmpD-deficient attenuated Salmonella Typhimurium aroA--deficient strain 
Inactivation of OmpD through Tn10 Insertion 




Robert A. Kingsley 
 
OmpR-deficient attenuated Salmonella Typhimurium aroA--deficient strain 
Deletion of OmpR through red recombinase technology 
SL3261 aroA OmpR::Tn10 (tetR) 
50 
 
2.2.1.1 Bacterial Growth Conditions 
STm for infection studies was incubated overnight in Luria-Bertani (LB) broth (Invitrogen, Paisley, UK) at 
37°C with aeration (180 rpm) and STm for bacterial culture was grown on plates at 37°C. LB broth was 
supplemented with 2% w/v granulated agar (Melford Laboratories, Ipswich, UK) for plates. Media for 
growth was prepared by dissolving powders in deionised water (dH2O) and autoclaving at 121°C for 15 
minutes. Media was left to cool at room temperature prior to use. Where appropriate, culture medium 
was supplemented with antibiotics following filtration through a 0.22 μm filter (Millipore, MA, USA). 
Ampicillin was used at 50 μg/ml whilst Kanamycin and Tetracycline at 25 μg/ml.  
 
2.2.1.2 Infection with STm 
For studies addressing immune responses to flagellin (Chapter 3.0), following incubation STm was 
harvested as bacteria entered late log/early stationary phase (ODλ600 nm of 1.2-1.4) when flagellin 
expression is optimal. Cultures that had ODλ600 nm of >1.4 were disregarded due to the potential of 
having increased levels of dead cells. For studies addressing antibody responses to porins (Chapter 
4.0) STm was harvested at mid-exponential phase (ODλ600 nm of 0.5-0.8) for optimal OmpD 
expression, whilst STm was harvested at ODλ600 nm of 1.0 for the dual infection study (Chapter 5.0). 
 
For immunisation into the peritoneum 1 ml of bacteria were harvested by centrifugation at 6, 000 x g for 
5 minutes at 4°C. Pelleted cells were washed twice in sterile Phosphate Buffered Saline (PBS) (pH 7.4) 
(Sigma Aldrich, Dorset, UK) at 6, 000 x g for 5 minutes at 4°C prior to re-suspension in 1 ml PBS. 
Bacteria were diluted to give the appropriate infectious dose in a final volume of 200 μl PBS. Mice were 
infected at doses of 5x105 or 5x106 per mouse with attenuated bacteria (SL3261 strains) or infected with 
virulent bacteria (SL1344 strains) at a dose of 3x103 per animal. For oral infection studies with 
attenuated STm, STm was grown overnight until it reached ODλ600 nm of 1.4. Bacteria were then 
harvested at 3, 000 x g for 15 minutes at 4°C and re-suspended in PBS to a density of 1x1010 per ml. 
Bacteria were then diluted 1:1 with 3% NaHCO3 to obtain a dose of 1x109 per mouse (5x109 per ml). 
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Mice were immediately infected by oral gavage in a final volume of 200 μl. In each experiment the 
administered dose was confirmed using the Miles and Misra CFU counting technique by plating serial 
dilutions onto agar plates and incubating overnight at 37˚C (Miles et al., 1938).  
 
2.2.1.2.1 Infection with Heat-Killed STm 
For infection with heat-killed STm bacteria were harvested and washed as described. Once bacteria 
were diluted to 2.5x106 organisms per ml, cells were heat inactivated at 72˚C for 1 hour and mice were 
infected thereafter. Bacteria were plated to confirm the absence of live organisms. 
 
2.2.1.2.2 Infection with Serum-Opsonised STm 
For STm opsonisation studies the serum to be tested was heated at 56C for 30 minutes to inactivate 
complement prior to use. In each experiment two mice were tested with each serum, and at least three 
different sera were tested per group. After heat-inactivation, complement-inactivated sera were mixed 
with bacteria which had previously been harvested, washed and the bacterial concentration adjusted to 
2.5x106 organisms per ml. Sera was added at dilutions where antibody was at sub-saturation as 
determined by ELISA. Bacteria and sera were mixed under gentle agitation for 30 minutes at room 
temperature. Mice were infected with 5x105 bacteria and bacteria were cultured to ensure no loss of 
viability and to assess lack of agglutination. 
 
2.2.2 Parasite Antigens 
2.2.2.1 Maintenance of N. brasiliensis Life Cycle 
N. brasiliensis worms (originally provided by Klaus Erb, Wurzburg, Germany) were maintained by 
routine passage through Wister Rats every two weeks. Live third stage (L3) larvae were prepared in 
0.65% NaCl at 10, 000 larvae per ml. Six to eight rats were injected subcutaneously into the nape of the 
neck with 5000 larvae (500 µl) using 20G needles. At day 5 post-infection rats were transferred to 
gridded cages for faecal collection. The cages were lined with damp paper to keep the faecal pellets 
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moist. Faecal pellets from infected mice were collected daily from day 6 to 8 post-infection and soaked 
each day in MilliQ water containing fungizone (Gibco® Life Technologies). Pellets were emulsified and 
mixed into a paste-like consistency with an equal volume of activated charcoal and spread onto culture 
dishes. A culture dish consisted of a large petri dish containing a moist filter paper and square gauze, 
moistened in fungizone. The dishes were incubated in humidified containers at 25ºC for at least 5 days 
to allow L3 larvae to migrate to the edge of the filter paper. The outer layers of the filter paper containing 
the worms were removed and transferred to fresh culture dishes for further incubation where infective 
live L3 larvae were used for infectious studies.  
 
2.2.2.2 Preparation of N. brasiliensis for Infection 
For infection studies pieces of filter paper containing fresh L3 larvae were washed briefly in 0.65% NaCl 
to release the worms. Worms were counted using a dissecting microscope and diluted to 2500 worms 
per ml in NaCl. Mice were injected subcutaneously with 500 L3 larva in a final volume of 200 µl NaCl in 
an Animal Biosafety Level 2 Laboratory (Animal Unit, UCT). 
 
2.2.3 Protein Antigens 
 
1. Endograde® Ovalbumin was commercially obtained from Hyglos, Regensburg, Germany 
 
2. Soluble recombinant flagellin (sFliC) and sFliC bearing a modified TLR5 ligating motif (ΔTLR5) 
were generated as described in 2.2.3.1 and 2.2.3.2 respectively.  
 
3. Surface-isolated polymeric flagella was generated as described in 2.2.3.3 
 
4. Purified porins from ST (strain ATCC 9993) or STm (strain ATCC 14028) were generated by Dr. 
Cristina-Gil Cruz through repeated extraction with sodium dodecyl sulphate (SDS). The detailed 
methods used to generate them and the techniques used to functionally characterise them are 
outlined in Appendix C.  
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Protein antigens were diluted to 100 μg per ml in sterile PBS and mice were immunised intraperitoneally 
for 35 days with 20 µg unless stated otherwise. For studies with alum precipitated ovalbumin mice were 
immunised intraperitoneally with 50 µg ovalbumin precipitated in alum in a final volume of 200 µl. 
Briefly, ovalbumin was mixed with an equal volume of 9% alum (aluminium potassium sulphate (Sigma 
Aldrich, Dorset, UK)) and the pH was then adjusted to 7.0 using 10 M sodium hydroxide. This was then 
left to precipitate in the dark for 30 minutes at room temperature. Following precipitation, ovalbumin was 
washed three times in excess PBS and made up to volume for immunisation. On some occasions mice 
were co-immunised and infected with sFliC or alum precipitated ovalbumin and SL3261 respectively. 
Here, sFliC or alum precipitated ovalbumin was prepared at 100 μg per ml or 250 μg per ml, 
respectively and SL3261 was then added at 5x105. 
 
2.2.3.1 Soluble Recombinant Flagellin (sFliC) 
Soluble recombinant flagellin (sFliC) was isolated from STm as described (Cunningham et al., 2004a). 
In brief, fliC was amplified from SL3261 and ligated into pET22b+ (Merck Chemicals, Nottingham, UK) 
to create pET22b+ FliC Xho1 which contained a C-terminal His-Tag, a beta-lactamase gene which 
conferred ampicillin resistance, and expressed FliC under the control of Isopropyl β-D-
Thiogalactopyranoside (IPTG) induction of the Lac operon. This was transformed into chemically 
competent BL21 DE3 and sFliC was isolated following over-expression in LB. Here bacteria were 
incubated overnight at 37°C with aeration in LB supplemented with ampicillin. After incubation the 
culture was diluted 1:100 in fresh media and incubated at 37°C until mid-log phase (ODλ600 0.6-0.8) 
where IPTG (Promega, Southampton, UK) was added at a final concentration of 1 mM to induce sFliC 
expression. Culturing was continued post-induction for a further 2.5 hours after which the cell paste was 
harvested at 6000 x g for 20 minutes at 4°C.  
 
Protein purification was achieved through a two-step process. Initially, cells were re-suspended in 
Bugbuster (Merck Chemicals, Nottingham, UK) and agitated at room temperature for 20 minutes. The 
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cell lysate was spun at 16, 000 x g for 20 minutes at 4ºC to remove cellular debris. The resulting lysate 
was filtered through a 0.22 µm filter (Millipore, MA, USA) and incubated with Ni-NTA Sepharose 
(Qiagen, Hilden, Germany) for 45 minutes at room temperature. Flagellin was then purified by Nickle-
affinity chromatography using a disposable Polypropylene Column (Qiagen). After the lysate had 
passed through, the column was washed with five bed volumes of PBS and the His-tagged protein 
(sFliC) was eluted in 5 ml PBS containing 100 mM Imidazole (Melford Laboratories). sFliC was then 
extensively dialysed against PBS under gentle agitation at 4°C.  
 
After dialysis, sFliC was filtered and purified to homogeneity by affinity chromatography using an anti-
FliC monoclonal antibody in conjunction with Dr Margaret Goodall. Purified sFliC was then further 
dialysed and protein identity and purity was assessed by SDS-PAGE which revealed sFliC was present 
at the expected molecular weight (56 kDa), and that no contaminating proteins were detectable post 
affinity chromatography (Fig 2.1A). Protein concentration was determined using the BCA assay (Thermo 
Fisher Scientific, MA, USA). LPS contamination was assessed using the Sigma E-TOXATE Kit as per 
manufacturer’s guidelines and shown to be ≤1 Endotoxin Unit EU/300 μg. Sterile protein was stored at -
20ºC. The detailed methods for SDS-PAGE and protein quantification are described in Appendix C. 
 
2.2.3.2 Soluble Recombinant sFliC (ΔTLR5) 
Additionally, pET22b+ FliC Xho1 was further modified using the GeneEditor in vitro mutagenesis system 
(Promega) to delete the putative TLR5 binding site as described (Andersen-Nissen et al., 2005). The 
methods used to create the construct are outlined in Appendix B. The plasmid clone encoding the 
modified protein (ΔTLR5 sFliC) conferred resistance to ampicillin and expressed ΔTLR5 sFliC with a C-
terminal His-tag. It was over-expressed in BL21 and purified to homogeneity as described for sFliC. 
Protein identity and purity was determined by SDS-PAGE (Fig 2.1B). This revealed ΔTLR5 sFliC was 
present at the expected molecular weight and that no contaminating proteins were detectable post 
affinity chromatography.  
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2.2.3.3 Surface Isolated Polymeric Flagella 
Flagella were isolated from the surface of SL3261 by acid hydrolysis as described (Ibrahim et al., 1985). 
Briefly, bacteria were grown overnight and were diluted 1:100 in fresh LB the following morning where 
growth was continued until late-log phase (ODλ600 = 1.4). Bacteria were harvested at 6000 x g for 20 
minutes at 4°C and then re-suspended for an hour in acid at pH 2.0 under gentle agitation. This 
suspension was then spun at 100, 000 x g for 90 minutes at 4°C. The pH of the supernatant was 
restored to pH 7.4 before protein fractions were separated by size-exclusion chromatography in 
conjunction with Dr. Denisse Leyton. LPS content was assessed using the E-TOXATE Kit and shown to 

















Figure 2.1: Assessment of sFliC by SDS-PAGE: Purification fractions and purified proteins were analysed by 
SDS-PAGE and visualised using Gel-Code Blue: (A) Soluble Recombinant Flagellin (sFliC) was purified by His-
Tag purification and affinity chromatography. Lane 1: Fermentas PageRuler Plus. Lanes 2-3 His-Tag Purification 
fractions: Flow Through (2) and Elute (3). Lanes 4-5: Purified sFliC post-Affinity Chromatography. (B) Purified 
ΔTLR5 sFliC and sFliC were purified to homogeneity by His-Tag and affinity chromatography: Lane 1: Purified 
sFliC, Lane 2: Fermentas Page Ruler Plus and Lane 3: Purified ΔTLR5 sFliC. Proteins were separated using a 4-
20% gradient gel (Thermo Fisher Scientific). 
1             2              3             4    5 
A B 
 1        2        3            
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2.2.4 Lipopolysaccharide (LPS) 
TLR Grade LPS, which is isolated and purified from STm S-form, was commercially obtained (Axxora, 
Cambridge, UK (ALX-581-011-L002)) and has been highly purified to eliminate any cross-reactivity with 
TLR2. STm C5 LPS was purchased from List Biologicals, CA, USA (Product 225) and Single-Step 
Purified LPS (SSP) was prepared from this using the Phenol-Water extraction method originally 
described by Westphal, and Jann (1965). Additionally, SSP LPS was further purified as a phenol re-
extracted preparation through extensive washing in phenol and triethylamine, as described (Hirschfeld 
et al., 2000). LPS preparations were diluted to 100 μg per ml in PBS (pH 7.4) and mice were immunised 
intraperitoneally with 20 µg of the immunogen for 35 days unless stated otherwise.  
 
2.3 Experiment End-Point 
At defined time-points mice were anaesthetised and peripheral blood obtained by cardiac puncture. 
Cells were isolated from the peritoneal cavity for FACS (Fluorescence Activated Cell Sorting). The 
spleen was isolated and weighed for analysis by FACS, cytokine assessment by ELISA, 
immunohistochemistry and bacterial culture. The liver was also isolated for bacterial culture. Worm 
burdens were assessed in the small intestine and a section of the jejunum was retained for histology. All 
organs were isolated under aseptic conditions.  
 
2.4 Bacterial Culture 
The bacterial burden in the spleen and liver was determined by direct culturing. Tissues were disrupted 
in PBS (Sigma Aldrich, Dorset, UK) through a 70 μm nylon-cell strainer (BD Biosciences) and serially 
diluted in PBS. The diluted suspension was plated on LB agar supplemented with appropriate antibiotics 
and incubated overnight at 37ºC. Bacterial colonies were counted and the total CFU per organ was 




2.5 Assessment of Worm Burdens  
Adult worm burdens were determined from N. brasiliensis infected mice. The entire small intestines 
were removed from sacrificed mice and incised longitudinally before being placed in 10 ml of 0.65% 
saline. The intestines were incubated at 37˚C for 3 hours to enable the worms to migrate into the salt 
solution. The salt solution was poured into a petri dish and the intestinal fragments were discarded 
before adult worm burdens were counted under a dissecting microscope.  
 
2.6 Extraction of Cells Ex-Vivo 
 
2.6.1 Preparation of Splenocytes 
Single cell suspensions of splenocytes were obtained by disruption of the spleen in RPMI-1640 media 
supplemented with 10% heat-inactivated foetal calf serum (FCS) and 1% penicillin/streptomycin (P/S), 
followed by filtration through a 70 µm nylon cell strainer (BD Biosciences). Cells were then harvested at 
375 x g for 4 minutes at 4°C and erythrocytes lysed using ammonium chloride buffer for 4 minutes at 
room temperature (BD Biosciences). Cells were then washed in 10% FCS RPMI as before to remove 
residual lysis buffer and live cell density was determined using Trypan Blue staining to exclude dead 
cells.  
 
2.6.2 Preparation of Peritoneal Exudate Cells (PEC) 
Cells were isolated from the peritoneal cavity in 5 ml PBS (pH 7.4) to purify peritoneal cell populations. 
Isolated cells were washed in PBS at 375 x g for 4 minutes at 4°C. If cells were contaminated with blood 






2.7 Extracellular FACS Staining by Flow Cytometry 
Immunostaining of single cell splenocytes or PEC suspensions was carried out for 20 minutes at 4°C in 
FACS buffer (PBS containing 1% FCS, 2 mM EDTA and 1 mM HEPES). The antibodies used and their 
optimised concentrations are listed in Table 2.3. Before staining, cells were diluted in FACS buffer to 
obtain an equal cell density for each sample. Cells were then pelleted at 375 x g for 4 minutes at 4°C in 
V-bottom 96-well plates (Corning Life Sciences, Netherlands). Five million cells were used for assessing 
cell populations and one million cells were used as single colour controls for gating. Cells were 
incubated with anti-CD16:CD32 for 20 minutes to block CD32/FcγIIi and CD16/FcγII receptors, prior to 
staining. Cells were then pelleted and labelled for FACS analysis of B or T cell populations. Cells 
stained with biotinylated-antibodies were incubated as described and subsequently washed twice in 
FACS buffer prior to incubation with secondary, fluorochrome-conjugated strepavidin. After incubation, 
cells were washed prior to re-suspension in FACS buffer for acquisition of data. Samples were acquired 
on a FACS Calibur Cytometer (Becton Dickinson) and analysed using FlowJo 7.6.1 software (TreeStar). 
 
2.8 Splenocyte Stimulation and Cytokine Detection 
Intracellular cytokines were detected following re-stimulation of total splenocytes in-vitro with either anti-
CD3 or antigen-specific preparations, and cytokines measured by one of the following methods: 
 
2.8.1 Intracellular FACS Staining (ICS) 
Cytokines were detected by ICS using flow cytometry. For anti-CD3 stimulation a 24 well plate was pre-
coated overnight at 4°C with 10 µg/ml purified anti-mouse CD3 in PBS. Following incubation anti-CD3 
was aspirated and the wells were washed in PBS before cells were plated. For antigen-specific re-
stimulation, splenocytes were plated into a 48-well plate and cells were re-stimulated in the absence of 
anti-CD3, but in the presence of either sFliC or somatic NES at 5 μg/ml (the preparation of NES is 
described in section 2.10.1.3). Cells were plated at a density of 5 million splenocytes per well and all 
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stimulations were carried out in the presence of anti-CD28 at 1 µg per ml. Furthermore, in each re-
stimulation assay control wells containing only anti-CD28 were included. Cells were incubated at 37°C 
for 2.5 hours in the absence of the protein transport inhibitor monensin (GolgiStop) and then 2.5 hours 
in the presence of monensin as per manufacturer’s guidelines (BD Biosciences).  
 
After stimulation cells were surface stained as described. WT cells were stained for CD3, CD4 and 
CD62L. Antigen-specific SM1 cells were stained with Vβ2-biotin and visualised with SA-PerCP Cy 5.5, 
or CD45.2-phycoerythcin (PE) whilst OTII Boy J cells were stained with CD45.1-PE. Cells were then 
fixed and permeabilised using the Cytofix/Cytoperm Plus Kit as per manufacturer’s instructions (BD 
Biosciences). Intracellular staining was achieved by staining cells as described, but in permeabilisation 
buffer with APC- or PE-conjugated cytokine antibodies, or the isotype control antibodies as outlined in 
















Table 2.3: Antibodies used for Immunostaining  













Antibodies used for Extracellular FACS 
 
  Purified CD16 CD32  93 1:150 e-Bioscience Blocking FcγIII and FcγII 
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ELISPOT was performed using anti-mouse IFNγ antibody (XMG 1.2 – a kind gift from Prof. Peter Lane, 
Birmingham, UK) as capture antibody and a biotin anti-mouse IFNγ for detection. IL-4 ELISPOT was 
carried out with a mouse IL-4 ELISPOT kit (eBioscience, Hatfield, USA). In brief, plates (MultiScreen, 
Millipore, MA, USA) were coated overnight at 4°C with capture antibody at 10 μg/ml in PBS. Following 
incubation, plates were washed in PBS and blocked in PBS containing 1% BSA for 1 hour at 37°C. 
Splenocytes were added in triplicate at 4x105 cells per well and were stimulated with 5 μg/ml sFliC in the 
presence of 1 μg/ml anti-CD28 or were un-stimulated in the presence of anti-CD28 for 48 hours at 37°C. 
After stimulation cells were aspirated and plates extensively washed in PBS containing 0.05% Tween-
20. Plates were then incubated for 2 hours at room temperature with biotinylated anti-IL-4 (BVD6-24GB) 
or anti-IFNγ (XMG 1.2) (Pharmingen). Subsequently, plates were washed as before and then incubated 
with Streptavidin-peroxidase for 45 minutes at room temperature. Plates were then washed and the 
reaction was developed with 3-3’-diaminobenzidine tetrahydrochloride (DAB) (Sigma Aldrich) as per 
manufacturer’s guidelines. Plates were washed in dH2O and air-dried before spots were counted using 
the AID ELISPOT Reader System and AID software version 3.5 (Autoimmune Diagnostika, Germany). 
Counts were expressed as Spot-Forming Units (SFUs) per 4x105 splenocytes.  
 
2.8.3 Cytokine ELISA 
Intracellular cytokines were also detected by ELISA (Enzyme-Linked Immuno-Sorbent Assays). In brief, 
4x105 splenocytes were plated per well in NUNC Maxisorb flat-bottomed 96-well plates (Thermo Fisher 
Scientific). Cells were re-stimulated in a total volume of 200 μl with either anti-CD3 at 10 μg/well which 
was pre-coated overnight in PBS, somatic NES at 10 μg/well or heat-killed STm at 1x105 organisms per 
well. Control wells contained media only. Cells were incubated for 72 hours at 37ºC in a humidified 5% 
CO2 incubator. After incubation the supernatants were harvested and stored at -20°C. ELISAs were 
performed on these supernatants.  
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The composition of buffers used for Cytokine ELISAs is provided in Appendix A. Briefly, NUNC 
Maxisorp 96-well plates were coated overnight at 4°C with either 1 μg/ml purified anti-mouse IFNγ (R4-
6A2), IL-10 (JES5-16E3) (both BD Biosciences) or IL-13 (38213) (R&D Systems, Germany) capture 
antibody in coating buffer. Following incubation plates were washed four times in wash buffer and then 
incubated overnight at 4°C in blocking buffer. Three-fold dilutions of the samples were prepared in 
dilution buffer ranging from a 1/3 dilution to a 1/27 dilution, while recombinant mouse standards were 
diluted two-fold from either 100 ng/ml for IFN-γ or 200 ng/ml for both IL-13 and IL-10. After blocking, 
plates were washed as before and then incubated with the diluted standards and samples overnight. 
Following incubation, plates were washed and bound cytokines were probed with corresponding 
biotinylated rat anti-mouse monocolonal antibodies (XMG1.2 for IFN-γ, SXC-1 for IL-10 and 38213 for 
IL-13) for 2 hours at 37°C. Subsequent to further washing, plates were incubated for 1 hour at 37°C 
with alkaline-phosphatase conjugated strepavidin (AP) at 1:1000. Plates were then washed and probed 
with the ELISA substrate solution. The developing reaction was stopped by adding 25 μl of 1M NaOH 
and the absorbance was measured at 492 nm (against the reference measurement at 405nm) on a 
VersaMax microplate reader (Molecular Devices Corporation, Sunnyvale, CA, U.S.A).  
 
2.9 Cell Sorting 
 
2.9.1 Generation of Chimeras  
Chimeras were generated by adoptive transfer of sorted cell populations or total splenocytes. For total 
splenocytes, spleens from OTII Boy J or SM1 mice were pooled and splenocytes were isolated as 
described. The proportion of antigen-specific cells was determined from the total number of splenocytes 
by FACS. 10 million cells were usually transferred intraperitoneally into age and sex matched recipients 
(such as Rag1 deficient or WT animals) in a volume of 200 μl. On some occasions, PEC cells from mice 
previously immunised with porins were labelled (as described in Table 2.3) and B1b cells were purified 
to >98% purity by Roger Bird using a MoFlo high speed cell sorter (Dako, Ely, UK). Sorted cells were 
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harvested and washed at 375 x g for 4 minutes at 4°C. The cell density was then determined and 2x105 
cells were transferred intraperitoneally into B cell-deficient mice. Chimeras were usually immunised or 
infected 24 hours post-transfer and transferred cells identified by FACS at time of sacrifice. 
 
2.9.2 Cell Sorting for Real-Time RT-PCR  
Splenocytes from SM1-Rag1 deficient chimeras, SM1-OTII Boy J chimeras, SM1-WT chimeras, WT 
mice, T-bet deficient and IL-4Rα deficient mice immunised with sFliC or infected with STm, were 
isolated to enable purification of CD4 T cells. Purified CD4 T cells were then divided into effector and 
naïve populations on the basis of CD62L expression. In brief, splenocytes were labelled as described, 
except the entire population of recovered cells were stained. Cells were then re-suspended in 500 μl 
10% FCS RPMI and were sorted into naïve CD3+CD4+CD62Lhi and effector CD3+CD4+CD62Llo 
populations by Roger Bird using a MoFlo high speed cell sorter.  
 
SM1 cells from chimeras were defined as CD4+Vβ2+, these were the only lymphocytes present in SM1-
Rag1 deficient chimeras, or CD45.2+CD90.1+ in SM1-OTII Boy J chimeras. OTII Boy J cells were 
defined as CD45.1+ in OTII-WT chimeras. Sorts typically recovered 2x105 cells at >98% purity. Post 
sort populations were checked for purity and were immediately harvested, washed and frozen at -80ºC. 
 
2.10 Enzyme-Linked Immunosorbent Assay (ELISA) 
ELISA was used to assess antigen-specific antibodies in the blood pre and post-infection. Blood was 
collected at times of sacrifice from each animal and serum separated from clotted blood by 
centrifugation at 6,000 x g for 5 minutes. Serum was stored at -20˚C until required. 
 
2.10.1 ELISA Antigens 
Antibody-specificity was tested against various antigens including flagellin, purified porins and LPS 
which were described earlier. Here we describe the preparation of antigens specifically for ELISA. 
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2.10.1.1 Total STm Homogenate 
STm lysate was prepared by harvesting on overnight culture of STm at 6, 000 x g for 5 minutes. The 
cells were then re-suspended in PBS containing 0.01% NaN3 and were disrupted through vigorous 
agitation, using a mini bead-beater (Biospec Products) and 0.1 mm zirconia-silicon glass-beads. The 
concentration of the resulting homogenate was quantified using the BCA assay (Appendix C).  
 
2.10.1.2 Total Outer Membrane Proteins 
Total OMP preparations were prepared by 2% Triton X-100 extraction as described (Henderson et al., 
1997). Briefly, cells were harvested at an ODλ600 nm of 1.0 by centrifugation at 10, 000 x g for 10 
minutes at 4°C. Cells were washed in 10 mM Tris-HCl (pH 7.4) under the same conditions and re-
suspended in this buffer containing 2 mM PMSF (Roche). Cells were then disrupted using a French 
pressure cell at 20, 000 psi and harvested at 6, 000 x g for 10 minutes at 4°C to remove unbroken cells. 
The lysate was spun at 30, 000 x g for 90 minutes at 4°C and pelleted cell envelopes were incubated in 
10 mM Tris-HCl containing 2% Triton X-100 for 15 minutes at room temperature. This was then spun at 
30, 000 x g as before and the soluble OMPs were washed extensively in 10 mM Tris-HCl to remove the 
detergent. The total OMP preparation was re-suspended in this buffer and protein concentration was 
determined using the BCA Assay (Appendix C) before storage at -20°C.  
 
2.10.1.3 Somatic NES Antigen 
For re-stimulation assays and antibody ELISAs N. brasiliensis excretory-secretory antigen (NES) was 
prepared. Briefly, L3 stage larvae were harvested in 0.65% NaCl and re-suspended in a final volume of 
25 ml. Larvae were washed in dH2O containing 250 ng/ml fungizone followed by 5 washes in cold filter-
sterilised PBS containing 1000 U/ml penicillin (Invitrogen) and 1 mg/ml streptomycin (Invitrogen), with 
30 minute waiting periods between each wash step to allow worms to settle. The PBS was aspirated 
and larvae were snap-frozen in liquid nitrogen before being finely homogenized. The resulting 
homogenate was diluted 1:10 in PBS and spun at 6, 000 x g for 20 minutes at 4°C. Supernatants were 
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collected and filtered using a 0.22 μm syringe filter (Millipore Corporation). The concentration of the 
supernatant was quantified using the BCA Assay (Appendix C) and then aliquoted and stored at -80°C. 
 
2.10.2 Antibody Detection 
Relative serological antibody titres were assessed for specificity against these antigens by ELISA. 
Briefly, NUNC Maxisorp flat-bottomed 96 well plates (Thermo Fisher Scientific) were coated overnight at 
4°C with the antigen of interest at 5 μg/ml in carbonate coating buffer (Appendix A). Additionally, to 
detect serum IgM in chimeric mice, plates were coated with 10 µg/ml Rat anti-mouse IgM (MCA199, 
AbD Serotec, Oxford, UK). After coating, plates were blocked for 1 hour at 37ºC in blocking buffer, and 
then washed in wash buffer. Sera and secondary antibodies were diluted stepwise in dilution buffer 
starting at 1:10 or 1:20 and plates were incubated as before. After incubation, plates were washed and 
probed with AP-conjugated goat anti-mouse IgM (I:2000) or IgG, IgG1 and IgG2a (1:1000) secondary 
antibodies (Southern Biotech, AL, USA). Plates were then washed in wash buffer and signal detected 
using Sigma-Fast p-Nitrophenylphosphate (pNPP) tablets as per manufacturer’s guidelines. Plates were 
incubated with the substrate at 37ºC until desired positivity was obtained. Plates were read at λ405 nm 
using the softmax pro programme on a Emax Precision Microplate Reader (Molecular Devices).  
 
2.11 Histology 
2.11.1 Immunohistochemistry (IHC) 
IHC was carried out on spleens which were slowly frozen in liquid Nitrogen and stored at -80C until 
required. Prior to sectioning, spleens were mounted onto a chuck through a bed of OCT TissueTek 
compound (Dako, Glostrup, Denmark) and 5 μm sections were obtained on a cryostat (Bright 
Instruments, Huntington UK) and mounted onto four-spot slides (CA Hendley Essex Ltd, Essex UK). 
Sections were left to dry for one hour before fixation for 20 minutes at 4C in acetone, and dried before 
storing at -20C in polythene bags.  
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IHC was carried out as described (Toellner et al., 1996). In brief, slides were brought up to room 
temperature and hydrated in Tris buffer (pH 7.6) (Appendix A). Sections were subsequently kept in this 
buffer throughout. Primary antibodies were added at the optimum dilution for 1 hour and then washed 
twice for 5 minutes in fresh buffer. Secondary antibodies were initially adsorbed with normal mouse 
serum which was diluted 1:10 prior to addition to the slides. Slides were incubated with secondary 
antibodies for 45 minutes. All antibodies used are outlined in Table 2.4 and were prepared in Tris buffer 
at pH 7.6. Slides were then washed as before and strepavidin-complex with alkaline phosphatase (AP) 
was added (Dako, Glostrup, Denmark) for 30 minutes. Horse-Radish Peroxidase (HRP) and AP 
reagents were developed sequentially using DAB and napthol AS-MX phosphate with Fast Blue salt, 
respectively (Appendix A). After development slides were washed in Tris buffer (pH 7.6) and then dH2O. 
Slides were dried at room temperature prior to mounting with coverslips using Immu-mount (Thermo 
Electron Corporation). Photographs were taken using a  Leica CTR6000 microscope (Leica, Milton 
Keynes, UK) and QCapture software. Images were processed using Image J. 
 
IHC was used to ascertain the area of the follicle occupied by GC and quantify cell populations. For 
GCs, sections of spleen were stained for PNA and IgD. Using a graticule the number of intercepts that 
fell on GC (PNA+), as well as the total number of intercepts that covered the entire follicle were counted, 
and from this the percentage of grid intercepts occupied by GCs was calculated. Individual cells were 
quantified per square millimetre using a point counting technique.  
 
2.11.2 Periodic Acid Schiffs (PAS) Staining 
For mice infected with N. brasiliensis a portion of the jejunum was retained for PAS staining to view 
goblet cells and assess intestinal mucus production. The jejunum was stored in 4% phosphate buffered 
formalin before embedding in paraffin wax. Sections for histology were generated at 5-7 μm and stained 
with Periodic Acid Schiffs (PAS). The embedding, sectioning and staining was carried out by the 
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Department of Histology, Groote Schuur Hospital, Cape Town and is described in Appendix A1. 
Photographs were taken as described.  
 
Table 2.4: Antibodies used for Immunohistology 
Table shows primary and secondary antibodies used for histological staining of spleen tissues.  
 
Target Isotype Dilution Source 
Primary Antibodies 
CD3 Rat anti-mouse 1:500 Serotech, Oxford, UK 
IgD Sheep anti-mouse 1:1000 The Binding Site, Birmingham 
IgM Rat anti-mouse 1:600 Serotech, Oxford, UK 
IgG1 Rat anti-mouse 1:400 Serotech, Oxford, UK 
IgG2a Rat anti-mouse 1:300 Serotech, Oxford, UK 
PNA Biotin 1:100 Vector Laboratories 
CD138 Rat anti-mouse 1:200 BD Biosciences 
Secondary Antibodies 
Rabbit anti-Rat Biotin  1:600 Dako 
Donkey anti-Sheep PX  1:50 Dako 
 
 
2.12 Real-Time RT-PCR 
2.12.1 Extraction of mRNA and Reverse Transcription 
RNA was purified from cell populations or spleen tissue using the RNeasy Mini Kit (Qiagen, UK) in 
accordance with the manufacturer’s guidelines. RNA was eluted in water and reverse transcribed using 
1 µg OligodT12-18 and Superscript III (Invitrogen) in a cDNA Hybaid PCR machine at 42°C for 60 
minutes before RNA polymerase was heat inactivated at 90ºC for 10 minutes. Each reaction was made 
in a final volume of 30 µl containing the following components: 2 μl dH2O, 8 μl 5xfirst strand buffer, 4 μl 
0.1 M DTT, 2 μl dNTPs (10 mM), 1 μl RNAse Inhibitor (40 units/μl) and 1 μl Superscript III (200 units/μl). 
The amplified cDNA was made up to 100 μl with RNase free-water and stored at -20ºC until use.  
68 
 
2.12.2 Real Time-PCR 
Relative quantification of specific cDNA species to β-actin message was carried out using standard 
conditions for the TaqMan PCR on the Stratagene MxPro 3000 PCR machine using 2x PCR Master Mix 
(Applied Biosystems, Warrington, U.K). Reactions were carried out in a 96-well optical reaction PCR 
plate in a final volume of 25 μl. For each reaction a forward primer, reverse primer, and probe specific to 
the gene of interest was added at the optimum concentration (Table 2.5), into the same reaction, a 
forward primer, reverse primer, and probe specific to the house-keeping gene β-actin was added. 
Probes for the house-keeping and target gene were labelled with VIC and FAM, respectively. TaqMan 
probes and primers were designed using Primer Express computer software (Applied Biosystems) and 
synthesised by Eurogentec. Each reaction also contained 2 μl cDNA. The plate was sealed using a 
MicroAmp™ Clear Adhesive Film before the reaction was run. Relative quantification of signal per cell 
or tissue was achieved as described (Cunningham et al., 2002). In brief, thresholds within the 
logarithmic phase of the PCR for the house-keeping gene and the target gene were set and the cycle 
number at which the threshold was reached (CT) was determined. The CT for the target gene was 
subtracted form the CT for the house-keeping gene and the relative amount was calculated as 2-CT. 
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2.13 Functional Studies 
2.13.1  Motility Assay 
Swimming of STm in the presence of anti-sFliC specific sera was assessed using semi-solid agar 
containing 0.3% agar. Semi-solid agar was mixed with high-titre, complement inactivated anti-sFliC 
specific sera or naïve sera at a 1:300 dilution. STm from an overnight culture that had just reached 
ODλ600 nm of 1.4 was injected into the agar. The swim zones diameters (distance of migration away 
from the point of inoculation) were measured after overnight incubation at room temperature. 
 
2.13.2 Western Blotting 
The detailed methods used for protein analysis, including western blotting are described in Appendix C. 
Here we describe specific blots.  
 
2.13.2.1 Assessment of Flagella Shedding 
Western blot analysis was used to detect the presence of flagella on the surface of STm following 
incubation with anti-sFliC specific sera. STm and FliC-locked STm (only express FliC) from an overnight 
culture which had just reached ODλ600 nm of 1.4 was harvested and washed at 6000 x g for 5 minutes 
at 4°C. Pelleted cells were re-suspended in PBS and incubated for 1 hour at room temperature under 
gentle agitation with complement inactivated sera from naïve or sFliC-immunised WT mice at a 1:300 
dilution. Following incubation, cells were harvested, washed and run on a SDS-PAGE gel. Proteins were 
transferred to a Polyvinylidene Fluoride (PVDF) membrane which was sequentially probed with an anti-
FliC specific monoclonal antibody and HRP-conjugated goat-anti mouse IgG at 1:100. Signal was 




2.13.2.2 Assessment of Antibody Binding to OMPs 
Western blotting was used to assess the specificity of anti-porin specific antibody against OMP 
preparations of STm. In brief, OMP preparations (Section 2.10.2) isolated from STm or strains of STm 
bearing selective deletions of specific OMPs, were separated by SDS-PAGE and transferred to PVDF 
membranes. Proteins were probed with sera from naive T-cell deficient mice and T-cell deficient mice 
immunised with porins for 7 days at 1:50 and 1:150, respectively. Subsequently, HRP-conjugated goat-
anti-mouse IgM secondary antibodies were added and signal developed as described. 
 
2.14 Statistical Analysis 
Data are presented as bar charts where bars show the arithmetic mean (usually from 4-6 mice per 
groups) and error bars represent the standard deviation of the arithmetric mean. Both the mean and 
standard deviation are presented on a log scale throughout. Statistical analysis was conducted using 
GraphPad PRISM version 5.01 where the median was compared between groups and significance was 
accepted where P≤0.05. Significant differences were determined using the Mann-Whitney non-
parametric sum of ranks test. Experiments were repeated at least once to ensure consistency between 













3.0: Flagellin induces a primary Th2 response yet promotes T-
bet regulated Th1 clearance of STm upon challenge 
3.1 Introduction 
Innate immunity controls early infection with STm before adaptive immunity clears the infection, in a 
CD4 T cell dependent manner requiring IFNγ (Mastroeni et al., 1999; Mastroeni et al., 1996; Mittrucker 
et al., 2000). Identifying key potential antigenic targets against STm and assessing their influence on the 
immune system is necessary for vaccine design. Surface exposed antigens are ideal candidates and 
include the flagellar proteins, FliC and FljB, which are the focus of this study. These highly conserved 
proteins are powerful adjuvants (Bates et al., 2009; McSorley et al., 2002b) and important targets for the 
immune response to STm. Flagellin is recognised by PRR and can drive potent and sustained antigen-
specific CD4 T cell responses (Cookson and Bevan, 1997; McSorley et al., 2000). Although immunity to 
STm after systemic immunisation with flagellin has been described previously (Harada et al., 2002; 
McSorley et al., 2002a; Strindelius et al., 2004), the characteristics of the CD4 T cell response to 
flagellin remain relatively unknown.  
 
We and others have previously shown flagellin drives T and B cell responses with a strong Th2 bias to 
itself and co-administered antigens (Cunningham et al., 2004a; Didierlaurent et al., 2004). However, the 
direction of antibody switching to flagellin when attached to the surface of STm reflects Th1 responses 
(Cunningham et al., 2004a). This capacity of flagellin to drive directional switching to IgG1 or IgG2a 
depending on the context in which it is initially encountered in vivo (Cunningham et al., 2004a), makes 
flagellin a good model to study the mechanisms operating in vivo during the onset of T cell priming and 
T-dependent (TD) antibody switching. In addition, whether this bi-directional switching induced by 
flagellin is reflected in the T cell response raises questions as to how the immune system responds in 
two distinct manners. This prompted assessment of how the immune response to flagellin informs on 
the correlates of immunity. The immune response to flagella when given alone using soluble (s) 
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recombinant flagellin (sFliC) or when attached to the bacterial surface was assessed which illustrates 
that antigen-context in vivo is important in directing subsequent T and B cell responses. These studies 
were extended to examine whether flagellin immunisation can protect against a subsequent systemic 
STm infection. The model of infection used throughout this study is first described before providing in-
depth analysis of responses to flagellin. 
 
3.1.1 Model of Infection 
Since the severity of NTS is associated with systemic infection (Graham et al., 2000), to induce a 
synchronised disseminated infection we typically use an intraperitoneal route, and all the data presented 
in this thesis has been generated following intraperitoneal immunisation of mice with STm, unless stated 
otherwise. Other routes of infection exist for STm, such as intravenous infection, but intravenous 
administration does not allow a full assessment of the role of antibody to protection to be made. 
Subcutaneous infections, such as in the foot are typically restricted to only the draining lymph node, 
especially in the early stages of infection, and the kinetics of dissemination are both varied and vastly 
delayed.  
 
Intraperitoneal infection allows a compromise to be made. It induces a low grade bacteraemia which 
resembles the bacteraemia in NTS. Furthermore, this model has advantages of allowing protective T 
cell and antibody responses to be examined, as well as ensuring responses after dissemination can be 
assessed. There are disadvantages to this model, including the failure to translocate across epithelial 
cells and the subsequent impaired ability to induce mucosal antibody responses, which are protective in 
ST (Salazar-Gonzalez et al., 2004) as demonstrated by oral infection. However, oral infection with 
attenuated strains of STm is not applicable to susceptible mouse strains, and factors such as gastric 
acid may restrict colonisation. We are aware of the limitations of this and are cautious in how data 
obtained from oral infection studies is interpreted. 
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3.2 T cells are important at day 18 for clearance of STm 
The known immune correlates of protection against STm were examined to ascertain the kinetics of the 
response, with particular emphasis on identifying when CD4 T cells are important. WT C57BL6/J mice 
were infected intraperitoneally with 5x105 STm and bacterial numbers were quantified from the spleen at 
days 4, 7, 20, 28 and 35 post-infection to establish a time-course of bacterial clearance (Fig 3.1A). This 
demonstrated that bacterial numbers were comparable at days 4 and 7 post-STm infection, but fell at 
day 20 and continued to decline thereafter. By day 35 the average bacterial load was a hundred 
organisms.  
 
The contribution of the different components of the adaptive immune system was then assessed. WT 
mice and mice lacking B and T cells (Rag1-deficient) were infected with 5x105 STm for 7 or 18 days (Fig 
3.1B). This revealed the bacterial burden in the spleen and liver at day 7 post infection was comparable 
between WT and Rag1-deficient mice. However, by day 18 post-infection WT mice had significantly 
reduced splenic and liver bacterial numbers relative to day 7, whilst bacterial numbers in Rag1-deficient 
mice largely remained unchanged, highlighting the importance of adaptive immunity for resolution of 
infection. As an additional control the contribution of T and B cells during STm infection was examined. 
Since T cells are critical for the resolution of STm (Mastroeni and Menager, 2003) WT, TCR-deficient 
(βδTCR-deficient) and B cell deficient (IgH-deficient) mice were infected intraperitoneally with 5x105 
STm. As expected, quantification of the bacterial load in the spleen at day 7 post-infection found no 
differences between the groups (Fig 3.1C). At day 18 post-infection both WT and B cell deficient mice 
had significantly lower bacterial numbers relative to day 7, and they were comparable to each other, 
whilst numbers in TCR-deficient mice were similar to day 7. These data demonstrate that during a 
systemic STm infection T cells are needed by day 18 onwards for resolution of infection as is in 







3.3 Immunisation with flagellin promotes a Th2 response 
3.3.1 Mice immunised with sFliC induce IL-4 mRNA and protein 
Previous studies have shown that responses to flagellin directs polarisation of B cells to IgG1, indicative 
of Th2 activity (Cunningham et al., 2004a) whereas when attached to the surface of STm, the anti-
flagellin B cell response to IgG2a reflects Th1 activity. The properties of the CD4 T cell response to 
sFliC, prepared as described in section 2.2.3.1 were examined. The purity of the protein is illustrated in 
Fig 2.1 which demonstrates a dominating band at 55 kDa and a smaller species directly beneath this 
following his-tag and affinity chromatography purification. Both bands correspond to the expected 
molecular mass of flagellin (55 kDa). The identity was further confirmed by immunoblotting which 
revealed that both bands were recognised by an anti-FliC monoclonal antibody (data not shown). 
 
To examine the CD4 T cell response to sFliC WT mice were immunised with 20 μg sFliC or 5x105 STm 
intraperitoneally. After 3 days splenic CD3+CD4+ T cells were sorted into naïve (CD62Lhi) and effector 
(CD62Llo) populations. Gene expression was then assessed by real-time RT-PCR (Fig 3.2). Expression 
of the Th2 associated transcription factor GATA-3 (Farrar et al., 2001) and cytokine IL-4 (Mosmann et 
al., 1986) were strongly induced in mice immunised with sFliC relative to STm-infected mice, with the 
signal predominantly from the effector cell population rather than the naïve population. In contrast, 
induction of the global Th1 regulator T-bet (Szabo et al., 2000) and cytokine IFNγ was mostly detected 
in mice immunised with STm, with greatest expression found in the effector population.  
 
This experiment was repeated using flagellin-specific CD4 T cells (SM1) (McSorley et al., 2002a). SM1 
T cells were adoptively transferred into OTII Boy J mice (CD45.1) and chimeras were immunised with 
20 μg sFliC or infected with 5x105 STm intraperitoneally (Fig 3.3A). Antigen-specific T cells were sorted 
at day 3 post-immunisation using CD45.2 as a marker and further sub-divided into naïve and effector 










effector (CD62Llo) SM1 T cells sorted from STm-infected chimeras. GATA-3 and IL-4 mRNA was mostly 
detected from effector SM1 T cells after sFliC-immunisation.  
 
To confirm that the IL-4 mRNA induced reflected protein production secreted IL-4 was evaluated in re-
stimulated T cells by ELISPOT (Fig 3.4). SM1-Rag1 deficient chimeras were generated by adoptive 
transfer of SM1 cells into Rag1-deficient mice intraperitoneally. Chimeras were either non-immunised 
(NI), immunised with 20 μg sFliC or infected with 5x105 STm alongside WT mice. Splenocytes were 
isolated 7 days post-immunisation and re-stimulated in vitro with sFliC for 48 hours in an anti-IL-4 pre-
coated ELISPOT plate, and the number of IL-4 Spot-Forming Cells (SFC) quantified. Splenocytes from 
both WT mice and chimeras immunised with sFliC, had a marked increase in the number of IL-4 SFC 
relative to NI mice and mice infected with STm. Therefore, the number of IL-4 protein-producing cells 
increase upon immunisation with sFliC which is reflected at the protein level and in changes in mRNA 
expression.  
 
3.3.2 Mice immunised with sFliC fail to induce IFNγ 
Production of the Th1 cytokine IFNγ was then examined. WT mice were either NI or immunised 
intraperitoneally with 20 μg sFliC or infected with 5x105 STm. Splenocytes were isolated 7 days post-
immunisation and re-stimulated in vitro with anti-CD3 or sFliC in the presence of anti-CD28, and IFNγ 
production by CD4 T cells was measured by intracellular FACS (Fig 3.5). Anti-CD3 stimulation revealed 
sFliC immunisation unlike STm, failed to induce IFNγ in WT CD4 T cells, as levels were equivalent to NI 
mice in terms of both the proportion and total CD4 T cells. IFNγ production in mice infected with STm 
was almost entirely induced in effector (CD62Llo) CD4 T cells, agreeing with a previous study (Gaspal et 
al., 2008). To examine antigen-specific responses, cells were re-stimulated with sFliC which reflected 
these findings, but levels of IFNγ from STm-infected mice were half that observed after anti-CD3 
stimulation. This reflects previous studies that flagellin is a dominant antigen in the CD4 T cell response 









flagellin (Alaniz et al., 2006; McSorley et al., 2000). Responses were then examined in SM1 T cells 
following sFliC immunisation using a similar experimental design in SM1-WT chimeras which were 
generated by adoptive transfer of SM1 cells into WT mice (Fig 3.6). As expected, this showed a marked 
induction of IFNγ in chimeras immunised with STm, but little IFNγ in SM1 T cells after sFliC 
immunisation. The levels of IFNγ induced in SM1-WT chimeras were similar regardless of the 
stimulating conditions. Therefore, almost all of the activated SM1 T cells were responding to flagellin. 
 
To address if the low proportion of IFNγ-producing CD4 T cells induced after sFliC immunisation 
reflected levels induced to other Th2 antigens, responses were assessed after immunisation with the 
model Th2 antigen alum-precipitated ovalbumin in WT and OVA-specific CD4 T cells. WT-OTII 
chimeras were generated by adoptive transfer of splenocytes from transgenic OVA-specific CD4 T cells 
(OTII T cells) into WT mice (Fig 3.7). Chimeras received, 24 hours post-transfer, 5x105 of an OVA-
expressing strain of STm (Sal OVA) or 50 μg alum-precipitated ovalbumin. Splenocytes were isolated 7 
days post-immunisation and were re-stimulated in-vitro with anti-CD3 in the presence of anti-CD28. 
IFNγ production was assessed in antigen specific CD45.1 cells which were sorted from host CD45.2 
cells by FACS. Immunisation with alum-precipitated ovalbumin failed to induce IFNγ relative to mice 
infected with Sal OVA as reflected in the fraction and number of CD4 T cells. Therefore, similar levels of 
IFNγ were induced in WT or OTII CD4 T cells by alum-precipitated ovalbumin as observed in WT or 
SM1 CD4 T cells in response to sFliC. 
 
3.3.3 Mice immunised with polymeric flagella fail to induce IFNγ 
To test if the Th2 features observed after sFliC immunisation would be maintained when using the 
native polymeric antigen, responses were examined in WT mice immunised with 20 µg polymeric 
flagella filaments isolated from the surface of STm or infected with 5x105 STm (Fig 3.8). Splenocytes 
were isolated 7 days post-immunisation and were re-stimulated in vitro with anti-CD3 or sFliC in the 












immunised with polymeric flagella filaments also failed to induce detectable levels of IFNγ relative to 
mice infected with STm. This suggested that in terms of IFNγ production, CD4 T cell responses in mice 
immunised with the polymeric isolate was similar to mice immunised with the monomeric protein. 
Therefore, the source (surface isolated or a recombinant protein) and conformation (polymeric or 
monomeric) of flagellin is not responsible for the failure to produce IFNγ. 
 
3.3.4 Immunisation with sFliC fails to induce T-bet 
Although IFNγ is the Th1 type cytokine, not all Th1 cells produce this cytokine therefore, expression of 
the global Th1 regulator T-bet (Szabo et al., 2000) was examined. SM1-WT chimeras were generated 
as described previously. Chimeras were infected 24 hours post-transfer with 5x105 STm or immunised 
with 20 μg sFliC intraperitoneally. Splenocytes were isolated 7 days post-immunisation from these 
chimeras alongside NI chimeras and stimulated with anti-CD3 or sFliC in the presence of anti-CD28, 
and intracellular T-bet expression was quantified in SM1 CD4 T cells by FACS (Fig 3.9). This revealed 
mice immunised with STm induced expression of T-bet from effector CD4 T cells, but T-bet expression 
was not seen in NI mice or mice immunised with sFliC. This lack of T-bet expression after sFliC 
immunisation reflected the failure to induce IFNγ production.  
 
3.3.5 The sFliC-Th2 response is stable in the absence of IL-4Rα signalling. 
The stability of this sFliC-driven Th2 response was then assessed using IL-4Rα-deficient mice. WT and 
IL-4Rα deficient mice were immunised with sFliC for 4 days and CD3+CD4+ splenocytes were sorted 
into effector (CD62Llo) and naïve (CD62Lhi) populations. Real-time RT-PCR was then used to measure 
mRNA expression of GATA-3 and IL-4 (Fig 3.10A). This showed that sFliC selectively upregulated 
expression of GATA-3 and IL-4 mRNA in the effector CD4 T cell population, and the response was 
equivalent between WT and IL-4Rα deficient mice. To assess whether T-bet was required for the 









(Fig 3.10B). This revealed that both IL-4 and GATA-3 mRNA was strongly induced from effector CD4 T 
cells and was comparable between the mice.  
 
Previously, it was demonstrated that immunisation with soluble flagellin failed to induce switching to 
IgG2a. The data presented here show that sFliC drives a CD4 T cell response that reflects Th2 
switching in vivo. This is not influenced by whether flagellin is presented in a monomeric or polymeric 
form or whether it is administered as a recombinant protein or isolated from the surface of STm. 
Furthermore, this study highlights that this potent sFliC driven Th2 response is stable in the absence of 
IL-4 and IL-13 signalling through IL4-Rα, and does not require T-bet for its induction. 
 
3.4 Co-immunisation of sFliC and STm 
3.4.1 Soluble FliC can suppress IFNγ induced by STm 
Since sFliC and STm can induce potent Th2 and Th1 responses respectively, the response when both 
antigens were given together was examined. SM1-WT chimeras were generated as described earlier 
which were infected 24 hours post-transfer with 5x105 STm or immunised with 20 μg sFliC, or co-
immunised with both. Splenocytes were isolated 7 days post-immunisation and re-stimulated in-vitro 
with anti-CD3 in the presence of anti-CD28, and the proportion of IFNγ in endogenous (WT) and 
antigen-specific (SM1) CD4 T cell populations was quantified by FACS (Fig 3.11). As expected, 
immunisation with STm induced IFNγ, but sFliC did not. Surprisingly, chimeras which were co-
immunised with sFliC and STm, had a significantly lower proportion of IFNγ CD4 T cells than chimeras 
which were only infected with STm. This pattern of IFNγ was similar in WT and SM1 CD4 T cells, and 
thus, not an intrinsic property of transgenic SM1 T cells.  
 
To assess whether this reflected a general suppression of Th1 responses by Th2 antigens and thus, a 
common property of Th2 immunogens, the experiment was repeated using WT-OTII chimeras which 






OVA or immunised with 50 μg alum precipitated ovalbumin, or co-immunised with both and responses 
were assessed 7 days post-immunisation (Fig 3.12). The suppression of IFNγ observed in SM1-WT 
chimeras co-immunised with STm and sFliC was not observed in WT or OTII CD4 T cells isolated from 
mice which were co-immunised with STm OVA and alum-precipitated ovalbumin, indicating this was not 
a general phenomenon. Thus, immunisation with sFliC suppresses the Th1-induced IFNγ in response to 
STm. 
 
3.4.2 IFNγ suppression in response to sFliC in independent of IL-10 
One way the IFNγ response may be suppressed was through a general suppression of Th1 responses 
by means of IL-10 (Bai et al., 1997). This cytokine is induced by both STm and sFliC (data not shown) 
and can be produced by numerous innate and adaptive cell types. To address the role of IL-10 the CD4 
T cell response to sFliC in WT and IL-10 deficient mice immunised with 20 μg sFliC was first assessed. 
Quantification of total CD4 T cell populations in the spleen 7 days post-immunisation revealed a lower 
proportion of CD4 T cells in IL-10 deficient mice relative to WT mice, but similar numbers (3.13A) whilst 
little differences were seen in the activation status of these CD4 T cells (Fig 3.13B). 
 
Responses in IL-10 deficient mice which were either infected with 5x105 STm, immunised with 20 μg 
sFliC, or co-immunised with STm and sFliC were then examined. Assessment of the splenic CD4 T cell 
response 7 days post-immunisation revealed mice immunised with sFliC had a greater proportion, but 
not number of CD4 T cells relative to mice immunised with STm or STm and sFliC (Fig 3.14A). Analysis 
of CD4 T cell activation demonstrated sFliC immunised mice had a lower proportion of effector T cells 
than mice infected with STm, but the proportion was equivalent to co-immunised mice, whilst numbers 
were broadly equivalent between the three groups (Fig 3.14B). Lastly, splenocytes were stimulated in 
vitro with anti-CD3 in the presence of anti-CD28 and intracellular IFNγ was quantified by FACS (Fig 
3.14C). This demonstrated the proportion and number of IFNγ producing CD4 T cells was significantly 















WT mice. This suggested that the suppression of Th1 responses to STm upon co-immunisation with 
sFliC was independent of IL-10. 
 
3.4.3 sFliC can suppress IFNγ during secondary responses to STm 
Since resolution of STm requires Th1 responses and sFliC is capable of suppressing this response in 
primary infection models upon co-administration with STm, the impact of priming with STm and sFliC on 
the subsequent response to STm challenge was addressed. NI WT mice, and WT mice infected with 
5x105 STm or co-immunised with 5x105 STm and 20 μg FliC were subsequently challenged on day 35 
with 5x106 STm (Fig 3.15A). Quantification of the splenic bacterial burden 5 days post-challenge 
revealed, both STm-primed and STm and sFliC co-primed mice had a significantly lower bacterial 
burden relative to non-primed mice. Interestingly, STm and sFliC co-primed mice consistently had a 
higher bacterial load than STm-primed mice (Fig 3.15).  
 
Quantification of the CD4 T cell response in the spleen revealed the proportion of CD4 T cells was 
enhanced in both STm-primed and STm and sFliC co-primed mice relative to non-primed counterparts 
(Fig 3.15B). In the main, there were no differences in total CD4 and effector CD4 T cell responses 
between STm-primed and STm and sFliC co-primed mice. To further dissect the CD4 T cell response 
splenocytes were FACS sorted into naïve and effector CD4 populations for assessment of mRNA 
expression by real-time RT-PCR (Fig 3.16A). The relative expression of T-bet and IFNγ revealed the 
signal was largely detected from effector CD4 T cells, consistent with previous experiments (Fig 3.2). 
Interestingly, the relative expression of both T-bet and IFNγ was significantly lower in STm and sFliC co-
primed mice in comparison to STm-primed mice, and was similar to non-primed mice. Analysis of 
relative IL-4 mRNA revealed no differences between non-primed and primed mice.  
 
As an additional control, IFNγ was assessed by intracellular FACS following anti-CD3 re-stimulation in 









co-primed mice induced significantly more IFNγ compared to non-primed mice. Furthermore, as 
observed by RT-PCR the expression of IFNγ was significantly lower in STm and sFliC co-primed mice 
relative to STm-primed mice which was apparent both as a proportion and total numbers.  
 
Finally, antibody responses in these mice post-challenge were assessed. Assessment of anti-STm and 
anti-sFliC IgM titres revealed no differences between the three groups (Fig 3.17). As expected, anti-
STm IgG2a was only detected in STm-primed and STm and sFliC co-primed mice and titres were 
comparable, whilst anti-sFliC IgG2a and IgG1 antibody titres were only detected in STm and sFliC co-
primed mice. This suggested, the impact of co-immunisation with STm and sFliC did not appear to 
impinge upon antibody switching. 
 
These data show that sFliC can suppress IFNγ induced in response to primary and secondary STm 
infections upon co-administration. This IFNγ suppression by sFliC is not typical of co-administration of 
Th2 antigens and STm, but it is an intrinsic property of sFliC as shown by experiments using STm-OVA. 
Furthermore, this study shows that this suppression of IFNγ by sFliC is independent of IL-10 expression. 
Additionally, it demonstrates that co-immunisation with sFliC and STm can negatively affect the benefit 
afforded by STm immunisation upon challenge. This was independent of B cells and IL-4 expression, 
but was driven through this suppression of the Th1 response upon co-immunisation with sFliC and STm.  
 
3.5 Immunisation with sFliC protects at discrete stages of a systemic 
STm infection 
Since sFliC induces potent Th2 responses which can suppress IFNγ upon co-administration with STm 
negatively impacting on early clearance of STm from the tissues, whether priming with sFliC by itself 
would influence a subsequent systemic STm challenge in a vaccine model was investigated. WT mice 
were immunised intraperitoneally with 20 µg sFliC and on day 35 they were challenged with 5x105 STm 









bacterial numbers revealed non-primed and sFliC-primed mice had a comparable bacterial load at day 
5. In contrast, by day 18 and 35 sFliC-primed groups had significantly lower bacterial numbers relative 
to non-primed groups. Whether sFliC immunisation promoted mucosal immunity was also investigated. 
WT mice were immunised intraperitoneally with 20 µg sFliC and on day 35 mice were orally challenged 
with 109 STm (SL3261) for 2 days. Bacterial numbers were enumerated from the spleen, mesenteric 
lymph nodes and liver (Fig 3.18B). This revealed that there was a small trend towards lower colonisation 
in these tissues in sFliC-primed mice relative to non-primed mice, but this did not reach significance 
despite the large group sizes (at least 7 mice per group), except for in the liver, where the difference just 
reached significance.  
 
These data demonstrate that sFliC immunisation does not confer early benefits in controlling systemic 
STm infection. Nevertheless, despite inducing potent Th2 features which can suppress IFNγ in primary 
and secondary responses to STm, immunisation with sFliC accelerates bacterial clearance after the first 
week of a subsequent infection with STm.  
 
3.6 Antibody to sFliC fails to control systemic STm infection 
3.6.1 Antibody to sFliC can impair the motility of STm  
Previous studies have shown that immunisation with heat-killed STm or subunit vaccines against STm 
can reduce systemic infection through antibody-mediated mechanisms, which are effective by day 5 
after infection (Chapter four) (Gil-Cruz et al., 2009). Antibody in STm infections is likely to act to inhibit 
bacterial colonisation rather than clear the organism from infected tissues. The lack of early protection 
after infection of sFliC-immunised mice suggested that anti-sFliC antibody may not inhibit bacterial 
colonisation. To address this, properties of the anti-sFliC antibody response in sFliC-immunised mice 




WT mice were immunised intraperitoneally with 20 μg sFliC or 20 μg surface-isolated flagella for 35 
days and serum anti-sFliC IgG1 and IgG2a antibody titres were assessed by ELISA (Fig 3.19A). This 
showed that both sFliC-immunised and flagella-immunised mice induced a potent IgG1 response 
relative to IgG2a at day 35 post-immunisation. Functional properties of the anti-sFliC antibody response 
were then investigated, including assessment of whether anti-sFliC antibody could cause loss of flagella  
from the bacterial surface. Flagellated FliC-locked STm (which only express FliC) and STm (which can 
express both FliC and FljB) were adsorbed with complement-inactivated (CI) sera from NI WT mice or 
WT immunised twice with sFliC for 14 days. Following incubation, bacteria were harvested and 
analysed by immunoblot analysis (Fig 3.19B). This demonstrated the binding of an anti-FliC monoclonal 
antibody to flagella attached to FliC-locked STm which had been absorbed with either NI or sFliC-
specific sera. Furthermore, the immunoblot of STm adsorbed with sFliC-specific sera revealed binding 
of the anti-FliC monoclonal. This suggested that flagella were not shed from the bacterial surface upon 
binding of anti-sFliC antibody.  
 
Whether anti-sFliC antibody could impair the motility of STm was then examined. CI sera from NI or 
sFliC-immunised WT mice was mixed with semi-solid agar prior to inoculation with STm, and the effect 
of antibody on bacterial motility was assessed by measuring the colony radius from the point of 
inoculation (Fig 3.19C). This demonstrated that bacterial swimming through agar containing sFliC-
specific antibody was reduced relative to swimming in agar containing sera from NI mice. Thus, sFliC 
promotes antibody responses that can limit bacterial motility. 
 
3.6.2 Antibody to sFliC does not impair early colonisation with STm  
The influence of sFliC-immunisation on inducing protective antibody responses to STm was then 
assessed. WT and IgH-deficient mice were NI or immunised intraperitoneally with 20 μg sFliC and on 
day 35 they were subsequently challenged with 5x105 STm, and responses were evaluated at 5 or 18 









sFliC-primed WT and IgH-deficient mice had a significantly lower bacterial load relative to non-primed 
counterparts at day 18, reflecting earlier observations. However, in the main no differences were seen 
between WT and IgH-deficient mice at both time-points.  
 
To confirm that antibody to sFliC was dispensable in this model, STm was opsonised immediately prior 
to infection with antibody from mice immunised with different antigens. STm was incubated with CI sera 
from either NI mice, mice primed and boosted with sFliC for 14 days, mice immunised with STm porins 
for 14 days which we show later can confer protection (Chapter 4), or mice infected with STm for 35 
days. WT mice were then infected and bacterial numbers were quantified from the spleen and liver 5 
days post-infection (Fig 3.20B). Mice immunised with STm-opsonised with porin-specific or STm-
specific sera had a significantly lower bacterial load relative to mice immunised with STm opsonised 
with NI or sFliC-specific sera, which were comparable. Thus, opsonisation of STm with sFliC-specific 
antibody could not impair the capacity of STm to subsequently colonise mice.  
 
3.6.3 Antibody to sFliC impairs early infection when STm cannot phase-
switch 
Lastly, whether the lack of benefit afforded by sFliC-specific antibody was due to the capacity of STm to 
phase-switch their flagellin expression between FljB and FliC was investigated. WT mice were 
immunised intraperitoneally with 20 μg sFliC and at day 35 they were infected with 5x105 STm that can 
express both phases of flagellin, or only FljB (FljB-locked), or only FliC (FliC-locked). Quantification of 
the bacterial burden in the spleen and liver at day 5 post-infection revealed, mice infected with FliC-
locked STm had a 10-fold lower bacterial load relative to mice infected with either STm or FljB-locked 
STm, which were equivalent (Fig 3.21A). Thus, some of the capacity to avoid early antibody-mediated 








To exclude the possibility that FliC-locked STm were intrinsically more susceptible to killing by innate 
mechanisms, naïve Rag1 deficient mice were infected with these different STm strains and bacterial 
numbers were enumerated in the spleen and liver 7 days post-infection (Fig 3.21B).This showed that all 
strains colonised similarly. Lastly, we assessed whether this benefit seen in sFliC-immunised mice upon 
subsequent infection with FliC-locked STm was sustained. WT mice were immunised with 20 μg sFliC 
and at day 35 they were challenged with either STm or FliC-locked STm (Fig 3.21C). Quantification of 
the splenic bacterial burden at day 18 post-infection found no differences between sFliC-immunised 
mice infected with STm or FliC-locked STm. This suggests, the early impairment in STm colonisation 
was not sustained later during infection, irrespective of whether the ability of STm to phase-switch its 
flagellin genes was compromised.  
 
Flagellin varies significantly between serovars, and antibody to flagellin is used to type these serovars 
through the Kauffman-White scheme. The data presented here demonstrate that immunisation with 
sFliC or flagella induces a potent and sustained antibody response that can impair bacterial motility, but 
not early colonisation, partly through the ability of STm to phase-switch its flagellin genes.  
 
3.7 Enhanced clearance of STm in sFliC-immunised mice correlates 
with augmented IFNγ production.  
 
3.7.1 Benefit afforded by sFliC immunisation is CD4 T cell dependent 
Immunisation with sFliC reduced bacterial numbers at discrete stages after STm challenge (from day 
18) (Fig 3.18A) which was independent of B cells. Earlier we demonstrated that T cells were not 
important for controlling STm infection in the first week of infection but were necessary after this (Fig 
3.1), as in agreement with other studies (Hess et al., 1996; Hormaeche et al., 1990; Nauciel, 1990). 
Therefore, we sought to investigate whether the protection conferred by sFliC immunisation on day 18 
after a subsequent STm infection was mediated through T cells.  
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Before this, whether the benefit afforded by sFliC immunisation upon subsequent STm challenge was 
due to a direct effect by sFliC on the innate immune system was assessed. Rag1 deficient mice were 
immunised intraperitoneally with 20 μg sFliC and on day 7 they were challenged with 5x105 STm 
alongside naïve counterparts, and responses were assessed at days 7 and 18 (Fig 3.22A). 
Quantification of the bacterial load in the spleen and liver found no differences between non-primed and 
sFliC-primed mice at both time-points. Thus, lymphocytes are required for the protection seen in sFliC-
immunised mice. 
 
To assess the importance of T cells in sFliC-immunised mice, WT and TCR-deficient mice were 
immunised intraperitoneally with 20 μg sFliC and on day 35 mice were challenged with 5x105 STm 
alongside NI counterparts, and responses were assessed at days 7 and 18 post-infection (Fig 3.22B). 
As expected, quantification of bacterial numbers on day 7 revealed both WT and TCR-deficient mice 
had equivalent bacterial numbers, irrespective of sFliC immunisation, in both the spleen and liver. 
However, at day 18 WT mice had significantly fewer bacteria than TCR-deficient mice regardless of 
sFliC immunisation. As expected, at day 18 sFliC-primed WT mice had a lower bacterial load than non-
primed WT mice whilst sFliC immunisation did not influence bacterial numbers in TCR-deficient mice. 
These data demonstrate that the benefit afforded by sFliC-immunisation at day 18 upon subsequent 
STm infection is dependent on T cells.  
 
3.7.2 The benefit of sFliC immunisation upon STm challenge correlates with 
augmentation of IFNγ 
As the clearance of STm is associated with Th1 priming the influence of sFliC-priming on the Th1 
response to STm was assessed. NI WT mice and WT mice primed with 20 μg sFliC were challenged 
with 5x105 STm on day 35 and CD4 T cell responses were assessed by FACS at days 5, 18 and 35 
post-infection (Fig 3.23). This revealed the proportion of splenic CD4 T cells and effector (CD62L lo) CD4 









assessed post-STm infection. Subsequently, the influence of sFliC immunisation on IFNγ production by 
CD4 T cells during subsequent STm challenge was examined. Splenocytes were re-stimulated in vitro 
with anti-CD3 in the presence of anti-CD28 and IFNγ production was quantified by intracellular FACS 
(Fig 3.24). This revealed that at day 5, IFNγ expression was significantly lower in sFliC-primed mice 
relative to non-primed mice, and this was reflected both in terms of the proportion and number of CD4 T 
cells. In contrast, when responses were assessed at day 18 IFNγ expression was significantly greater in 
sFliC-primed mice relative to non-primed mice and by day 35, when the infection had nearly resolved in 
both sFliC-primed and non-primed mice, IFNγ expression was comparable between the two groups. As 
discussed earlier (Fig 3.5) at each time point assessed the signal for IFNγ was almost entirely detected 
from effector CD4 T cells. 
 
As an additional control secreted protein was assessed by ELISPOT (Fig 3.25). Splenocytes from non-
primed and sFliC-primed mice subsequently challenged with STm for 18 days were re-stimulated in vitro 
with sFliC for 48 hours in an anti-IFNγ pre-coated ELISPOT plate, and the number of IFNγ SFC were 
enumerated. This demonstrated sFliC-primed mice had more IFNγ SFC relative to both NI and non-
primed mice at day 18 post-STm challenge. IL-4 responses were also examined by ELISPOT but were 
largely undetectable in all groups (Fig 3.25). Together, the ELISPOT and intracellular FACS data 
suggested that the enhanced clearance of STm observed at day 18 in sFliC-primed mice was 
associated with increased numbers of IFNγ producing CD4 T cells. 
 
3.7.3 T-bet is essential for the protection provided by sFliC immunisation 
In STm infections IFNγ secretion correlates with T-bet induction (Ravindran et al., 2005). As sFliC 
immunisation promoted accelerated clearance of STm through an enhancement of IFNγ, whether this 
was regulated by the global Th1 regulator T-bet was investigated, although this would be surprising 
since sFliC did not induce T-bet expression (Fig 3.9). Initially, the importance of T-bet in the clearance of 









were included. BALB/c (WT) and IL-4Rα deficient mice or C57BL6/J (WT) and T-bet deficient mice were 
infected with 5x105 STm and responses assessed 18 days post-infection (Fig 3.26A). Quantification of 
bacterial numbers in the spleen and liver showed no differences between WT and IL-4Rα-deficient 
mice, whilst T-bet deficient mice had an appreciably elevated bacterial load relative to WT mice. Thus, 
T-bet but not IL-4 and IL-13 signalling through IL-4Rα is required for the control of primary STm 
infections.  
 
Quantification of splenic CD4 T cell responses in WT and T-bet deficient mice revealed, the total 
number of CD4 and effector CD4 T cells were comparable between infected WT and T-bet deficient 
mice 18 days post-STm infection (Fig 3.26B). However, the proportions were lower in infected T-bet 
deficient mice relative to infected WT mice. Subsequently, IFNγ CD4 T cell responses were examined 
by intracellular FACS following anti-CD3 re-stimulation in the presence of CD28 (Fig 3.27). This 
demonstrated IFNγ was virtually undetectable in splenocytes isolated from T-bet deficient mice with 
levels comparable to NI WT mice. Thus, the impaired ability to drive IFNγ production in the absence of 
T-bet signalling correlated with the failure to clear STm from the tissues relative to WT mice, as in 
agreement with previous studies (Ravindran et al., 2005).  
 
Given the importance of T-bet for the clearance of primary STm infections at day 18, whether T-bet was 
also important for the benefit afforded by sFliC immunisation upon subsequent STm challenge was 
assessed. T-bet deficient mice were either NI or immunised with 20 µg sFliC and subsequently 
challenged on day 35 with 5x105 STm. Quantification of the bacterial burden in the spleen and liver at 
day 18 post-STm infection revealed immunisation with sFliC did not influence the bacterial load in T-bet 
deficient mice (Fig 3.28A). This suggested T-bet expression was required for the benefit observed in 
sFliC-primed mice 18 days post-STm challenge.  
 
The proportion and total number of CD4 and effector CD62L lo CD4 T cell responses were comparable 












Quantification of IFNγ expression by CD4 T cells following anti-CD3 re-stimulation in the presence of 
anti-CD28 revealed the absence of IFNγ in both sFliC-primed and non-primed T-bet deficient mice (Fig 
3.29). As a control to show that sFliC-primed and non-primed T-bet deficient mice could produce 
cytokines, cells were also stained for IL-5 which showed the induction of IL-5 in both sFliC-primed and 
non-primed CD4 T cells. Thus, the loss of the benefit in sFliC-primed mice upon subsequent STm 
challenge at day 18 correlated with the absence of IFNγ which was dependent on T-bet expression.  
 
3.7.4 T-bet expression is not required for sFliC Priming 
Immunisation with sFliC did not induce T-bet (Fig 3.9) yet surprisingly, the benefit afforded by sFliC 
immunisation upon subsequent STm challenge was T-bet dependent. To ascertain whether this was 
because T-bet was required for the induction of responses to sFliC, WT and T-bet deficient mice were 
immunised with 20 μg sFliC and splenic CD4 T cell responses were assessed 4 days post-
immunisation. This revealed the proportion and total number of CD4 T cells and effector CD62L lo T cells 
were equivalent between WT and T-bet deficient mice (Fig 3.30). In addition, CD4 T cells were FACS 
sorted from these mice into naïve CD62Lhi and effector CD62Llo populations for assessment of mRNA 
expression by real-time RT-PCR (Fig 3.31A). This revealed the expression of both GATA-3 and IL-4 
was equivalent between WT and T-bet deficient mice. This suggests that T-bet expression is not 
required for induction of the early features of the sFliC-specific CD4 T cell response.  
 
To address whether the antibody response to sFliC was influenced by T-bet signalling, serum anti-sFliC 
antibody titres were assessed by ELISA in WT and T-bet deficient mice which were either NI or 
immunised with sFliC for 7 or 35 days (Fig 3.31B). This revealed immunisation with sFliC induced an 
anti-sFliC specific IgM response by day 7 and as expected, by day 35 both WT and T-bet deficient mice 
had a significantly lower IgM titre, but the response was equivalent between WT and T-bet deficient 
mice at both time-points. Assessment of the IgG1 response found both sFliC-immunised WT and T-bet 












Interestingly, T-bet deficient mice displayed a trend for lower IgG1 titres. This trend was also observed 
to other antigens such as alum-precipitated ovalbumin (data not shown). Anti-sFliC IgG2b was induced 
in sFliC-immunised WT and T-bet deficient mice at both days 7 and 35, and as observed with the IgG1 
response, this revealed a trend for lower antibody titres in sFliC-immunised T-bet deficient mice relative 
to WT mice at both time-points. Therefore, T-bet may not be required for the induction or maintenance 
of Th2 features in response to sFliC immunisation, but may contribute to antibody switching.  
 
These data demonstrate that immunisation with the Th2 antigen sFliC can offer limited protection 
against subsequent STm challenge, dependent upon when responses are assessed. Protection is 
independent of B cells but requires T cells at day 18. This protection is associated with augmentation of 
Th1 responses which is dependent on T-bet expression, suggesting that under certain conditions the 
Th2 antigen sFliC can promote Th1 responses. Significantly, sFliC requires T-bet expression to promote 
clearance of STm but it does not require T-bet to induce sFliC-specific Th2 features. 
 
3.8 The loss of flagella does not influence the clearance of STm 
Since flagellin is an important target for innate and adaptive immunity, whether loss of flagella could 
influence the clearance of STm from the tissues and the subsequent response initiated by the host was 
assessed. WT mice were infected intraperitoneally with 5x105 flagellated STm (STm) or STm lacking 
flagella (aflagellated STm) and primary responses were assessed 18 days later (Fig 3.32A). 
Quantification of the bacterial burden in the spleen and liver found no differences between mice infected 
with flagellated or aflagellated STm.  
 
Assessment of splenic CD4 T cell responses revealed the proportion and total number of CD4 and 
effector CD62Llo CD4 T cells were equivalent between mice infected with the flagellated or aflagellated 
strain of STm (Fig 3.32B). IFNγ production by CD4 T cells was then assessed following re-stimulation of 









CD3 induced IFNγ production relative to non-stimulated splenocytes. However, there were no 
differences in both the proportion and number of IFNγ producing CD4 T cells between mice infected 
with the flagellated or aflagellated strain of STm. These data demonstrate that the loss of flagella from 
the surface of STm does not influence the clearance of STm from the host, or alter the direction of the 
immune response at day 18 post primary infection.  
 
3.9 Deletion of some of the putative TLR5 ligating motif does not 
influence sFliC-specific antibody responses 
TLR5 recognises an evolutionary conserved site on flagellin (Andersen-Nissen et al., 2005). However, 
not all bacterial flagellin monomers are able to ligate TLR5 owing to variations in this site. To investigate 
whether TLR5 ligation of this site was responsible for the properties of sFliC, a sFliC construct was 
generated in which part of the recognised TLR5 ligation motif was deleted to create ∆TLR5 sFliC as 
outlined in Chapter Two and Appendix B. Once the construct was generated it was assessed whether 
an anti-sFliC monoclonal antibody was still able to recognise it by ELISA (data not shown). This 
demonstrated the monoclonal antibody recognised both sFliC and the mutated ∆TLR5 sFliC protein 
with comparable avidity, but failed to recognise flagellin isolated from BL21.  
 
To address whether the antibody response to ∆TLR5 sFliC was similar to sFliC and thus, reflective of 
Th2 responses, WT mice were infected with 5x105 STm or immunised with 20 μg sFliC or 20 μg ∆TLR5 
sFliC and serum anti-sFliC antibody titres were assessed by ELISA 14 days post-immunisation (Fig 
3.33A). This demonstrated that IgM was present in all groups but greatest after sFliC. In contrast, the 
relative titres for both IgG1 and IgG2a were only detectable in mice immunised with sFliC or ∆TLR5 
sFliC and titres were comparable. Thus, altering part of the putative TLR5 binding motif in sFliC did not 
impinge upon sFliC-specific switching to IgG1. To ascertain whether altering this putative TLR5 ligating 






and double-stained for PNA (to identify GC) and IgD (to identify follicular B cells) (Fig 3.33B). GCs were 
then quantified as a percentage of the follicle which demonstrated that both sFliC and ∆TLR5 sFliC 
induced a comparable GC response relative to NI mice and mice infected with STm. This study 
suggests that some aspects of the sFliC response are not dependent on the amino acids removed in the 
mutated sFliC protein. Indeed, both sFliC and ∆TLR5 sFliC failed to induce IFNγ and selectively 
induced expression of IL-4 and GATA-3 mRNA (data not shown). 
 
3.10 The protection seen in sFliC-immunised mice upon STm challenge 
can be TLR5 independent. 
To ascertain whether the benefit afforded by sFliC immunisation upon subsequent challenge with STm 
at day 18 was observed in the absence of TLR5 signalling, WT and TLR5-deficient mice were 
immunised with either PBS or 20 μg sFliC and on day 35 mice were challenged with 5x105 STm. 
Quantification of the splenic bacterial burden 18 days post-STm challenge, consistently revealed both 
sFliC-immunised WT and TLR5-deficient mice had a significantly lower bacterial burden relative to non-
primed counterparts (Fig 3.34A). Interestingly, TLR5-deficient mice demonstrated a trend for greater 
bacterial numbers relative to sFliC-immunised WT mice. Quantification of CD4 T cell responses in the 
spleen revealed the proportion and total number of CD4 T cells was comparable between WT and 
TLR5-deficient mice, irrespective of sFliC immunisation (Fig 3.34B). In terms of the effector CD4 T cell 
response, TLR5-deficient mice had a significantly greater proportion of effector T cells relative to WT 
mice, regardless of sFliC immunisation, but totals number of effector cells were comparable between all 
four groups of mice.  
 
Antibody responses in sFliC-primed (35 days) WT and TLR5-deficient mice 18 days post-STm 
challenge were examined. Assessment of the anti-STm IgM response revealed TLR5-deficient mice 












assessment of the anti-sFliC IgM response where TLR5-deficient mice had significantly lower IgM titres 
compared to WT mice (Fig 3.35B). Furthermore, TLR5-deficient mice displayed a trend for lower anti-
sFliC IgG1 titres, and had significantly lower IgG2b titres relative to WT mice. These data demonstrate 
that the benefit afforded by sFliC-immunisation upon subsequent STm challenge at day 18 can bypass 
TLR5 ligation. Although some of the properties of sFliC may be induced independently of TLR ligation, 
TLR5 ligation may be involved in antibody responses to sFliC.  
 
3.11 Discussion 
This study examined the immune response to flagellin which can stimulate innate and adaptive immune 
responses. Immunisation with sFliC induced a predominantly Th2 response, irrespective of whether 
mice were immunised with monomeric or polymeric flagellin. This supports earlier studies demonstrating 
flagellin is capable of provoking T and B cell responses with a strong Th2 bias to itself and co-
administered antigens (Cunningham et al., 2004a; Didierlaurent et al., 2004; Huleatt et al., 2007). This 
work addressed this further by examining responses in flagellin-specific T cells. The Th2 response 
induced to sFliC in vivo developed in the absence of exogenous adjuvants. Only a select few antigens 
have been identified with auto-adjuvant activity, tetanus toxoid and pertusis toxin, and in mice and 
humans responses to these antigens are predominantly Th2 (Barnes et al., 2007; Cunningham et al., 
2004a; Didierlaurent et al., 2004; Divekar et al., 2006; Sugai et al., 2005).  
 
It is surprising that flagellin can drive Th2 features, since flagellin signals through TLR5 and initiates 
signalling through MyD88 (Hayashi et al., 2001; Smith et al., 2003a). MyD88-dependent TLR signalling 
is classically associated with Th1 responses (Schnare et al., 2001) and the development of Th2 
responses has been proposed to be independent of this pathway. Nevertheless, Didierlaurent and 
colleagues demonstrated flagellin promoted Th2-type immunity through MyD88 signalling (Didierlaurent 
et al., 2004). Additionally, we found that despite deletion of part of the putative TLR5 binding site 
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(Andersen-Nissen et al., 2005) immunogenic properties affiliated with sFliC immunisation, such as the 
induction of GC and antibody switching to IgG1 were maintained. Therefore, it is probable that this 
region of flagellin is not fully responsible for TLR5 ligation or TLR5 ligation may not be fully responsible 
for the properties of sFliC which we assessed. Indeed, recently a recombinant flagellin from C. jejuni 
was constructed in which TLR5 activity was reconstituted (de Zoete et al., 2010). Activation of TLR5 in 
this construct required the presence of a β-hairpin domain in addition to the putative TLR5 motif (Smith 
et al., 2003a).  
 
Antibody responses (IgM and IgG subclasses) to flagellin were reduced in TLR5 deficient mice relative 
to WT mice. This was surprising as TLR5-deficient mice have been shown to maintain comparable 
antibody responses to flagellin as WT mice, whilst the dual loss of TLR5 and Ipaf has been shown to 
markedly reduce humoral responses to flagellin (Vijay-Kumar et al., 2010). In the main, the mechanism 
by which flagellin functions remains poorly understood. Although it is not clear why sFliC drives a Th2 
response, our ongoing work has now revealed differences in the DC populations in response to STm or 
sFliC, which can influence the direction of T cell polarisation. This work by Dr. A. Flores-Langarica 
shows that STm needs to recruit monocyte-derived DC to drive Th1 responses. Thus, the reason sFliC 
may induce a Th2 response may be because it fails to recruit this additional DC subset. 
 
We found co-immunisation with STm and sFliC suppressed the Th1 response to STm. This was not 
observed when alum-precipitated ovalbumin was co-administered with STm, nor was it apparent in our 
dual infection model, with the Th2 inducing parasite N. brasiliensis and STm (discussed in Chapter 
Five). This suggests that Th2 suppression of Th1 responses does not always occur when divergently 
polarising antigens are given, such as whole pertussis vaccine with alum-proteins. Indeed Th1 and Th2 
responses to co-administered antigen can develop in parallel in the same lymph node (Toellner et al., 
1998). This implies that sFliC has a specific capacity to mediate this effect, perhaps through the need to 
signal through TLR5, whilst alum may be able to function through a TLR-independent mechanism 
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(Gavin et al., 2006). It would be interesting to assess if this suppression is apparent in TLR5 deficient 
mice and to elucidate the mechanism through which it occurs as IL-10 did not appear to be a likely 
candidate. Nevertheless, it does suggest that the combination in which component antigens are 
administered may affect the properties of the primary response initiated, and should be considered in 
vaccine design.  
 
Directing the immune response to an antigen has been a significant focus of research, particularly for 
adjuvants, because the type of T cell help initially induced to an antigen can indicate whether it will 
confer protection. The absolute need for this is challenged by our findings. Indeed, despite the Th2 
polarisation of sFliC and its remarkable capacity to suppress IFNγ upon co-administration with STm, 
sFliC immunised mice showed enhanced protection upon STm challenge. Surprisingly, this benefit 
afforded by sFliC immunisation was driven by augmentation of the Th1 response to STm upon 
subsequent infection.  
 
Th2 differentiation to sFliC was the dominant CD4 subset in the primary response, and only low levels of 
IL-17 producing CD4 T cells, FoxP3+ regulatory T cells and BCL6+ follicular T-helper cells were 
detected post-sFliC immunisation (data not shown). Nevertheless, it is possible that other primed CD4 T 
cell subsets were recruited into the response upon STm challenge. Indeed, it is also possible in this 
model that T cells specific to antigens other than flagellin account for this effect and that flagellin simply 
mediates the effect. This could be easily tested by priming mice with flagellin and subsequently infecting 
with aflagellated STm. 
 
Historical studies have postulated that Th1 and Th2 subsets are mutually suppressive as they reinforce 
their own development whilst reciprocally inhibiting other differentiation programs (Szabo et al., 1997; 
Usui et al., 2006). For example, several reports have found Th2 cells are stably committed and resistant 
to re-programming towards Th1 in-vitro (Murphy et al., 1996; Szabo et al., 1995). Nevertheless, it is 
possible that the polarisation of T cells to Th2 may not be stable throughout the course of a STm 
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infection in vivo. Thus, the increased numbers of Th1 cells seen after STm infection of sFliC-primed 
mice could result from the redirection of Th2 cells to Th1. Indeed, it was recently demonstrated that the 
Th1 cell promoting lymphocytic choriomeningitis virus (LCMV) re-programmed otherwise stably 
committed Th2 cells to adopt a GATA-3+T-bet+ phenotype, with a remarkable capacity to co-produce 
Th1 and Th2 cytokines (a feature also displayed by NK T cells) which was stably maintained in vivo for 
months (Hegazy et al., 2010). Our study supports this and we illustrate the likelihood of Th2 plasticity in 
vivo in a different infection model. This is of particular importance in allergy and asthma where the 
persistence of Th2 cytokines is associated with exacerbation of disease and such re-programming may 
offer an avenue for potential treatment. 
 
As primary T and B cell responses to sFliC were T-bet independent it was possible that the Th1 
augmentation after sFliC would also be T-bet independent. Indeed, although the expression of T-bet is 
often required for the induction of IFNγ, T-bet can be dispensable in other infections (Way and Wilson, 
2004; Ylikoski et al., 2005). In contrast, LCMV-specific in vitro-primed Th2 cells can redirect to Th1 in 
vivo and produce IFNγ in a T-bet-dependent manner (Hegazy et al., 2010). Similarly, our study supports 
this as we found the enhanced Th1 response in sFliC-immunised mice also required T-bet. Interestingly, 
the LCMV study demonstrated the acquisition of additional Th1 attributes by stable committed Th2 cells 
was marked by a mixed response, as cells co-expressed GATA-3 and T-bet as well as Th2 and Th1 
cytokines (Hegazy et al., 2010). However, we failed to detect any IL-4 by ELISPOT in sFliC-immunised 
mice 18 days post STm-challenge suggesting sFliC-primed Th2 cells may not have retained their initial 
differentiated state (or their frequency may be lower than the detection level for ELISPOT). 
 
Additionally, it has been demonstrated that antigen stimulation of naïve CD4 T cells in vivo and in vitro 
can lead to the production of a unique subset of primed, but uncommitted (precursor) CD4 T cells which 
fail to induce the characteristic cytokine profile of Th1 and Th2 responses (Wang and Mosmann, 2001; 
Yang and Mosmann, 2004). These studies were expanded to show that human CD4 T cells primed by 
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protein subunit vaccines largely remain uncommitted, and this population of uncommitted CD4 T cells 
induced by protein vaccines could differentiate into Th1 or Th2 phenotypes under appropriate polarising 
conditions. These primed, uncommitted precursor cells may constitute an expanded pool of antigen-
specific T cells which have the potential to differentiate into Th1 or Th2 phenotypes during subsequent 
responses (Divekar et al., 2006; Wang and Mosmann, 2001; Yang and Mosmann, 2004). The data from 
our study may also mean that primed, yet non-committed CD4 T cells, act as a reservoir from which the 
enhanced Th1 responses after STm infection of sFliC-immunised mice are derived.  
 
The direction of the T-helper response may be of secondary importance if protective antibody responses 
are induced, as most vaccines work through antibody. Potent antibody responses were induced to 
flagellin which had the capacity to inhibit the motility of STm. Despite these functional attributes, 
antibody to flagellin did not have a significant role against systemic STm infection in these studies. 
Indeed, we found antibody to surface isolated flagella was able to impair subsequent infection with STm 
at day 5. However, this was attributed to contaminants within the preparation (data not shown) which 
emphasises the purity of our recombinant flagellin preparation and demonstrates that antibody to highly 
pure flagellin would not be protective.  
 
Interestingly, although limited, antibody to flagellin was able to moderate infection with STm when the 
ability of STm to phase-switch its flagellin genes was compromised. There is some evidence that FljB-
locked STm is attenuated in vivo (Bergman et al., 2005). Furthermore, O’Brien and colleagues 
demonstrated FliC-locked STm had a selective advantage over FljB-locked STm once in the tissues 
(Ikeda et al., 2001), and although we used a different route of infection (intraperitoneal rather than 
intravenous or oral) we found differences between the two strains to be modest. Indeed, even after 
infection of sFliC-immunised mice with FliC-locked STm the benefit afforded by antibody was small and 
was not sustained at day 18. The limited benefit afforded by antibody to flagellin is surprising as we 
have previously shown antibody can reduce bacterial numbers by several orders of magnitude (Gil-Cruz 
136 
 
et al., 2009), and antibody to STm is clearly important at preventing infection in humans and mice (Gil-
Cruz et al., 2009; MacLennan et al., 2008; McSorley and Jenkins, 2000).  
 
The benefit afforded by sFliC immunisation was antibody-independent and provided entirely through 
CD4 T cells, but only operated after the end of the first week of a subsequent STm infection. The 
inability of CD4 T cells to protect early in infection was surprising, as more than 50% of CD4 T cells 
were activated by day 14 in primary responses to sFliC (data not shown) indicating the potency of 
flagellin for driving adaptive responses, as in agreement with other studies (Alaniz et al., 2006; McSorley 
et al., 2002b). As the benefit afforded by sFliC immunisation was late in the response to STm this has 
two implications: firstly, it suggests that T cells in recall responses do not promote accelerated bacterial 
clearance after STm infection. Thus, sFliC-immunisation may not confer significant protection against 
virulent strains of STm as its contribution to immunity is made when infection is already well established. 
Secondly, it suggests that there is some bioavailability of flagellin during infection. There is some 
evidence that flagellin synthesis, expression and availability is down-regulated during intracellular 
infection in macrophage-like cells (Alaniz et al., 2006; Cummings et al., 2005; Cummings et al., 2006; 
Hautefort et al., 2008). However, other studies suggest suppression of flagellin synthesis and 
expression may not be absolute during infection (Srinivasan et al., 2004; Subramanian and Qadri, 
2006). Indeed, it was demonstrated that bacterial recognition and contact with host cell 
lysophospholipids can induce the active synthesis and secretion of monomeric flagellin, which through 
activation of TLR5 and subsequent recruitment of inflammatory cells to the site of infection, could 
promote systemic dissemination (Subramanian and Qadri, 2006). 
 
Nevertheless, it is unclear whether the modest T cell-mediated protection after flagellin immunisation is 
because CD4 T cells induced after immunisation are not efficient at promoting bacterial killing, or 
whether only a proportion of infected cells contain flagellin-expressing bacteria. Flagellin phase-
switching is unlikely to promote immune evasion since CD4 T cell responses to FliC are directed against 
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multiple epitopes which co-localise in the conserved regions of the protein. Furthermore, CD4 T cells 
are able to recognise both FliC and FljB, although with a small bias towards FliC (Bergman et al., 2005; 
Ikeda et al., 2001). Interestingly, this conserved region of the STm FliC protein also contains the T cell 
epitope recognised by SM1 CD4 T cells (McSorley et al., 2002b) and this site is conserved across 
several Gram-negative enteric bacterial species. Therefore, this offers the possibility that sFliC 
vaccination could provide broad acting T cell, but not B cell, mediated immunity. 
 
The adjuvant properties of flagellin (Bergman et al., 2005; Cunningham et al., 2004a; Didierlaurent et 
al., 2004) underlie the rationale of employing it in vaccine preparations. Indeed, its intrinsic adjuvant 
activity is currently being employed in experimental recombinant vaccines against human influenza, 
West Nile fever, malaria and tuberculosis (Bargieri et al., 2008; Honko et al., 2006; Le Moigne et al., 
2008; McDonald et al., 2007; Song et al., 2008). In closing, although sFliC induced potent humoral and 
cellular immune responses, only cellular immunity was able to modestly contribute to controlling 
infection, and then only from the second week. Therefore, the potential of sFliC as a subunit vaccine 
has major drawbacks, largely due its failure to promote antibody-mediated immunity means it may not 













4.0 The porin OmpD is a key target for a protective B1b cell 
antibody response against NTS 
4.1 Introduction 
The identification of antigens that can induce protective antibody is fundamental in vaccine design. 
Whilst antibody does not impact upon clearance of primary STm infection or the intracellular phase of 
bacterial growth (Cunningham et al., 2007; Mastroeni et al., 2000; McSorley et al., 2000; Mittrucker et 
al., 2000), the extracellular growth of bacteria in the blood requires humoral immunity. Antibody present 
at the time of infection has been shown to be effective in moderating bacteraemia (Cunningham et al., 
2007; Mastroeni and Menager, 2003) which may be pivotal in the control of NTS infections. 
 
NTS infections in SSA cause a progressive bacteraemia in HIV+ adults and children, and is a strong 
correlate of disease severity, killing around 50% of infected individuals. Additionally, NTS infections also 
cause fatal disease in children under the age of two who are HIV negative. The period of initial 
susceptibility in these infants coincides with when maternally acquired antibody levels wane and occurs 
before the development of STm-specific antibody (MacLennan et al., 2008). Indeed, this risk inversely 
correlates with the presence of specific antibody which provides compelling evidence that antibody is 
important in NTS infections, and restricting bacteraemia is likely to be central to controlling disease.  
 
Previously we reported that STm induces atypical antibody responses characterised by an early, 
accelerated expansion of extra follicular (EF) plasma cells without the parallel induction of Germinal 
Centres (GCs). The early switched antibody response was T-dependent (TD), and OMPs were major 
targets of this response (Cunningham et al., 2007). The outer membrane of STm contains many OMPs 
including the related porins OmpC, OmpD and OmpF which can associate to form trimers. In the 
absence of exogenous adjuvants purified porins from ST can induce an atypically sustained antibody 
response that confers bacteriocidal benefit against ST (Secundino et al., 2006). These properties in 
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combination with our earlier work showing OMPs were an early antibody target (Cunningham et al., 
2007), prompted this assessment of the properties of the antibody response to purified porins isolated 
from STm. Particular emphasis was placed on whether immunisation with STm porins can provide 
protection against a systemic STm infection. 
 
4.1.1 Experimental Design  
The characteristics of the antibody response to purified porins from STm were examined by assessing 
the following: 
 
1. Early B cell switching to IgG2a in response to OMPs was TD. Using TCR-deficient mice, 
whether induction of the early EF plasma cell response to OMPs also required T cells was 
assessed. 
 
2. To ascertain whether porin immunisation could provide protection against a subsequent 
systemic STm infection, and whether this could offer cross-protection against other Salmonella 
serovars a prime-challenge model of infection was used. All challenges post-porin immunisation 
were with the attenuated SL3261 strain unless stated otherwise. Highly purified porins isolated 
from STm were kindly provided by our collaborator Prof. C. Lopez-Macias.  
 
3. The STm porins in this study are trimeric complexes, by utilising different STm strains bearing 
selective deletions of specific OMPs the relative contribution of the individual porins OmpC, 




4.2. STm induces a TI plasma cell response against porins in the outer 
membrane  
Previous studies have reported STm induces a rapid and extensive antibody response, and that a major 
target of the early switched response were the OMPs, and not LPS or sFliC (Cunningham et al., 2007). 
As this EF plasma cell response was apparent by day 4 its induction suggested a T-independent (TI) 
element. To further dissect this, the response in βδTCR-deficient mice (TCR-deficient) was assessed. 
TCR-deficient mice were infected intraperitoneally with 5x105 STm for 4 days. Spleens were isolated 
and sections were generated for immunohistology which were double-stained for CD138 (a plasma cell 
and plasmablast marker) and IgD (to identify follicular B2 cells) (Fig 4.1A). Quantification of the number 
of CD138+ cells demonstrated that infection with STm resulted in an increase in these cells by day 4 
relative to NI TCR-deficient mice. 
 
The specificity of this antibody response against a preparation of homogenised total STm by ELISA was 
then assessed. This revealed that the observed increase in CD138+ plasma cells upon STm infection 
was paralleled by a rapid induction of STm-specific serum IgM, which was significantly enhanced 
relative to NI mice (Fig 4.1B). Subsequently, this anti-STm IgM response against a range of surface 
components associated with the outer membrane of STm was further examined. This revealed serum 
IgM in TCR-deficient mice infected with STm was also strongly induced to LPS and a preparation 
containing a mixture of total OMPs, but was less marked in response to sFliC (Fig. 4.1B). Therefore, this 
early EF plasma cell response developed rapidly in the absence of T cells and a major target of this 
antibody response were OMPs. Since IgG levels did not increase above background levels (data not 
shown) it suggests that T cell help was required to induce switching as demonstrated by our previous 
work (Cunningham et al., 2007). 
 
It was surprising that proteins could induce a TI antibody response, so we focussed on this by assessing 






co-purifying porins OmpC, OmpD, and OmpF, which are referred to as porins hereafter. The porins 
were prepared by Dr Cristina-Gil Cruz in collaboration with Prof. C. Lopez-Macias as described in 
Appendix C. Before assessing the in vivo response to the porins their identity was confirmed by trypsin 
digest and QTOF mass spectrometry (data not shown). Subsequent to this, their purity was examined 
by SDS PAGE which revealed a highly purified protein at the expected molecular weight (Mr = ≈ 38 
kDa). Upon more extensive separation using a higher percentage acrylamide gel it was apparent that 
the purified porins contained OmpC (36 kDa) and OmpD (34 kDa), with trace amounts of OmpF (35 
kDa) (Fig. 4.2A).  
 
Once the purity and identity was confirmed the structural composition of the porins was examined. 
Quantitative structural analysis using circular dichroism (CD) revealed a characteristic CD spectra of a 
folded protein with an absorbance spectrum consistent with that of β-sheets (minimum at 218 nm), 
suggesting that the protein was folded in a native conformation (Fig. 4.2B). Furthermore, the porins 
were separated by SDS-PAGE under heat-denaturing conditions at 100°C or under semi-native 
conditions at 25°C. This showed when heated to 100°C in SDS PAGE sample buffer, purified porins 
migrated at their expected molecular mass of 38 kDa, but under semi-native conditions porins migrated 
mostly as a 70-kDa protein (Fig 4.2B). This suggested that a large portion of the porins adopted a β-
barrel conformation, which is stable in SDS unless heated (Sugawara et al., 1996). Interestingly, this 
heat-modifiable mobility displayed by porins to SDS PAGE is a feature of folded β-barrels such as 
porins (Nikaido, 1996). Finally, the structural conformation of porins in solution was examined using 
analytical ultracentrifugation. The mass profile from the sedimentation coefficient (rate of movement) of 
the porins had a broad distribution with a peak coefficient of 8.1, indicative of oligomeric structures with 
a molecular weight of 120-240 kDa, suggesting they adopted a trimeric or hexameric configuration (Fig 
4.2B). The structural and biophysical assessments demonstrated the porins isolated from STm were 
folded in a native conformation and formed oligomeric structures, which was consistent with their normal 






Following porin characterisation, it was assessed whether they could induce an antibody response in 
the absence of T cells by immunising TCR-deficient mice with 20 μg porins intraperitoneally. Spleen 
sections were generated 7 days post-immunisation for immunohistology and double-stained for IgM and 
IgD (Fig 4.3A). Qualitatively, this revealed mice immunised with porins induced a substantial IgM 
response relative to NI mice. We next examined antigen-specificity by ELISA and western blot analysis. 
Both methods confirmed that immunisation with porins induced a large increase in anti-porin IgM 
relative to NI mice (Fig 4.3B). Western blot analysis demonstrated that IgM in sera from NI and porin-
immunised TCR-deficient mice were both able to detect non-porin targets induced independently of 
porin immunisation (Fig 4.3C the band at 27 kDa). Thus, both groups of mice had natural IgM that 
bound some STm proteins. However, only porin-immunised mice specifically reacted with the porin 
target, which was rarely bound by natural antibody (only one out of seven sera showed some reactivity). 
These data demonstrate that a porin preparation can induce an early and prominent plasma cell 
response in the absence of T cells. Furthermore, since natural antibody can recognise some 
components in STm, the binding of natural antibody is likely to be insufficient in immunity to STm. This 
point has been verified by challenge of WT and B cell deficient mice (data not shown). 
 
4.3 The anti-porin IgM response is sufficient to impair STm infection 
The antibody titres induced by vaccines can be a good marker for the degree of protection (Engels et 
al., 1998; Xu et al., 1993). Since immunisation with porins induced a robust antibody response, whether 
antibody induced after immunisation with a single dose of porins could reduce the bacterial burden of a 
subsequent STm infection was examined. WT mice were immunised intraperitoneally with 20 µg porins 
or 5x106 heat-killed STm and on day 35 they were infected with 5x106 STm alongside NI WT mice (Fig 
4.4A). Heat-killed organisms are used in current vaccines against ST and were therefore, an ideal 
comparative. Assessment of the splenic bacterial burden at day 5 post-STm infection showed mice 









capacity, as both immunogens reduced splenic bacterial burdens by a median 2-3 logs compared to NI 
WT mice. Therefore, a single dose of porins was sufficient to impair subsequent STm infection. 
 
4.4 The protection conferred by porin immunisation requires B cells  
To identify the cellular components necessary for the protection observed upon immunisation with 
porins, the role of B cells was examined. To do this, WT mice and B cell-deficient mice (IgH-deficient) 
were immunised intraperitoneally with 20 μg porins and on day 35 they were infected intraperitoneally 
with 5x106 STm for 5 days alongside NI counterparts (Fig 4.4B). The spleen mass was broadly 
equivalent between the groups, except porin-immunised IgH-deficient mice had significantly larger 
spleens relative to porin-immunised WT mice. Assessment of the splenic bacterial load revealed 
bacterial numbers were equivalent between immunised and NI B-deficient mice, whereas porin 
immunised WT mice had a markedly reduced bacterial load relative to NI mice and porin-immunised B-
cell deficient mice. This suggested, B cells were required for the protection provided by porin-
immunisation. 
 
As the protection was B cell mediated and early it suggested that antibodies may be involved through 
their ability to opsonise STm and facilitate phagocytosis. STm was opsonised with complement-
inactivated sera from NI TCR-deficient mice or from TCR-deficient mice immunised with 20 μg porins for 
4 days, and IgH-deficient mice were immediately infected (Fig 4.4C). The spleen mass 5 days post-
infection was significantly lower in mice infected with STm opsonised with immune sera relative to those 
infected with STm opsonised with non-immune sera. Quantification of the splenic and liver bacterial 
burden showed that mice infected with STm opsonised with immune serum, had significantly lower 
bacterial numbers relative to mice infected with STm opsonised with non-immune serum. Therefore, the 
benefit of porin immunisation was mediated through B cells as reductions in bacterial titres were ablated 
if B cells were not present during immunisation, but were restored upon opsonisation of STm. 
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It was apparent that the protection provided by porin immunisation to STm infection was B cell-mediated 
and TI. To assess whether switched antibody conferred additional benefit over and above the IgM 
response, WT and TCR-deficient mice were immunised with 20 μg porins intraperitoneally and on day 
35 they were infected intraperitoneally with 5x105 STm alongside NI counterparts. Assessment of the 
spleen mass 5 days post-infection revealed no differences between WT or TCR-deficient mice, 
irrespective of porin-immunisation, but the spleen masses in porin-immunised mice were significantly 
lower than non-immunised mice (Fig 4.5A). Quantification of the splenic and liver bacterial burden 
demonstrated porin-immunised TCR-deficient mice had a lower bacterial burden than NI TCR-deficient 
mice. However, porin-immunised TCR- deficient mice had a 15-fold and 10-fold higher bacterial load in 
the spleen and liver, respectively relative to porin-immunised WT mice. Subsequently, the anti-porin 
antibody response was assessed by ELISA (Fig 4.5B). This revealed that although the induction of IgM 
was unimpaired in porin-immunised TCR-deficient mice relative to porin-immunised WT mice after 
infection, porin-specific IgG was largely undetectable. Since >90% of the benefit after porin 
immunisation was mediated through switched antibody it means promoting T cell recruitment is 
important because in the absence of T cells, IgG switching is diminished.  
 
4.5 Porin immunisation is effective in eliminating bacteraemia and 
protecting against virulent STm  
Bacteraemia is a marker of severity during NTS infections so the influence of porin immunisation on the 
blood bacterial burden was assessed. WT mice were immunised intraperitoneally with 20 μg porins and 
infected on day 35 with 5x106 STm alongside NI mice. Quantification of the bacterial burden in the blood 
on day 5 post-infection (which we have historically shown is the peak of the bacteraemia (unpublished 
findings)) revealed the median bacteraemia in NI mice was 6000 bacteria per ml, but no bacteria were 
cultured from the blood post porin-immunisation (Fig. 4.6A). Thus, antibody induced against porins is 









As virulent strains of NTS induce infections in clinical settings it was assessed whether anti-porin 
antibody could moderate infection with the virulent STm strain, SL1344. WT mice were immunised with 
20 μg porins and infected intraperitoneally on day 35 with 3000 SL1344 organisms alongside NI mice 
(Fig. 4.6B). A single porin immunisation reduced splenic and liver bacterial numbers 4 days after 
infection by 20 and 40 fold respectively relative to NI mice. Whether a second porin immunisation could 
enhance this affect was then examined. WT mice were immunised with 20 μg porins twice for 14 days 
and subsequently infected with SL1344 as before (Fig 4.6C). Quantification of the bacterial burden 
demonstrated that when porin-immunised mice were boosted with a second porin immunisation, splenic 
and liver bacterial numbers were reduced by 1700 and 400 fold respectively at day 4 post infection 
relative to NI mice. Additionally, assessment of the blood bacterial load revealed mice boosted with 
porins had a significantly lower blood bacterial load (median = 30) relative to NI mice (median = 105). 
 
To eliminate the possibility that residual LPS contamination could account for these findings, and to 
elucidate whether porins from ST could provide cross-protection against STm, WT mice were 
immunised intraperitoneally with either 20 μg of TLR grade LPS from STm or 20 μg of highly purified 
porins from ST or STm. Mice were then infected on day 35 with 5x105 STm (Fig 4.7). Quantification of 
the splenic bacterial burden 5 days post-infection showed that TLR grade LPS did not confer protection 
against STm. Surprisingly, the same porin preparation from ST did not confer protection to STm relative 
to porins isolated from STm, despite the high degree of homology between OmpC and OmpF from 
these two serovars. These data show that a single immunisation with porins can moderate subsequent 
infection with virulent STm through reduction in bacterial numbers, which although could prolong 
survival, would not prevent death. Interestingly, the protection conferred by porins showed species-








4.6 Antibody to the porin OmpD is sufficient to impair STm infection 
A major difference between the outer membranes of STm and ST is the absence of the porin OmpD in 
ST (Santiviago et al., 2003). This suggested that responses observed against STm porins may be 
directed against this third STm porin. To test whether OmpD specific antibody could account for the 
differing results observed after immunisation with STm or ST porins, WT mice were immunised 
intraperitoneally with 20 μg porins and infected on day 35 alongside NI mice with either STm or STm 
lacking OmpD, and responses assessed 5 days post-infection (Fig. 4.8A). Assessment of the spleen 
mass showed no differences between mice infected with STm or STm lacking OmpD, irrespective of 
porin immunisation. As expected, splenic and liver bacterial numbers were markedly reduced in porin-
immunised mice upon subsequent challenge with STm relative to NI mice. Interestingly, splenic and 
liver bacterial burdens were equivalent between NI and porin-immunised mice after subsequent 
challenge with OmpD-deficient STm. This suggests deletion of OmpD is not further attenuating for STm, 
at least at this stage of the infection. Subsequently, bacterial numbers in the blood were assessed and 
despite the failure to confer protection in the tissues, porin-immunisation offered some protection 
against bacteraemia upon challenge with OmpD-deficient STm (Fig. 4.8B).  
 
The failure to confer protection upon infection with OmpD-deficient STm in porin-immunised mice could 
be correlated with the failure of anti-porin antibody to bind to the porin target in OmpD-deficient bacteria, 
as identified earlier. IgM-specificity of sera isolated from TCR-deficient mice immunised with porins for 7 
days and NI controls was examined by western blot analysis, against a total OMP preparation isolated 
from STm and OmpD-deficient STm (Fig. 4.8C). This showed that non-immune sera recognised the 
same targets in the OMP preparation from STm and STm-lacking OmpD. However, anti-porin IgM 
bound the porin fraction in STm that were OmpD sufficient, but failed to bind to the porin fraction in the 
OMP preparation from STm that were OmpD-deficient. This suggested that OmpD was possibly a target 






As an additional control, the relative contribution of the individual porins to offer protection against STm 
infection was investigated by repeating this study using STm lacking the transcription factor OmpR, 
which fail to express OmpC and OmpF, but continue to express OmpD. WT mice were immunised with 
20 μg porins and infected on day 35 alongside NI mice with either STm or STm lacking OmpR and 
responses were assessed 5 days post-infection (Fig. 4.9A). Assessment of the spleen mass showed 
porin-immunised mice had significantly smaller spleens relative to NI mice, irrespective of infection with 
STm or OmpR-deficient STm.  
 
Quantification of the splenic and liver bacterial burden demonstrated that OmpR-deficient STm were 
intrinsically more attenuated than STm, as bacterial numbers were significantly lower than mice infected 
with STm, regardless of porin-immunisation, in agreement with earlier studies (Dorman et al., 1989; 
Meyer et al., 1998). Nevertheless, porin-immunisation markedly reduced bacterial numbers further in the 
tissues of mice subsequently infected with OmpR deficient STm (Fig. 4.9A). Furthermore, assessment 
of the blood bacterial load revealed bacteraemia was not detectable in porin-immunised mice upon 
subsequent infection with OmpR deficient STm, relative to NI mice (Fig. 4.9B). This indicates that OmpF 
and OmpC are dispensable for the protective function of porins. 
 
Finally the IgM-specificity of sera was assessed by western blot analysis as before, against a total OMP 
preparation isolated from STm and OmpR-deficient STm (Fig. 4.9C). Immunoblot analysis revealed that 
anti-porin IgM antibody bound the porin fraction in STm that were OmpR-sufficient and OmpR-deficient. 
These data demonstrate that whereas porin-immunisation induced protection against STm lacking both 
OmpF and OmpC, porin-immunisation did not moderate infection when mice were subsequently 
challenged with STm lacking OmpD. This indicates that OmpD is an important immunogenic target of 
antibody to STm, and antibody to OmpD alone is sufficient to provide protection against subsequent 







4.7 Porin-Immunisation induces an increase in the peritoneal B1b cell 
population 
The data thus far showed that the effectiveness of porin immunisation was wholly dependent upon B 
cells, and the induction of antibody to these proteins could occur in the absence of T cells. In 
conjunction with Drs. JL Marshall and C. Gil-Cruz WT mice were immunised intraperitoneally with either 
20 μg of the following: porins, TLR Grade LPS or sFliC or 5x106 heat killed STm or 5x105 STm and 
peritoneal responses were assessed 4 days later using 7 colour FACS, alongside NI mice (Fig. 4.10). B 
cells were gated from the lymphocyte population as CD19+ and IgM+ cells. In the peritoneum B1 cells 
were gated to remove B2 cells as a CD21 and CD23 low/negative population. This population of B cells 
was examined for CD5 and B220 expression, and the B1b B cell population was gated as CD5-B220int. 
Phenotypically, the B1b population was characterised as: CD19+IgM+B220intCD5- with low CD21 and 
CD23 expression. 
 
Relative to NI mice immunisation with porins showed a significant induction of B cells with 
characteristics of B1b B cells (Fig 4.10). This population of B1b B cells was also significantly induced in 
response to viable STm and surprisingly by highly purified LPS, but it was not induced by heat-killed 
STm or sFliC. We then characterised CD11b expression by B1b B cells, as this has historically been 
used to define B1 B cells (Wells et al., 1994). This revealed that CD11b expression was significantly 
lower in mice infected with viable STm relative to NI mice, and generally, CD11b expression was 
variable between the groups. However, this was not surprising since CD11b- B1b B cells have the 
potential to become CD11b+ after transfer into lymphopenic recipients, and its expression instead may 








Subsequent to this, we assessed if this B1b population detected in response to porins was induced in 
the absence of T cells. TCR-deficient mice were immunised with 20 μg porins or infected with 5x105 
STm intraperitoneally, and peritoneal B cell responses were assessed 4 days later alongside NI mice 
which were gated as before (Fig 4.11). As can be seen mice immunised with porins or infected with 
STm showed a significant induction of B1b B cells relative to NI mice. Furthermore, as observed with 
WT mice the expression of CD11b by B1b B cells was variable. These data presented here demonstrate 
that viable STm and porins induce a peritoneal population of TI B cells that have a B1b B cell 
phenotype. 
 
4.8 Anti-Porin antibody from B1b B cells is sufficient to impair 
subsequent STm infection 
Finally we sought to assess whether antibody produced by B1b B cells in response to porin 
immunisation could impair STm infection. To do this, peritoneal B220+CD5- B cells were sorted from NI 
WT mice. 2x105 of these sorted were adoptively transferred into IgH-deficient mice to generate B1b B 
cell chimeras that lack B1a cells and have relatively few B2 cells (Fig. 4.12A) (Hsu et al., 2006). 
Although this population of transferred cells would include some B2 follicular cells, these cells do not 
expand after transfer into lymphopenic mice, and consequently will only contribute a small proportion of 
the final B cell population after expansion of B1b cells (Sprent et al., 1991). To establish that the 
transferred B cells re-populated the IgH deficient mice the serum IgM levels of the B1b B cell chimeras 
was assessed by ELISA 20 days after adoptive transfer. This revealed the chimeras were able to 
produce natural IgM antibody in the absence of porin immunisation, and as expected, this did not react 












Having established that the transferred B cells re-populated in IgH deficient mice we generated B1b B 
cell chimeras as before. After transfer (48 hours), B1b B cell chimeras and IgH-deficient mice were 
immunised with 20 μg porins. After 20 days the success of immunisation was confirmed by measuring 
anti-porin IgM titres from these mice. This showed that only immunised-chimeric mice induced an anti- 
porin IgM response relative to IgH-deficient mice (data not shown). The next day, the porin-immunised 
chimeras, porin-immunised IgH-deficient mice and NI IgH-deficient were infected with 5x105 STm. 
Quantification of the splenic bacterial burden at day 5 post STm-infection revealed that only the 
chimeric-mice that received both peritoneal B1b B cells and were immunised with porins, were able to 
impair STm infection. IgH-deficient mice that were immunised with porins in the absence of B1b cells 
had bacterial numbers equivalent to NI IgH-deficient mice (Fig 4.12B). This demonstrates that only 
those mice that had anti-porin antibody at the time of infection were able to impair STm infection. As a 
further control we also examined the B cell content of the peritoneal cavity in the generated chimeras 
(Fig. 4.12C). This revealed an absence of B cells in porin-immunised IgH-deficient mice that were 
present in porin-immunised chimeras. The peritoneal B cell population in the chimeras was IgM+ and 
approximately half of these isolated cells were also CD11b+. This suggested that TI antibody isolated 
from B1b B cells induced in response to porins is sufficient to impair infection with STm. 
 
Importantly, this study shows that a single immunisation with porins from STm, but not ST can reduce 
bacterial colonisation by both attenuated and virulent strains of STm. Protection was shown to be due to 
antibody directed against OmpD, a porin present in STm but absent in ST, since ST porins fail to protect 
against STm infection and STm porins fail to protect against OmpD-deficient STm. This protection was 







This study examined responses to a highly purified preparation of porins isolated from STm containing 
the OMPs, OmpC, OmpD and OmpF. OmpD is a trimeric porin that shares a degree of homology with 
OmpF and OmpC, primarily in the barrel structure (Benz et al., 1980; Nikaido, 2003). Despite 
representing the most abundant OMP in STm its role in infection has been understudied relative to 
OmpF and OmpC, presumably due to its absence in ST. The loss of OmpD on virulence has not been 
fully investigated whilst the loss of OmpR, which regulates expression of OmpC and OmpF, profoundly 
affects virulence (Dorman et al., 1989; Meyer et al., 1998). Although, this is likely to be because of other 
effects of OmpR, including its proposed regulation of SPI-2 genes through interactions with the 
SpiR/SsrB two-component system (Feng et al., 2003). Interestingly, the virulence of Salmoporc (a 
licensed live STm vaccine for pigs) and a mutant lacking OmpD (SalmoporcΔOmpD) are 
indistinguishable in terms of the LD50 in BALB/c mice . This suggest that loss of OmpD is not further 
attenuating in STm Salmoporc (Selke et al., 2007) which is in agreement with our studies using OmpD-
deficient SL3261.  
 
Purified porins are immunogenic in mice and rabbits (Hofstra and Dankert, 1981; Overbeeke et al., 
1980) and were identified over 20 years ago as potentially protective antigens. However, there has been 
debate about the role of contaminating LPS in purified porin preparations, and whether the response 
was actually directed against LPS (Barber and Eylan, 1976; Bhatnagar et al., 1982). Indeed, some 
porins including OmpF are known to exist as a protein-LPS complex, with at least one LPS molecule 
tightly associated with each trimer. Consequently, the immunogenicity of porins has been disputed 
(Kuusi et al., 1981; Ried et al., 1990). Furthermore, a recent study identified that classically prepared 
LPS preparations are often contaminated with compounds such as peptidoglycan or proteins such as 
OmpA (Hirschfeld et al., 2000; Ried et al., 1990). In this study LPS was unlikely to be a potential 
confounder since purified porins had undetectable levels of LPS contamination (< 0.01 EU/100 μg of 
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porins). Furthermore, immunisation with highly purified STm LPS did not moderate infection with STm. 
Additionally, infecting porin-immunised mice with OmpD-deficient STm that were LPS-sufficient, resulted 
in the loss of binding of anti-porin antibody to OmpD-deficient bacterial cell walls, and the associated 
loss of benefit from porin immunisation. Together these findings strongly implicate that antibody to 
porins, and in particular OmpD, not LPS can moderate infection with STm. 
 
Multiple studies have assessed the potential of porins as vaccines to STm, often with conflicting results. 
Some studies have demonstrated that immunisation with porins can induce long-lasting immunity 
against STm (Isibasi et al., 1994; Matsui and Arai, 1990; Singh et al., 1999). Other studies have shown 
no benefit from porin immunisation (Singh et al., 1996). This latter study demonstrated that the passive 
transfer of anti-porin monoclonal and polyclonal antibodies could not prevent death, but significantly 
extended survival. However, it was not clear if the antibodies used by (Singh et al., 1996) sufficiently 
covered the full breadth of the potential porin epitope repertoire. Indeed, epitope mapping studies have 
shown a lack of cross-reactivity between surface binding monoclonal antibodies to these three porins. 
Moreover, even within OmpD many antibodies only recognise the protein when in trimeric form but not 
in monomeric form (Pai et al., 1992). This suggests that these exposed regions are under selective 
pressure by the immune system and may mean that a broad range of epitopes need to be recognised to 
obtain the maximum benefit from immunisation.  
 
Isolated porins from STm containing the OMPs OmpC, OmpD and OmpF could induce a rapid and 
strong antibody response which had the capacity to moderate infection with STm. Moreover, this porin-
induced protection could reduce STm infection as effectively as immunisation with heat-killed STm. 
Heat-killed bacteria have been established as an effective vaccine used to protect against typhoid in 
humans, and can confer comparable protection as current subunit vaccines (Guzman et al., 2006), 
possibly even more so than live vaccines (Engels et al., 1998). In addition to reducing bacterial loads in 
the tissues we found anti-porin antibody was effective at restricting bacteraemia. The greatest proxy for 
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disease severity in NTS is bacteraemia which can be fatal (Graham et al., 2000). The peak incidence of 
this complication is in children and coincides with the loss of passively acquired maternal IgG, and 
before acquisition of adaptive immunity. Indeed, nearly all children have antibody to NTS by the age of 
three which correlates with decreased susceptibility (MacLennan et al., 2008). It is tempting to 
hypothesise that since children in this age-group have an impaired capacity to respond to TI-2 antigens 
that one of the predisposing risks to NTS, is this inability to make antibody responses to STm porins, 
which enhances the likelihood of bacteraemia and complications resulting in death.  
 
The sterilising immunity necessary to protect against infection with virulent STm SL1344 in susceptible 
strains of mice may overstate the degree of immunity required to protect against NTS or typhoid in 
humans. This is because whilst protection to SL1344 identifies absolute protection anything less will 
mean potentially effective vaccine candidates will be missed. Furthermore, NTS bacteraemia is 
generally of a low grade (less than a hundred organisms per ml of blood) and therefore, the same 
kinetics of protection may not apply for NTS and typhoid. We consistently saw reductions in bacterial 
numbers of 50-1000 fold in the tissues, irrespective of whether the infecting organism was virulent or 
attenuated - levels of protection comparable to killed organisms that are used as current vaccines 
against typhoid. Whilst it is unlikely that antibody to STm-porins can offer sterilising immunity, it may be 
sufficient to diminish bacterial numbers at the time of infection and the extracellular dissemination that 
can lead to fatal bacteraemia. Thus, even modest reductions in bacterial numbers may result in 
substantial clinical benefits for NTS. In this study we have not attempted to optimise the potential dose 
or route of porin administration but to identify OmpD as a vaccine candidate that may work primarily 
through a TI route. Indeed, unsurprisingly in WT animals an additional dose of porins enhanced 
protection and we are currently assessing whether this is sufficient to augment the response. 
 
Both viable STm and STm porins induced antibody through recruitment of a population of B1b B cells in 
the absence of T cells. Antibody from B1b cells induced in response to porin immunisation was sufficient 
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on its own to moderate infection. For typhoidal strains of Salmonella, responses induced upon 
vaccination of adults with capsular polysaccharide (Vi antigen) may involve B1b cells, as well as other B 
cell subsets, and so immunisation with STm porins or Vi antigen may act similarly in their respective 
infections. However, antibody to purified Vi antigen in humans is wholly TI (Guzman et al., 2006) whilst 
immunisation with porins has the added attraction of inducing antibody responses with bactericidal 
activity, as well as cell-mediated immunity (Salazar-Gonzalez et al., 2004). Indeed, we found that T-
dependent induction of IgG upon porin-immunisation enhanced protection and additionally, T cell help is 
essential for the induction of life-long B cell memory, a desirable feature of vaccine design. 
 
TI antibody to protein antigens have been described previously to the glycoprotein of vesicular stomatitis 
virus (Freer et al., 1994) and complement factor H-binding protein from the bacterial pathogen Borrelia 
hermsii (Colombo and Alugupalli, 2008). For the latter, self-renewing B1b cells have been shown to 
confer long-lasting immunity to re-infection (Alugupalli et al., 2004). Furthermore, B1b cells have been 
shown to be important in the early defence to pneumococcal infections (Haas et al., 2005). These 
studies, together with the work presented here suggests B1b cells may play significant roles in a range 
of infections and reflects our ever increasing understanding of the diversity of B cell responses to 
pathogens (Racine et al., 2008). Furthermore, this work broadens the repertoire of TI protein antigens, 
and specifically suggests that the B1b cell repertoire may be broader than originally thought. 
 
Infants and the elderly have impaired responses to TI-2 antigens such as capsular polysaccharides, 
despite the presence of B1b cells. Whilst the reason for this is complicated, and it is tempting to 
speculate, as others have, that it is lack of B1b memory in children that is responsible for their 
susceptibility to encapsulated bacteria (Alugupalli, 2008), in mice it is likely to involve two sets of B cell 
responses to TI-2 antigens, B1b cells and MZ B cells. Indeed, mice deficient for the tyrosine kinase pyk2 
lack MZ B cells, but not B1b B cells, and remain able to induce potent IgM and IgG responses to the TI-
2 antigen TNP-Ficoll (Guinamard et al., 2000). Furthermore, the transfer of B1b cells alone into RAG1-
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deficient mice is sufficient to support antibody responses to NP-Ficoll (Hsu et al., 2006). TI responses in 
humans and mice share some similarities (Gonzalez-Fernandez et al., 2008). For instance serum from 
both species during B. hermsii infection can react to FhbA, an antigenic target of B1b cells (Colombo 
and Alugupalli, 2008; Hovis et al., 2006), suggesting humans may have equivalent of B1b cells.  
 
Despite earlier reports appreciation of the importance of antibody in STm infection is now increasing 
(Mastroeni et al., 2000; McSorley and Jenkins, 2000; Mittrucker et al., 2000). There are at least two 
roles antibody could fulfil in restricting infection: firstly, to prevent the dissemination and subsequent 
bacteraemia during primary infections and secondly, prevent macrophage colonisation during secondary 
infections. Earlier studies have shown that antibody can perform both these roles (Cunningham et al., 
2007) and we now extend these findings to show that the natural response of antibody to OmpD is 
sufficient to reduce colonisation in the tissues and bacteraemia in a mouse model of NTS infection 
caused by STm. The protective benefit of antibody to porins has also been documented in our recent 
work on human responses to NTS (MacLennan et al., 2010). Interestingly, porcine responses to 
SalmoporcΔOmpD revealed that OmpD may not be a dominant protective antibody target as some of 
the protective efficacy of Salmoporc was largely retained upon its loss (Selke et al., 2007). Despite this, 
in the absence of OmpD the capacity of Salmoporc to reduce colonisation in the caecum, colon and 
ileum was reduced relative to mice immunised with the parent vaccine supporting a role for protective 
antibody to OmpD in the early colonisation of STm as in agreement with this study. The importance of 
antibody to OmpD does not exclude roles for antibody to OmpF and OmpC because other reasons may 
account for their minor role here, such as the amount of OmpF and OmpC in the preparations, or their 
expression in STm at different growth stages. 
 
In closing, we propose OmpD could be a possible candidate for a subunit vaccine against NTS. Indeed, 
porins from ST which are essentially prepared in the same manner as the STm porins described here, 
have already been shown to be safe and efficacious in humans (Salazar-Gonzalez et al., 2004). 
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Additionally, the importance of antibody to OmpD, a porin absent from ST may in part explain why 
porins from ST did not cross-protect despite homology between the shared porins OmpF and OmpC, 
supporting earlier studies showing anti-porin sera (ST) did not cross-protect against STm (Secundino et 
al., 2006). It is important to emphasise that the absence of OmpD from ST indicates that any vaccine 














5.0 Disrupted protective immunity in N. brasiliensis & 
Salmonella co-infection models 
5.1  Introduction 
Classically, models of experimental immunity to infection have addressed immune regulation to a single 
pathogen. Such studies have shaped our understanding of how infections develop and how they are 
controlled. Naturally we are exposed to multiple pathogens throughout our lives, and often by more than 
one pathogen at any given time. The relationship between co-infection and host immune responses is 
likely to be important, but has received limited detailed attention. Furthermore, how infectious history 
impacts on immunity to novel pathogens is relatively unknown. One model to assess this is how 
helminth infections, which are widespread and induce Th2 responses, can affect immune regulation to 
the Th1 inducing pathogen, STm.  
 
Previous studies have shown helminths can modulate host responses and this can influence the 
outcome to an unrelated pathogen (Correale and Farez, 2009; Zaccone et al., 2003). For instance, 
helminth infection is associated with increased susceptibility to infections such as malaria and TB (Su et 
al., 2005; Tetsutani et al., 2009). Interestingly, malaria-helminth co-infection can either exacerbate the 
severity of malarial disease (Helmby et al., 1998; Legesse et al., 2004; Tetsutani et al., 2009) or benefit 
host responses through counteracting strong inflammation (Hoeve et al., 2009; Lyke et al., 2005; 
Nacher et al., 2000). Moreover, emerging evidence from animal and human studies suggests the impact 
of chronic helminth infections can significantly impair responses to standard childhood immunisations 
(Cooper et al., 2001; Sabin et al., 1996).  
 
Generating a detailed understanding of how immunity induced to bacterial pathogens such as STm 
influences responses to a second pathogen such as a helminth that requires a different, distinct form of 
immune response for protection represents an important and poorly understood field. STm infections 
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are the leading cause of childhood bacteraemia in SSA (Graham et al., 2000) and parasitic nematode 
infections are extremely common throughout this region (Hotez, 2009). Moreover, the highest incident 
rates of NTS overlap with areas where helminth infections are common (Hotez, 2009). Due to this 
demographic overlap the likelihood of concomitant infections with STm and hookworm early in infancy in 
endemic areas is highly plausible, and lends an important relevance to this study. Three approaches 
were used in this study as detailed below. The findings from this work demonstrate clear correlates of 
immunity against both pathogens which are disrupted by exposure to an unrelated pathogen. 
 
Effect of primary N. brasiliensis infection on subsequent STm infection 
How helminth induced immunity influences the host’s ability to launch a protective response to STm was 
one aspect of this study. Mice were infected with N. brasiliensis and following worm expulsion (in an 
immune competent animal N. brasiliensis is expelled by day 9-11) mice were challenged with STm and 
the effects of N. brasiliensis on the kinetics of immunity to STm were examined. Furthermore, how pre-
exposure to N. brasiliensis can influence the efficacy of potential STm vaccine candidates, where 
protection requires the presence of porin specific antibody (Gil-Cruz et al., 2009) was addressed.  
 
Effect of primary STm infection on subsequent N. brasiliensis infection 
The influence of primary infection with STm on subsequent expulsion of N. brasiliensis was investigated. 
Mice were infected with STm and then challenged with N. brasiliensis when the STm infection was 
either still active or had resolved. The influence of STm on worm expulsion and the correlates of 
protection against N. brasiliensis: IL-13 production and goblet cell hyperplasia were then examined. 
 
Effect of dual STm and N. brasiliensis infection 
Particular importance was placed on how synchronous challenge with these potent Th1 and Th2 
pathogens impacted on the development of protective immunity against both pathogens relative to 
single infection. Throughout this study all infections with N. brasiliensis and STm were subcutaneous 
and intraperitoneal, respectively. 
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5.2 Primary infection with N. brasiliensis impairs the resolution of 
subsequent STm infection. 
Whether primary infection with N. brasiliensis (Nb) disrupted protective host responses to subsequent 
STm infection was investigated. BALB/c mice were infected with 500 L3 Nb larvae and at day 16 post 
infection (6-7 days post worm expulsion) mice were challenged with 5x105 STm (Fig 5.1A). Bacterial 
burdens in the spleen and liver at day 6 post-STm challenge were comparable between non-Nb primed 
and Nb-primed mice (Fig 5.1B). By day 25 post-STm challenge although both groups had significantly 
reduced bacterial numbers relative to day 6, Nb-primed mice had significantly elevated bacterial 
numbers when compared to non-Nb primed mice. Equivalent spleen cellularity and weight was found in 
both groups at days 6 and 25 post-STm infection (Fig 5.1C). This suggested that primary infection with 
NB negatively impacted on subsequent control of STm.  
 
Splenic CD4+ T cell populations showed increased cell numbers and proportions in both non-Nb primed 
and Nb -primed mice at day 25 post-STm challenge relative to day 6 (Fig 5.2A). Comparison of non-Nb 
primed and Nb-primed CD4+ T cell numbers and proportions were broadly equivalent, although the 
proportion of CD4+ T cells in Nb-primed mice when compared to non-Nb primed mice at day 25 post-
STm challenge was marginally, but significantly lower. Analysis of T cell activation revealed largely 
comparable proportions of CD62Llo T cells at both time points. Although consistently, there was a 
significantly higher proportion of CD62Llo T cells in Nb-primed mice when compared to non-Nb primed 
mice at day 25 post STm challenge (Fig 5.2B). Nevertheless, there were no differences in activated 
CD4 T cell numbers at both time-points between the two groups. 
 
Splenocytes were stimulated ex-vivo with pathogen-specific antigens or anti-CD3 for 72 hours and 
cytokine secretion in the supernatant was measured by ELISA. Anti-CD3 re-stimulation revealed 
equivalent levels of IFNγ in non-Nb and Nb-primed mice at both time points (Fig 5.3A). Anti-CD3 












challenge, and surprisingly, highest in the non-Nb primed group (Fig 5.3B). Cytokine secretion post- 
antigen specific re-stimulation of splenocytes showed increased levels of IFNγ in Nb-primed mice 
compared to non-Nb primed mice at day 6 post-STm infection, following re-stimulation with somatic Nb 
(NES) or Heat-killed STm. Levels were equivalent between both groups at day 25. As was observed in 
CD3 re-stimulated splenocytes, IL-13 secretion increased in both groups at day 25 post-STm infection 
following antigen-specific stimulation, and to a similar level. 
 
Assessment of serum anti-STm IgM showed titres increased similarly in both Nb and non-Nb primed 
mice at day 25 compared to day 6 post-STm challenge, whilst anti-NES IgM titres did not increase 
above background levels for non-Nb primed mice (Fig 5.4A). Anti-STm IgG titres increased in both 
groups at day 25 relative to day 6 post-STm challenge and interestingly, titres were significantly lower in 
Nb-primed mice compared to non-Nb primed mice. Anti-NES IgG titres were only detected in non-Nb 
primed mice and titres were comparable at each time-point (Fig 5.4B). Subsequently, IgG2a responses 
were assessed which revealed IgG2a was absent from either group at day 6 post STm-challenge, 
irrespective of antigen-specificity (Fig 5.4C). Anti-STm IgG2a was detected at day 25 in both groups and 
titres were equivalent, and as expected, anti-NES IgG2a titres were only induced in Nb-primed mice. 
Anti-STm IgG1 responses did not increase above background in both groups (data not shown).  
 
These data demonstrate that a prior infection with Nb disrupts the host’s ability to control a subsequent 
STm infection. Initial control of STm, when historically we and others have shown innate immunity is 
important (Fig 3.1) appears to be unaffected by a prior Nb infection. The impaired resolution of STm in 
Nb infected hosts correlated with the time when the adaptive immune response is required to control the 
later stages of infection. Initial analysis of the underlying immune responses associated with this 
heightened susceptibility did not reveal any obvious correlates of reduced T cell mediated protection. 
Nevertheless, these data do not exclude factors such as impaired communication and/or migration of 






5.3 Primary STm infection causes delayed expulsion of N. brasiliensis 
Whether primary infection with STm influenced the response to subsequent challenge with Nb was then 
investigated. BALB/c mice were infected with 5x105 STm and at day 17 post-STm infection mice were 
challenged with 500 L3 Nb larvae (Fig 5.5A). Quantification of the worm burden at day 5 post Nb 
infection (22 days post-STm) revealed no differences between non-STm primed and STm-primed mice. 
In contrast, at day 11 post Nb infection (28 days post-STm) STm-primed mice showed a significant 
delay in worm expulsion compared to non STm-primed mice.  
 
A caveat in this first experiment was that the initial STm-infection had not resolved so discrete stages of 
a STm infection were examined. BALB/c mice were infected with STm for 32 or 42 days prior to 
infection with 500 L3 Nb larvae for 11 days (Fig 5.5B). At the end of this experiment assessment of the 
splenic bacterial burden showed that mice infected with STm for 32 days prior to Nb challenge (43 days 
post-STm) had some residual bacteria, compared to mice infected with STm for 42 days before Nb 
infection (53 days post STm-challenge). This latter group had undetectable levels of infection, bar one 
mouse (which had 10 bacteria). Quantification of the worm burden revealed mice infected with STm for 
32 days prior to Nb infection (43 days post-STm) had a significant delay in worm expulsion relative to 
non-STm primed mice (Fig 5.5B). Interestingly, mice primed with STm for 42 days before Nb challenge 
(53 days post-STm) revealed Nb infection in a single animal, the same animal that had a residual STm 
infection. This suggests impaired worm clearance requires the presence of detectable numbers of STm. 
 
As expected, spleen weights for STm-primed mice were significantly greater compared to non-STm 
primed mice, irrespective of the number of days previously infected with STm, whilst differences in 
spleen cellularity were generally small (Fig 5.6). As the worm burdens were comparable in STm-primed 











Quantification of splenic CD4+ T cell responses in STm-primed and non-STm primed mice infected with 
Nb for 11 days revealed that total numbers were broadly similar (Fig 5.7). The proportion and number of 
CD4 T cells per 0.1 g spleen showed the greatest variability. Additionally, when effector CD4 T cell 
responses were examined, the proportion and density of effector CD4 T cells showed some variability 
but total numbers were broadly similar, bar mice-primed with STm for 32 days prior to infection with Nb 
for 11 days (43 days post-STm), which had significantly more effector CD4 T cells relative to non-STm 
primed mice (Fig 5.8). In the main, assessment of total and effector CD4 T cells did not demonstrate a 
clear correlation between the proportion or number of cells, and the failure to control Nb infection in 
STm-primed mice.  
 
As expulsion of Nb is associated with induction of IL-13 splenocytes were re-stimulated in-vitro with anti-
CD3 in the presence of anti-CD28 and cytokine responses were assessed by intracellular FACS. This 
showed the proportion, total number and density of CD4+IFNγ+ T cells in STm-primed Nb-infected mice 
was consistently greater than in non-STm primed mice (Fig 5.9A). Despite this, there was no clear effect 
on IL-13 production with the exception of mice primed with STm for 42 days before Nb infection (53 
days post-STm), which had a lower proportion and density of CD4+IL-13+ T cells compared to non-STm 
primed mice (Fig 5.9B). However, this group had cleared the Nb infection suggesting a highly complex 
relationship between Th1 and Th2 responses to these pathogens. As an additional control the intestinal 
mucus response was assessed by PAS staining (Fig 5.10). Indeed, induction of IL-13 typically 
correlates with goblet cell hyperplasia which is critical for the expulsion of many intestinal helminths, 
including Nb (Horsnell et al., 2007; Marillier et al., 2008). As expected, the response was comparable on 
day 5 post Nb-infection in mice primed with STm for 17 days before Nb infection (22 days post-STm) 
and non-STm primed mice. However, the response was qualitatively reduced on day 11 post Nb-
infection in mice primed with STm for 17 days before Nb-infection (28 days post-STm) relative to non-
STm primed mice. This suggests that the reduced mucus response upon priming with STm may 


















These data demonstrate primary infection with STm negatively influences the host’s response to 
subsequent infection with Nb. This delayed expulsion requires the persistence of STm in the host which 
strikingly prolongs Nb infection. Of interest, this study identified a reduction in the mucus response by 
STm-primed mice which could underlie the delayed expulsion of Nb. However, assessment of the CD4 
T cell response failed to identify any clear correlates of reduced protection, except for a small trend 
towards lower IL-13 expression.  
 
5.4  Dual Infection with STm and N. brasiliensis act reciprocally to 
impair the host’s response to both pathogens 
Since primary infection with either STm or Nb could negatively influence the subsequent host response 
upon challenge, the impact of simultaneous infection with Nb and STm on the host response to each 
pathogen at discrete stages of infection was investigated. BALB/c mice were infected with 5x105 STm, 
or 500 L3 Nb larva or both pathogens for 5, 10, 18 or 32 days. Quantification of bacterial burdens in the 
spleen and liver at day 5 post-infection revealed no differences in bacterial numbers between STm-only 
and co-infected mice (Fig 5.11A). From day 10 onwards splenic and liver bacterial numbers were 
consistently higher in dual-infected mice. Quantification of intestinal worm burdens revealed Nb-only or 
co-infected mice had a comparable worm burden at day 5 post-infection (Fig 5.11B). As expected, at 
day 10 post-infection Nb-only infected mice had largely cleared the infection and by day 18 no worms 
were detectable. Numbers were not assessed at day 32. In contrast, co-infected animals had 
consistently higher worm burdens from day 10, which persisted at day 18, with worms still being 
detected at day 32.  
 
STm-only and co-infected mice had bigger spleens from day 5 onwards and both the spleen mass and 
cellularity was significantly enhanced compared to NI or Nb-only infected mice at each time-point 
assessed (Fig 5.11C). No differences between STm-only and co-infected mice were apparent, except at 









5.4.1 Th1 and Th2 profiles remain faithful to STm and N. brasiliensis upon 
co-infection 
Quantification of splenic CD4 T cell responses revealed broadly equivalent T cell numbers and 
proportions in NI and Nb-only infected mice. The proportion and density of CD4+ T cells was lower in 
STm-only infected mice compared to both these groups at each stage (Fig 5.12). Primarily, CD4+ T cell 
counts in dual infected mice were equivalent to STm-only infected mice, except at day 5, where co-
infected mice had more CD4+ T cells than both STm-only and Nb-only infected mice. As expected, 
analysis of T cell activation in the spleen revealed proportions of CD4+CD62Llo T cells increased after 
infection in all groups compared to NI mice (Fig 5.13). The proportion of effector CD4+ T cells was 
consistent throughout infection in Nb-only infected mice. Once more, responses in co-infected mice 
largely resembled STm-only infected mice. Differences were marginal, but significant, at day 5 post-
infection where the density of effector CD4+ T cells was greater in co-infected mice relative to STm-only 
infected mice, and at day 18, where the proportion was lower compared to STm-only infected mice. This 
suggested that the CD4 T cell response, in terms of T cell activation, may not be responsible for the 
impaired clearance of STm and Nb in dual-infected mice. 
 
As distinct CD4 T cell responses are required for the resolution of STm and Nb, Th1 and Th2 responses 
were examined by intracellular FACS following re-stimulation of splenocytes with anti-CD3 in the 
presence of anti-CD28. This revealed the proportion, number and density of CD4+IFNγ+T cells from Nb-
only infected mice was equivalent to NI mice at each time point assessed (Fig 5.14A). Similar levels of 
IFNγ were apparent between STm-only and co-infected mice throughout, in terms of the proportion, 
absolute numbers and density, with the exception of a small augmentation in co-infected mice at day 5 
post-infection. As expected, the proportion of CD4+IL-13+T cells was significantly greater in Nb-only and 
co-infected mice when compared to NI and STm-only infected mice until day 32 post-infection (Fig 















infected mice had fewer cells. Interestingly, the number of CD4+IL-13+ T cells per 0.1 g spleen fell from 
day 10 onwards in co-infected mice relative to Nb-only infected mice, despite the presence of a 
pronounced worm burden. Despite this, in the main the intracellular FACS data suggested that CD4 T 
cell polarisation to Th2 and Th1 in response to Nb and STm respectively, remained largely intact in co-
infected mice.  
 
IL-10 can be secreted by regulatory T and B cells which can suppress CD4 T cell responses (Bai et al., 
1997). To examine IL-10 responses, splenocytes were re-stimulated with anti-CD3 for 72 hours and 
total IL-10 responses were analysed in the supernatants by ELISA (Fig 5.15). This revealed Nb-only and 
co-infected mice had a greater IL-10 response compared to STm-only infected mice at the equivalent 
time-points. Responses in co-infected mice closely resembled Nb-only infected mice, except at day 10, 
where responses were lower. This suggested that on the basis of cytokine secretion a highly complex 
host response was involved and in depth analysis of regulatory T cells may be warranted.  
 
5.4.2 Goblet cell hyperplasia is reduced co-infected mice 
Expulsion of Nb is associated with goblet cell hyperplasia and mucus secretion which is critical for 
expulsion of Nb (Horsnell et al., 2007). The mucus response was visualised in the small intestine by 
PAS staining which found no differences between mice infected with STm-only and NI mice throughout 
infection (Fig 5.16). As expected, at day 10 post-infection Nb-only infected mice displayed a pronounced 
mucus response and by day 18, this returned to levels observed in NI mice. Surprisingly, although the 
goblet cell response in co-infected mice at day 10 post-infection was enhanced relative to STm-only 
infected mice, it was reduced relative to Nb only infected mice. At day 18, the mucus response in co-
infected animals was enhanced relative to mice infected with a single pathogen, reflecting an active Nb 
infection. Moreover, despite a residual Nb infection in co-infected mice at day 32 the goblet cell 
response was comparable to STm-only infected animals. This suggests that the delay in worm 









5.4.3 Antibody responses are reduced upon co-infection 
Antibody responses were then examined which showed infection with STm, Nb or both pathogens 
induced pathogen specific IgM responses by day 5 post-infection (Fig 5.17). Nevertheless, close 
examination showed that co-infection gradually induced lower anti-STm and anti-NES IgM titres in 
comparison to mice infected with only STm or Nb, respectively. Switched antibody responses were then 
assessed to ascertain whether appropriate antibody isotypes were produced upon co-infection, IgG2a 
for STm and IgG1 for Nb. The anti-STm IgG response showed IgG was induced in STm-only and co-
infected mice from day 5 onwards and titres were comparable up to day 18. At day 32, anti-STm IgG 
titres were enhanced in STm-only infected mice relative to co-infected mice (Fig 5.18A). The anti-NES 
IgG response revealed co-infected mice had a significantly lower titre at day 10 post-infection relative to 
Nb-only infected mice, but titres were comparable at day 18 (Fig 5.18A).  
 
In terms of antibody isotype, at day 32 co-infected mice induced both an anti-STm IgG1 and IgG2a 
antibody response. As expected, STm-only infected mice induced IgG2a and titres were comparable to 
co-infected mice, whilst IgG1 was not detected. Furthermore, both Nb-only and co-infected mice 
induced an anti-NES IgG1 response relative to mice infected with STm-only, and titres were comparable 
at the time-points assessed (Fig 5.18 B&C). As an additional control, whether this pattern of switching in 
co-infected mice was reflected in the spleen by immunohistology was investigated. This revealed a 
marked induction of IgG1 in Nb-only infected mice at day 10 post-infection, and although IgG1 was 
detected in co-infected mice, qualitatively it was reduced relative to Nb-only infected mice. As expected, 
IgG1 was largely undetectable in STm-only infected mice (Fig 5.19A). In terms of IgG2a, as expected 
Nb-only infected mice did not induce switching to IgG2a whilst IgG2a cells were present in both STm-
only and co-infected mice at day 10 post-infection, and at a similar level (Fig 5.19A). Furthermore, 
spleens isolated from co-infected mice at day 32 post-infection demonstrated induction of both IgG1 and 
IgG2a, whilst STm-only infected mice showed induction of IgG2a only (Fig 5.19B). Thus, co-infected 















Since GCs are a late feature of the STm response (Cunningham et al., 2007) the GC response was 
examined in co-infected mice. Spleens were sectioned and stained by immunohistochemistry for IgD (to 
identify follicular B2 cells) and CD3 (to identify T cells) and follicular regions that were IgD- and CD3lo 
(GCs) were assessed (Fig 5.20). In mice infected with Nb-only GCs were present by day 10 post-
infection and as expected, GCs were largely absent from STm-only infected mice and surprisingly, also 
in co-infected mice. GCs were however, detected at day 32 in both groups. This suggested the GC 
response in co-infected mice mirrored the STm profile. 
 
These data show co-infection with STm which requires Th1 immunity and Nb which requires Th2 
responses, has a negative impact on the host’s ability to control either pathogen compared to a single 
infection. Assessment of immune responses did not identify any obvious correlates for this increased 
host susceptibility as polarisation to both Th1 and Th2 appeared unchanged. Interestingly, the antibody 
response was maintained to both pathogens, but was reduced upon co-infection. Furthermore, features 
of the antibody response were distinct after co-infection as demonstrated by the induction of high titres 
of both IgG1 and IgG2a to both Nb and STm, respectively. 
 
5.5 Primary Infection with N. brasiliensis impairs the efficacy of porin 
immunisation in a STm vaccine model 
As described in Chapter 4 immunisation with porins induces early control of subsequent STm infection 
which is dependent upon the presence of OmpD specific antibody. Since Nb infection could negatively 
impact on clearance of STm from the tissues, whether Nb infection also impaired vaccine mediated 
control of STm infection was investigated. BALB/c mice were infected with 500 L3 Nb larva for 19 days 
before immunisation with porins for 11 days prior to challenge with 5x106 STm for 5 days (Fig 5.21A). 
As a control, mice were either infected or immunised with Nb or porins respectively, for 11 days prior to 
challenge with STm. On reflection, a better control group for Nb may have been to infect mice with Nb 









Quantification of the splenic bacterial burden revealed that as expected, mice infected with Nb prior to 
STm challenge had a comparable bacterial load to NI mice at this time-point. Both porin-immunised and 
Nb infected-porin-immunised mice had a significantly lower bacterial load compared to NI mice. 
However, Nb infected-porin immunised mice had a 30-fold greater bacterial burden compared to porin-
immunised mice. This suggested Nb infection impaired the benefit afforded by porin vaccination. 
Interestingly, the anti-STm IgM and IgG responses were broadly equivalent between the groups, 
although porin-immunised STm-infected mice had a marginally lower IgM response yet the greatest 
level of protection (Fig 5.21B). This suggests that since there is antibody present but less protection in 
the Nb infected-porin-immunised mice, that the difference is likely to involve killing of STm rather than 
antibody, and the profile of responding macrophages should be considered.  
 
5.6  Discussion  
In this study we show that an infectious history with Nb or STm prior to subsequent challenge with STm 
or Nb respectively, or co-infection with both these pathogens can impact on the development of 
immunity and control to each respective pathogen. Furthermore, a history of Nb infection markedly 
impacted upon the success of vaccination with porins. Although the concept of dual-infection is not 
novel, previous studies have largely focussed on the effects of concurrent infection when both 
pathogens occupy the same anatomical site (Chen et al., 2005; Mansfield et al., 2003). Whilst helminths 
and enteric bacteria may colonise the same sites, this may not necessarily occur at the same time. For 
STm colonisation occurs through the gut, whereas for Nb, the gut is at the end stage of infection and is 
important for transmission to new hosts. For reasons of time and simplicity it was not possible to study 
all combinations of antigen encounter which is an important future aim. Compartmentalisation of 
pathogens was chosen because severity of STm infection is associated with systemic infection, and it is 
clear that adaptive cells can migrate within a few days of immunisation to secondary lymphoid tissues or 
effector sites such as the liver, after primary immunisation with alum-precipitated proteins or with STm 
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(Kool et al., 2008; Luther et al., 2007; Serre et al., 2009)(and unpublished observations from work by J. 
Hitchcock). 
 
Co-infection of STm and Nb has been studied previously (Sitepu et al., 1984), but this study did not 
address the impact of STm or Nb relative to each other or their influence on the immune response, but 
the outcome of infection to STm or Nb in mice selectively reared for high or low immune responsiveness 
to Nematospiroides dubius. This revealed high-immune responders (mice bred which display increased 
resistance to infection) of N. dubius were more susceptible to STm and more resistant to NB. 
Furthermore, it has been demonstrated that primary infection in rats with flukes (Fasciola hepatica) 
exacerbated the severity of subsequent infection with S. Dublin (Aitken et al., 1978), whilst primary 
Ostertagia ostertagia (Nematodes which infect cattle) infection did not influence subsequent challenge 
with S. Dublin in cattle (Aitken et al., 1984). The immunological detail from these earlier studies is 
limited, largely since they did not specifically aim to examine the immune response to STm and Nb 
relative to each other, and as such our data provides the first example of such a study. 
 
More recent STm and helminth co-infection studies have had inconsistent findings. For instance, 
primary infection of pigs with the strongyloide nematode Oesophagostomum spp, before challenge with 
STm, revealed no enhancement of STm infection or effect on the helminth using a range of helminth 
doses (Steenhard et al., 2006) however, STm infection was enhanced at the highest dose of helminth 
given (2500 worms given 14 times over a period of 7 weeks) (Steenhard et al., 2002). These studies 
suggest that helminth infection may not always influence the course of subsequent STm infection. 
 
In the model used in these studies Nb is expelled 6-7 days before mice were challenged with STm. 
Despite this, the influence of Nb infection remains detectable more than 40 days after initial Nb infection. 
This suggests that the increased susceptibility to STm does not require a continual helminth infection 
but can be driven by pre-exposure to Nb. This is not surprising, since infections with Nb can elicit 
persistent effects in the host that remain long after worms are expelled, such as Th2 differentiation or 
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effects on macrophages, this is likely in part, at least to be related to the deposition of large amounts of 
antigen by parasite moulting and secretions (Arizono et al., 1996; Marsland et al., 2008), and Nb antigen 
is likely to persist for longer than worms are detected.  
 
In contrast to this persistent effect of Nb on STm clearance, our data also indicates that after host 
resolution of STm infection the influence on Nb clearance was largely absent, with any delayed worm 
expulsion requiring STm to still be present in the host. It was demonstrated that direct interaction 
between enteric microflora (including STm) and macrofauna (intestinal dwelling helminths) can be 
beneficial for persistence of Trichuris muris in the host through impairment of Th2 immunity (Hayes et 
al., 2010). Our model shows that even in the absence of direct interaction, bacterial and helminth co-
infection can have a marked effect on host immunity, impairing control of either pathogen. 
 
In addition to examining the impact of infectious history, we found that simultaneous co-infection 
markedly affected clearance of each pathogen. This reflects earlier studies which demonstrated 
synergistic interactions between nematodes and bacteria can produce significant disease and pathology 
relative to single infection (Mansfield et al., 2003). Under all conditions assessed Nb infection did not 
influence STm clearance until after the first week of infection, when adaptive immunity is required. It was 
possible that the presence of two strongly polarising challenges could lead to an inappropriately 
activated immune response, resulting in ineffective immunity to each pathogen, yet Th1 responses were 
largely normal in co-infected mice, as were Th2 responses. This was surprising since natural exposure 
to helminths has been shown to dampen Th1 responses to other infections (Correale and Farez, 2009; 
Zaccone et al., 2003). Conversely, several malarial-helminth co-infection models have shown helminth 
elicited Th2 responses are reduced upon co-infection (Buendia et al., 2002; Hoeve et al., 2009). 
Nevertheless, in other systems Th1 and Th2 responses have been shown to develop in parallel in the 
same LN (Toellner et al., 1998) and DC co-pulsed with Th1 and Th2 antigens can induce appropriate 
polarised Th responses (Cervi et al., 2004).  
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It is possible that the T cell response may be defective in aspects other than polarisation, such as the 
impaired migration of T cells to sites of infection, inefficient or inappropriate interactions between T cells 
and macrophages, or macrophages failing to respond to T cell instructions. This may be because of 
different states of macrophage activation due to the influence of Nb exposure (discussed below). Due to 
time constraints we have not looked at in vitro interactions between T cells and macrophages, and this 
is currently being addressed by Dr. William Horsnell in Cape Town. Furthermore, we did not look at 
chemokines or migration profiles, and since differences in chemokine expression can further define Th1 
and Th2 polarity (Serre et al., 2008) it is an important area for future study. 
 
Effective resolution of Nb requires IL-13 signalling and activation of the STAT6 pathway (Barner et al., 
1998; McKenzie et al., 1999; Urban et al., 1998) which is associated with induction of goblet cell 
hyperplasia. In the main, the IL-13 response in STm-primed-Nb-infected mice and co-infected mice was 
relatively normal despite the pronounced delay in worm expulsion. Surprisingly, these mice did show a 
clear reduction in goblet cell hyperplasia. Thus, it could be speculated that impaired Nb expulsion in co-
infected mice and STm-primed Nb-infected mice may be related to this reduced mucus response. It 
would be interesting to assess whether the delay seen in Nb expulsion is exacerbated in the absence of 
IL-13 signalling. This may help identify the mechanism for the reduced mucus response upon co-
infection. 
 
In addition to the reasons already listed, other mechanisms may be at play, such as differences in 
macrophage populations and the influence of regulatory T cells. Regulatory T cells (Groux et al., 1998; 
Levings et al., 2001) and B cells (Yanaba et al., 2008) are potent sources of IL-10. In this study, the IL-
10 profile varied depending upon the antigen combination but generally having Nb increased the levels 
of IL-10 from splenocytes. Due to time constraints detailed assessment of regulatory cells was not 
possible but is important for future analyses. Indeed, helminth induced T cell regulatory populations can 
suppress Th1 proliferative responses in vitro (Tetsutani et al., 2009; Wammes et al., 2010) and 
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regulatory B cells can suppress T cell proliferation (Gray and Gray, 2010). IL-10 protein levels were 
lower in co-infected mice at day 10 relative to  Nb-only infected mice and it is possible the reduced IL-10 
in co-infected mice may be important for the observed phenotype, possibly through the action of 
regulatory cells. Therefore, identification of the source of IL-10 is important for future studies. 
 
The antibody profile of Nb-primed and STm infected mice showed induction of both anti-STm and anti-
NES IgM and IgG antibody. Furthermore, the anti-STm antibody profile in co-infected mice showed 
switching to both IgG1 and IgG2a, whereas mice infected with STm-only showed induction of IgG2a, but 
not IgG1. Antibody is dispensable for clearance of primary STm (Mastroeni et al., 2000; McSorley et al., 
2000; Mittrucker et al., 2000) and since Th1 priming to STm was normal, this suggests the impaired 
capacity to clear STm may involve inappropriate polarisation of other cells, such as macrophages. 
Macrophage function can vary significantly depending on the T cell response induced. In this study 
there was insufficient time to assess macrophage populations in detail but this is an important future aim 
since selective polarisation to CAM and AAMs can influence pathogen expulsion (Zhao et al., 2008). It is 
possible that AAMs induced in response to Nb impair the host’s ability to induce an effective CAM 
response to STm. Furthermore, it is unclear whether AAMs or CAMS can be reprogrammed to a 
classical or alternative phenotype. Indeed, AAMs have been shown to revert to a phagocytic role upon 
exposure to Leishmania mexicana (Mylonas et al., 2009). However, in the presence of Neisseria 
meningitidis the AAM phenotype is stable (Varin et al., 2010) suggesting this plasticity may be 
pathogen-specific. 
 
Nb infection significantly reduced the efficacy of porin immunisation against STm. Immunomodulatory 
effects of helminths on vaccination against bacterial pathogens have been documented before in 
response to immunisation with cholera toxin (CTB) (Harris et al., 2009), and tetanus toxoid vaccination 
(Sabin et al., 1996). Antibody to STm can function through the activation of complement, neutralisation 
or opsonisation. In the mouse model antibody-mediated opsonisation and cell killing is probably more 
210 
 
important than cell-free killing by complement (Siggins et al., 2011). Antibody was induced in all groups 
of mice, but anti-IgM was marginally lower in porin-immunised and STm-infected mice, which had the 
greatest level of protection, whilst anti-STm IgG titres were similar in all groups. This suggests that the 
reduced efficacy of porin-vaccination is likely to be independent of the ability to induce antibody, but 
may be related to the ability of macrophages and neutrophils after Nb-infection to kill the bacteria, due to 
alterations in the macrophage population. This is supported by a recent opsonisation experiment carried 
out by Dr. William Horsnell in Cape Town in which STm opsonised with STm-specific sera had a 
markedly impaired capacity to control infection in mice previously infected with Nb (data not shown) 
compared to naive mice. This suggests that cell-dependent complement function needs to be 
investigated. 
 
Simultaneous exposure to helminths and other pathogens are common in developing countries. Given 
the striking phenotype we found and the knowledge that both NTS and hookworm infections are 
clinically relevant and endemic to SSA, it is surprising that studies have not addressed these pathogens 
together in the context of host immunity. We have demonstrated that infectious history can imprint the 
host response to subsequent immune challenges, and furthermore, helminth infection impaired the 
efficacy of vaccination demonstrating a complicated relationship between the host and pathogen. This 
has important implications for vaccine efficacy and administration, and we suggest immunological 
background of target populations and their infectious history should be taken into careful consideration, 









6.0 Final Discussion and Future Work 
A major obstacle in developing a suitable vaccine for NTS has been a poor understanding of the nature 
of immunogenic moieties associated with protection. Micro-organisms contain a mosaic of antigens and 
as we have shown here the elicited immune response can be complex. However, surface components 
are at the interface between the bacteria and the host and represent ideal targets for protective 
immunity. Thus, a better understanding of immunity to infection, and the processes of immunity, is 
revealed through studying responses to microbial antigens. Our studies on the immune response to 
core bacterial structures embedded in the OM or attached to the surface of STm, has important 
implications in general for immunity against GN bacteria as these structures are largely conserved.  
 
T cells are important for clearance of STm infection within macrophages, but in SSA NTS infections also 
usually manifest in the blood, and predominantly in children under the age of two when anti-STm 
antibody is absent. Antibody can contain bacteraemia and restrict the level of initial colonisation 
(Cunningham et al., 2007; Mastroeni et al., 1993; McSorley and Jenkins, 2000). Therefore, the benefit 
afforded by humoral immunity can be immediate. We found that despite the induction of potent antibody 
responses, the capacity of antibody to influence STm infection was not apparent upon immunisation 
with either flagellin or LPS (data for LPS not shown), whilst immunisation with porins conferred 
substantial benefit. The lack of antibody-mediated protection by anti-sFliC antibody in the mouse was 
supported by our recent work on human responses to NTS in collaboration with Dr. Cal MacLennan 
(MacLennan et al., 2010). In this study, antibodies to flagellin had no clear protective role against 
infection whilst antibody to LPS could inhibit bacterial killing. However, antibodies to porins could direct 
complement-mediated killing of STm.  
 
Optimum killing of some GN bacteria requires participation of the terminal components of the 
complement system through formation of a pore, termed membrane attack complex (MAC) (Peitsch and 
Tschopp, 1991). It is likely that structures distal from the cell wall such as flagella or LPS O-chains are 
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not efficient targets of antibody, possibly because they do not allow MAC to develop sufficiently close to 
the body of the cell. Indeed, reducing the length of the O-antigen is sufficient to trigger bactericidal 
killing by complement and can impact upon interactions between macrophages and STm (Murray et al., 
2006). Nevertheless, we have identified that antibody to surface-localised OmpA is not protective in the 
mouse model, and antibody to the exposed trimeric autotransporter adhesin, SadA can induce limited 
antibody-mediated protection in the mouse model, but is not an ideal dominant protective antigen (data 
not shown). Therefore, it is possible that additional factors other than proximity to the cell wall are 
involved in determining whether antibody responses will be beneficial. In terms of OmpA it is likely that 
its abundance in the OM may serve as an immune decoy. 
 
In terms of antibody function, complement fixing bactericidal antibody has been documented to be 
protective in children with NTS in SSA (MacLennan et al., 2008). However, the benefit afforded by 
antibody in STm is not limited to its capacity to induce bactericidal killing, as the ability of neutrophils to 
induce oxidative burst and thus, killing of STm has been shown to correlate with the presence of anti-
STm opsonising antibody and C3 deposition on bacteria, indicating a requirement for both antibody and 
complement (Gondwe et al., 2010). This suggests that the ability to induce protective antibody is likely 
to be more important rather than the mechanism by which antibody may act. Although it is important to 
note that cell-free complement-mediated killing is not effective in the mouse unlike humans and antibody 
responses in the mouse may understate the effectiveness of antibody in humans (MacLennan et al., 
2008; Siggins et al., 2011) and this should be considered when interpreting and reaching conclusions 
from antibody-related studies. 
 
T cells are rapidly activated after STm infection but they are not effective at controlling infection during 
the first week, and only contribute to immunity once infection is already well established. Because the 
clearance of STm is protracted in the face of potent T cell activation this suggests that it may be unwise 
to focus simply on vaccines that evoke CD4 T cell-mediated benefit without antibody. Furthermore, 
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developing a vaccine to drive a particular T cell response to STm may be unnecessary, as we found that 
the T-helper response to sFliC and by implication other subunit vaccines, may change during the course 
of infection if encountered in a different context. This T cell flexibility after infection of vaccinated animals 
has been described in other systems (Divekar et al., 2006; Wang and Mosmann, 2001). Therefore, for 
NTS vaccination inducing T cell help for antibody switching is more important than directing a particular 
effector T cell subset.  
 
Immunisation with porins could moderate infection with STm via the early induction of antibody. 
Furthermore, porins have the additional capacity to induce T cell help which makes it an ideal target for 
the basis of a subunit vaccine. Flagellin has been an attractive and ideal candidate for protective 
immunity due to its auto-adjuvant properties, but it may not be an ideal choice for a subunit vaccine 
against STm due to its failure to promote protective antibody responses. Nevertheless, it is tempting to 
speculate that rather than focussing on the immunomodulatory effects of flagellin when given alone, it 
may be wise to exploit flagellin as an adjuvant when conjugated to known protective antigens against 
NTS. Therefore, it is seems plausible that a porin-flagellin conjugate vaccine may prove to be highly 
efficacious against STm. This has the potential to induce an early protective anti-porin antibody 
response which could be augmented by flagellin, and this may limit colonisation and restrict bacterial 
dissemination before flagellin-specific T cells can clear residual intracellular infection.  
 
Many pathogens gain access to the host after interactions with the mucosal epithelium followed by 
penetration of the mucosal barrier, typical of a natural STm infection. The mucosal barrier provides a 
major site for initial antigen presentation and T cell activation. Therefore, it seems plausible that vaccine 
design for STm should strive to induce mucosal antibody responses which may act as soon as STm 
infiltrates the intestinal mucosa and this may act to restrict the immediate dissemination of STm. Indeed, 
secretory IgA has the capacity to protect mice against STm (Michetti et al., 1992). Nevertheless, we 
found that after intraperitoneal flagellin immunisation bacteria were still able to colonise systemic sites 
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following oral infection and this was only modestly reduced in non-lymphoid tissues. Furthermore, we 
have recently found that colonisation of aflagellated and flagellated STm after oral infection is 
comparable (data not shown). Thus, we propose mucosal immunity may not be important for immune 
responses to flagellin in isolation. Although this is not surprising since flagellin is compartmentalised by 
intracellular bacteria which reduce antigen availability and presentation by antigen presenting cells 
(Alaniz et al., 2006).  
 
To assess whether the route of immunisation can impact on the efficacy of porin immunisation we have 
altered the route of administration, and have found no differences in bacterial colonisation upon 
subsequent challenge of mice (intraperitoneal) immunised with porins intravenously or intraperitoneally 
(data not shown). In the future we are hoping to look into oral immunisation or porins followed by oral 
challenge with STm. Furthermore, data from our lab has found immunisation of mice with the Vi antigen 
sub-cutaneously, intravenously or intraperitoneally does not substantially influence the antibody 
response (data not shown). This suggests that antibody responses to un-conjugated subunit fragments 
may not be influenced by the initial route of administration due to their capacity to invoke systemic 
responses. Indeed, Vi antigen is administered systemically and induces protective immunity. 
Nevertheless, we acknowledge that our studies need to encompass oral infection with STm. 
 
STm is highly complex and we have focussed on inducing protective T and B cell responses, but this 
may not be sufficient when the host is harbouring an infection with an unrelated pathogen. Ultimately, in 
terms of killing of STm we may have to consider whether the appropriate macrophage population is 
induced. Our dual infection study implies that the macrophage population is altered upon co-infection 
and this can impact on the capacity to phagocytose STm (data not shown). Furthermore, when 
identifying candidate vaccines the combination in which vaccines are administered should be 
considered. Co-immunisation of STm and sFliC negatively impacted on the benefit afforded to STm 
upon subsequent challenge, and more striking, immunisation with porins in mice previously infected with 
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N. brasiliensis significantly reduced the efficacy of vaccination. Since helminths and invasive NTS are 
clear problems in SSA, this is likely to mean such factors need to be considered before vaccination 
against NTS in endemic regions. 
 
In closing, in terms of vaccines against invasive STm an effective vaccine should encompass induction 
of protective antibody responses, T cell responses (induction of Th1 may not be a prerequisite) and 
appropriate macrophage populations. Identifying targets and the mechanisms by which they act are the 
first step. Porins are ideal candidates because they have the capacity to reduce bacteraemia and more 
importantly, invoke T cell help which has the capacity to confer long-lasting benefit.  
 
Future Directions 
The flagellin project has been advanced by Dr. Adriana-Flores Langarica. In particular, aspects of the 
Th2 response associated with flagellin immunisation have begun to become better understood, and 
assessment of gut-associated lymphoid tissues post-oral immunisation with flagellin has revealed 
discrete changes in T cell populations. Furthermore, studies on porin immunisation have been advanced 
by Dr. Jennifer L. Marshall to investigate other protective antigens. Finally, Dr. William Horsnell has 
continued to study the dual infection model in Cape Town, and begun to characterise the balance 
between AAM and CAM and evaluate their resistance/sufficiency to infection during co-infection. This 
has already revealed impaired opsonisation may be critical for the delayed clearance of STm and Nb 
upon dual challenge. Nevertheless, multiple questions still arise from each study and in particular I 
would like to assess the following aspects: 
 
Immune response to flagella and flagellin: 
Studies using the aflagellated strain of STm did not find any differences between the flagellated and 
aflagellated strain of STm in terms of bacterial colonisation upon primary infection when given 
intraperitoneally, and now by Dr. Adriana-Flores Langarica upon oral challenge. I would like to further 
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assess the immune response directed against the aflagellated strain to ascertain properties of flagella, 
especially during secondary responses. Specifically, it would be interesting to gain insight into STm 
infection in the absence of flagella expression in a TLR5 deficient mouse. 
 
Flagella is a known virulence factor in P. aeruginosa infections (Arora et al., 2005; Montie et al., 1982), 
and antibody induced to flagella is protective against pneumonia (Campodonico et al., 2010). In 
contrast, for STm the data is conflicting. Some studies suggest expression of flagella is critical for 
virulence (Fournier et al., 2009; Zeng et al., 2003) whilst other studies have demonstrated that neither 
flagella nor components of the flagellar synthetic apparatus are necessary for pathogenicity (Carsiotis et 
al., 1989; Lockman and Curtiss, 1990; Schmitt et al., 2001). These latter results are consistent with our 
study with the aflagellated strain of STm. Attempts to prime mice with flagella and subsequently 
challenge with STm or aflagellated STm to assess whether flagella can protect relative to flagellin have 
been made, but this has been held back due to limitations in obtaining a truly-pure preparation of 
polymeric surface-isolated flagella, and it is an area I would like to further pursue. 
 
Antibody Responses to STm: 
Infection with STm is orally acquired and protection against ST is mediated by mucosal and serum 
antibodies (mucosal IgA and serum IgG), as well as cell-mediated immunity (Salazar-Gonzalez et al., 
2004). Since porins can confer benefit it would be interesting to assess whether oral immunisation can 
confer additive benefit upon subsequent oral STm challenge.  
 
The impact of Dual Infection: 
Infectious history or co-infection may influence the specificity of the T cell response, and a proportion of 
the effector T cells may be specific for the primary pathogen. Moreover, the ratio of effector T cells in co-
infected mice may be altered. Thus, I would like to assess the antigen-specificity of the responding T 
cells to ascertain whether a mixed T cell response is induced upon co-infection.  
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Furthermore, during co-infection STm was administered intraperitoneally and Nb sub-cutaneously to 
assess the influence of infection when these pathogens occupy distinct niches. Intestinal sites are 
initially colonised upon oral administration before systemic dissemination, at least after infection of mice 
with strains of STm that are virulent. It is important we examine the immune response in Nb-infected 
mice subsequently infected orally with virulent STm to see potential interactions in their native 
immunological niches (gut) and assess whether mucosal control is influenced by infectious history. 
Additionally, sites of interaction between the two pathogens where T cell priming may by initiated should 
be investigated, such as the mediastinal and mesenteric lymph nodes. Looking at these sites may 


















Appendix A – Buffer Recipes 
This Appendix contains recipes for all the buffers and reagents used in this project which have not 
already been outlined. All buffers were filter sterilised with a 0.45 µm filter (Millipore, MA, USA) prior to 
use and stored at 4°C, unless stated otherwise.  
 
Buffers used for protein purification (Discussed in 2.2.3) 
The following buffers were used for purification of porins from STm and ST by Dr. Cristina Gil-Cruz. All 
buffers were prepared in MilliQ water.  
 
Wash Buffer 
50 mM Tris.HCl (pH 7.4) 
 
Solubilisation Buffer (For Solubilisation of Inner Membrane) 
50 mM Tris.HCl (pH 7.4) 
2% Sodium Dodecyl Sulphate (SDS) 
 
Nikaido Solubilisation Buffer (For Solubilisation and Extraction of the Outer Membrane) 
50 mM Tris.HCl (pH 7.4) 
1% Sodium Dodecyl Sulphate (SDS) 
3.25 mM EDTA 
0.05% β2-mercaptoethanol 
 
Nikaido Purification Buffer (For Purification of OMPs using the Sephacryl S-200 Column) 
50 mM Tris.HCl (pH 7.4) 
0.5% Sodium Dodecyl Sulphate (SDS) 
3.25 mM EDTA 
200 mM NaCl 
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Buffers used for Cytokine ELISAs (Discussed in Section 2.8.3) 
The following buffers were used for cytokine ELISAs. They were prepared in 1X PBS which was made 
up in MilliQ water. 
 
1 X Phosphate Buffered Saline (PBS) pH 7.4 
8.0 g NaCl 
0.2 g KCl 
1.44 g Na2HPO4 
0.24 g KH2PO4 
Weigh out chemicals and dissolve in 900 ml of MilliQ water and adjust pH to 7.4. Bring up to final 
volume of 1 L.  
 
ELISA Blocking Buffer 
20 g Powder Milk 
0.2 g NaN3 
Weigh out chemicals and dissolve in 900 ml of 1xPBS, bring up to final volume of 1L.  
 
ELISA Coating Buffer 
0.2 g NaN3  
Weigh out NaN3 and dissolve in 900 ml of 1xPBS, bring up to final volume of 1 L and store at room 
temperature.  
 
ELISA Dilution Buffer 
10 g BSA  
0.2 g NaN3  




ELISA Washing Buffer (20 X)  
20 g KCl 
20 g KH2HPO4.2H2O 
800 g NaCl 
50 ml Tween-20 
100 ml 10% NaN3 
Weigh out chemicals and dissolve in 4.5 L MilliQ water. Add 50 ml of Tween-20 and 100 ml of 10% 
NaN3. Bring final volume to 5 L and store at room temperature. Dilute 1:20 in MilliQ water for a 1X 
working concentration. 
 
ELISA Substrate Buffer (for alkaline phosphatase conjugates) 
0.2 g NaN3 
97 ml diethanolamine  
0.8 g MgCl2.6H2O 
Dissolve chemicals in 700 ml of MilliQ water. Add 97 ml of liquefied diethanolamine and adjust pH to 













Buffers used for Antibody ELISAs (Discussed in Section 2.10) 
The following buffers were used for antibody ELISAs. They were made just prior to use and not stored 
long-term, except for the Carbonate Coating Buffer which was stored at 4°C. 
 
ELISA Carbonate Coating Buffer 
0.83 g Na2HCO3 
1.42 g NaH2CO3 
0.1% NaN3 
Weigh out chemicals and dissolve in 400 ml MilliQ water, bring the final volume to 500 ml.  
 
ELISA Blocking Buffer 
1% Bovine Serum Albumin (BSA) 
Weigh out BSA and dissolve in 400 ml of 1xPBS, bring the final volume to 500 ml.  
 
ELISA Wash Buffer 
0.05% Tween-20 in 1X PBS 
 
ELISA Dilution Buffer 
0.05% Tween-20 
1% Bovine Serum Albumin (BSA) 









Buffers used for Immunohistochemistry (Discussed in Section 2.11.1) 
The following buffers were used for immunohistochemistry and were stored at room temperature.  
 
Tris Buffer pH 7.6 
1.0 L of 200 mM Tris Base 
1.5 L of 154 mM Physiological NaCl 
1.0 L of 0.1 N HCl 
 
Tris Buffer pH 9.2 
As above but at pH 9.2. Initially pH 200 ml to give pH 9.2 using HCl (dropwise with 1M or greater) and 
make up to desired volume with NaCl.  
 
Peroxidase Substrate 
Dissolve a single 3-3’-diaminobenzidine tetrahydrochloride (DAB) tablet (Sigma Aldrich, Dorset, UK) in 
15 ml Tris Buffer pH 7.6. Filter to 10 mls and add 1 drop of hydrogen peroxide (Sigma Aldrich). A single 
drop was added to each section until the desired level of positivity was reached, whereupon slides were 
washed.  
 
Alkaline Phosphate Substrate 
Alkaline phosphatase activity was detected using napthol AS-MX phosphate and Fast Blue salt. 
Dissolve 8 mg of Levamisole (Sigma Aldrich) in 10 ml Tris buffer (pH 9.2) to block endogenous 
phosphate activity. In a fume hood dissolve 4 mg of napthol AS-MX phosphate (Sigma Aldrich) in 380 l 
dimethyl-formamide in a glass bottle. Add this to the middle of the levamisole solution. Add 10 mg of 
Fast Blue BB salt. Vortex and filter the solution and add a single drop to each section until the desired 





Buffers used for Periodic Acid Schiffs (PAS) Staining (Discussed in Section 2.11.2) 
Reagents used for PAS Staining 
 
Fixative 
40 ml Formaldehyde 
Add 40 mls Formaldehyde to 960 ml 1X PBS and store at room temperature. 
 
Periodic Acid Solution 
0.1 g Periodic Acid in 100 ml dH2O 
 
Schiffs 
1.0 g Parasaniline (Sigma Aldrich) 
1.0 g NaCl 
2.0 g Activated Charcoal 
20 ml of 1 N   HCl   




1.0 g Haematoxylin (BDH, VWR International, PA, USA) 
50 g Ammonium Alum (Merck Chemicals, Nottingham, UK) 
0.2 g Sodium Iodate (Merck Chemicals, Nottingham, UK) 
1.0 g Citric Acid (Merck Chemical, Nottingham, UK) 
50 g Chloral Hydrate (BDH, VWR International, PA, USA) 
40 ml Formaldehyde (Sigma Aldrich) 
Dissolve reagents in 800 ml 1X PBS and add 40 ml formaldehyde. Bring up to final volume of 1 L and 
store at room temperature. 
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Appendix A1 – PAS Staining 
This Appendix contains the method used by the Department of Histology, Groote Schuur Hospital, Cape 
Town for PAS staining of jejunum sections as outlined in 2.11.2 and discussed in Chapter 5. 
 
Preparation of sections for PAS Staining 
Wax Embedding 
Jejunum tissue was stored in 4% phosphate-buffered formalin and tissues were dehydrated in an 
automated processor before embedding in wax as indicated: 
70 % alcohol     30 min    
96 % alcohol   (twice)   45 min 
100 % alcohol   (twice)   45 min      
Xylol    (twice)   60 min 
Wax (55°C-60°C)  (twice)      45 min with vacuum 
 
Wax-embedded tissues were sectioned at 5-7 μm with a microtome, mounted onto glass slides and 
fixed by incubation at 37°C overnight. Slides were heated at 60°C for 2-18 hours to remove the wax and 
sections were then re-hydrated and stained in PAS as follows: 
 
Periodic Acid Schiffs (PAS) Staining 
Xylol (twice)                                                    30 min 
100 % alcohol                                                1 min                    
96 % alcohol                                                  1 min 
70 % alcohol                                                  1 min 
Water                                                              1 min 
 
Once the sections were hydrated in water they were and oxidised in 1% aqueous periodic acid for 5 – 
10 min. They were then washed for 10 min in running H2O, and stained in Schiff reagent for 15 minutes, 
washed for 5 minutes, counter-stained in Mayer’s haemotoxylin, washed for 5 minutes, dehydrated and 
mounted with cover slips. 
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Appendix B – DNA Specific Techniques Used 
This Appendix details methods used to generate and screen the sFliC ΔTLR5 construct (Described 
2.2.3.2), and the technologies used by Dr. RA Kingsley to generate the STm strains used. 
 
Appendix B1 DNA Manipulation  
B1.1 Electrotransformation 
Plasmid DNA harbouring mutations of interest were transformed into electrocompetent SL3261 cells. 
Briefly, a single colony of SL3261 was incubated overnight in LB at 37°C with aeration (180 rpm). 
Following incubation the culture was diluted 1:10 in fresh LB and incubated until mid-exponential phase 
(ODλ600 0.6-0.8). Cells were harvested at 5000 x g for 10 minutes and washed in ice-cold MilliQ water 
before further centrifugation. Cells were then washed in 10% sterile ice-cold glycerol and pelleted once 
again before being washed a second time in glycerol to obtain electrocompetent cells. Electrocompetent 
STm (108) was mixed with plasmid DNA (1 µg) and chilled on ice for 1 minute. Cells were transferred to 
the bottom of a cold electroporation cuvette and placed between the electrodes of a BioRad 
Electroporator. The cuvette was pulsed once at 2.5 kV, set as 200 Ω and 25 μF. LB was added and the 
suspension was transferred to an eppendorf and incubated aerobically at 37°C for 1 hour. Cells were 
plated on LB-agar supplemented with appropriate antibiotics, and incubated overnight at 37°C.  
 
B1.2 GeneEditor Mutagenesis 
The GeneEditor in vitro Mutagenesis System (Promega, Southampton, UK) was used to delete the 
putative TLR5 binding motif of flagellin (Andersen-Nissen et al., 2005). This system utilises two 
oligonucleotides: a selection and a mutagenic oligonucleotide. The selection oligonucleotide is provided 
to introduce mutations in the β-lactamase gene of the target DNA, and confer new resistance to the 
GeneEditorTM antibiotic selection mix. The mutagenic oligonucleotide is designed to create the desired 
mutation. The following primer was designed for use with the GeneEditorTM System P5’---
AACGAAATCAACAACAACCTGCAGTCTGCTAACAGCACCAAC---3’. The primer was complementary 
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to sequences coding for residues 89-96 within the TLR5 ligating motif of flagellin. It was designed to 
incorporate a region of mismatch located in the centre through providing 17-19 perfectly matched 
nucleotides on either side or a deletion of the mismatched region.  
 
Deletion of the putative TLR5 ligating motif was achieved as per manufacturer’s guidelines. In brief, 
plasmid DNA pET22b+ FliC Xho1 was denatured under alkaline conditions allowing hybridisation of the 
mutagenic and selection oligonucleotides, enabling synthesis of the mutant strand which links the two 
oligonucleotides. The resulting plasmid was transformed into a repair minus (muts) E. coli strain (BMH 
71-18) to avoid repair of the desired mutation, and incubated overnight in the GeneEditorTM antibiotic 
selection mix. Positive transformants were isolated and transformed into BL21 for subsequent protein 
expression (Invitrogen, Paisley, UK). The resulting construct (pET22b+ FliC Xho1 TLR5∆89-96) was 
isolated using the Wizard Plus SV Minipreps DNA Purification System (Promega, Southampton, UK), 
and the mutation confirmed by PCR under standard thermal cycle conditions.  
 
B1.3 Construction of SL3261 Strains 
B1.3.1 Construction of Phase-Locked STm Strains 
Phase-locked strains of STm incapable of switching their flagellin genes were constructed as in (Ikeda 
et al., 2001) through disruption of the hin gene, which encodes a recombinase required for inversion of 
the DNA segment upstream of the fljBfljA operon. Therefore, when the DNA is locked in the ON position 
FljB is exclusively expressed, whereas only FliC is expressed when DNA is locked in the OFF position. 
The SL3261 aroA ON (RAK 121) and SL3261 aroA OFF (RAK 123) strains were generated by 
transduction of the kanamycin resistance gene using bacteriophage P22 from SL3201 ON fliC::kan and 
SL3201 OFF::Kan respectively into SL3261 by Dr. RA Kingsley (Wellcome Trust, Sanger Institute, 
Cambridge). The source strains for the phase locked mutants were kindly provided by Dr. Alison O’Brien 
(Uniformed Services, University of Health Science). The genotype of the strains was confirmed by PCR. 
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B1.3.2 Construction of Aflagellated SL3261 
A strain in which both the fljB and fliC genes were deleted and replaced with an aminoglycoside 
phosphotransferase gene (aph) and chloroamphenicol acetyltransferase (CAT) cassette, respectively 
was constructed using red recombinase methodology (Datsenko and Wanner, 2000) by Dr RA Kingsley 
(Wellcome Trust, Sanger Institute, Cambridge).  
 
Briefly, the fliC mutation was constructed using oligonucleotide primers A and B to amplify the cat gene 
from pKD3. The fljB mutation was constructed using oligonucleotide primers C and D to amplify the aph 
gene from pKD4 (Primer sequences are outlined in Table B1). The purified PCR products were 
electrotransformed into STm SL1344 expressing λ-red recombinase from pSIM18, and kanamycin 
resistant transformants were selected, one of which was designated SW552 (bearing the fliC deletion) 
and SW550 (bearing the fljB deletion). For construction of an aflagellate strain containing an additional 
aroA mutation in order to attenuate virulence, the fljB::aph was transferred to STm SL3261 aroA by 
P22 transduction and the resulting strain was designated SW556. The fliC::cat was transferred to STm 
SW556 by P22 transduction and the resulting strain was designated SW564. The expected genotype of 
strain SW564 was confirmed using oligonucleotide primers 5’ tatcatttacagccatacattcc 3’ and 5’ 
gataaggaagaattttagtcgc 3’, and 5’ ggctccggaattaaaaaaggc 3’ and 5’ caagggttacggtgagaaac 3’ that 
amplify the entire fljB or fliC locus, respectively, and motility was tested using semi-solid agar 
(containing 0.3% agar), where the absence of swimming in the aflagellated strain was compared against 
the swimming observed with SL3261 (Fig B1).  
 
B1.3.3  Construction of OMP-deficient SL3261 Strains 
B1.3.3.1 Omp D Deficient STm (RAK 126) 
The transposon Tn10 belongs to a group of mobile genetic elements which encodes tetracycline 
resistance. P22 transduction was used to create the OmpD-deficient SL3261 strain (RAK 126) by Dr. 
RA Kingsley (Wellcome Trust). Briefly, the host bacterial cell BRD455 in which OmpD was disrupted by 
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Tn10 insertion (Tn10::tetR) was infected with phage P22 (Dorman et al., 1989; Meyer et al., 1998). After 
infection the host plasmid harbouring the insertional mutation was integrated in place of the viral 
genome as a linear piece of DNA into the phage head to create a transducing particle. Upon lysis 
transducing particles were separated from virions and used to infect SL3261, where the insertional 
mutation was re-circulated by homologous recombination thus transferring the Tn10::tetR insertion in 
OmpD BRD455 into SL3261. The resulting genotype was confirmed by amplification of the entire OmpD 
locus by PCR, whilst phenotypic assessment was confirmed by polyacrylamide gel electrophoresis 
(PAGE) analysis of cell envelopes isolated from the strain to confirm the absence of OmpD. 
 
B1.3.3.2 Omp R Deficient STm (RAK 083) 
The OmpR-deficient SL3261 strain (RAK 083) was constructed using red recombinase mutagenesis 
methodology (Datsenko and Wanner, 2000) by Dr. RA Kingsley (Wellcome Trust). Briefly, the selectable 
antibiotic resistance gene aph, encoding kanamycin resistance that is flanked by FRT (FLP recognition 
target sites) was amplified from pKD13 by PCR using the following primers (5’-
GGATCGTCTGCTGACCCGTGAATCTTTCCATCTCATGGGTGTAGGCTGGAGCTGCTTC-3’ and 5’,-
GTCTGAATATAACGCGGATGTGCCGGATCTTCTTCTTCCACATTCCGGGGATCCGTCGACC3’). The 
primers were designed to bear extended nucleotides at their 5’ that were homologous to selected 
regions upstream and downstream to the target gene (OmpR) to be deleted. The purified PCR products 
were electrotransformed into STm SL1344 expressing λ-red recombinase from pSIM18. Kanamycin-
resistant transformants were selected and the resistance gene was then eliminated by using a helper 
plasmid encoding the FLP recombinase, which acts on the directly repeated FRT sites flanking the 
resistance gene to create directed disruption of the gene. The ompR::aph was transferred to STm 
SL3261 by P22 transduction and the genotype of the strain was confirmed by amplification across the 
entire OmpR locus by PCR, whilst phenotypic assessment was confirmed by PAGE analysis of cell 
envelopes isolated from the strain to confirm the absence of OmpC and OmpF. 
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Figure B1:  
Swimming Motility Assay: The motility of STm and aflagellated STm (SW564) was assessed using semi-solid 
agar. STm or aflagellated STm were harvested at late-log phase (ODλ600 nm of 1.4) and washed. The STm 
strains were injected just below the surface of semi-solid agar (containing 0.3% agar) and incubated at room 















STm SW564 – Aflagellated STm 
230 
 
Appendix C – Protein Specific Techniques Used 
This Appendix describes technologies used during the purification and screening of protein immunogens 
used in this study. Additionally, the method used by Dr. Cristina Gil-Cruz to purify porins from STm and 
ST is outlined alongside the detailed methods used to functionally characterise them. 
 
C1 Qualitative and Quantitative Assessment of LPS and Proteins 
C1.1 Limulus Amoebocyte Lysate (LAL Assay) 
The E-Toxate (Limulus Amoebocyte Lysate) assay was used to detect bacterial Endotoxin from purified 
proteins as per manufacturer’s guidelines (Sigma Aldrich, Poole, UK). Briefly, a series of Endotoxin 
standards were created ranging from 400 EU/ml to 0.015 EU/ml. The standards and the sample of 
interest were diluted 1:1 with a pre-supplied working reagent and incubated for 1 hour at 37°C. After 
incubation the presence of LPS was qualitatively determined by the formation of a gel. The level of 
endotoxin was quantified by determining the greatest dilution, and therefore, lowest concentration of 
Endotoxin standard required to form a gel using a standard curve. 
 
C1.2 Protein Quantification 
The concentration of purified protein was determined using the bicinchoninic acid (BCA) protein assay 
(Thermo Fisher Scientific, USA) which was adapted for microplates. In brief, 50 µl of the purified protein 
and diluent were mixed with 200 µl of the BCA working reagent (BCA and copper complex) and 
incubated at 37°C for 30 minutes. Albumin protein standards were run alongside. After incubation, the 
colour change observed upon the simultaneous reduction of copper in the working reagent upon protein 
binding, and the chelating of BCA by this resulting cuprous ion was read at 550 - 570 nm using an Emax 
Precision Microplate reader (Molecular Devices). A standard curve of absorbance was constructed 
against known concentrations of the protein standards which was used to determine the concentration 
of the protein of interest.  
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C1.3 Sodium-Dodecyl-Sulphate Polyacrylamide Gel Electrophoresis 
Purified proteins and the fractions collected during purification were analysed by Sodium-Dodecyl-
Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE). Briefly, protein was mixed with SDS loading 
buffer which was made as a 6x concentrated stock as outlined in Table C1. Samples were heat-
denatured at 95°C for 10 minutes prior to separation, unless stated otherwise. Precast gradient gels (4-
20%) were largely used (Thermo Fisher Scientific, USA) and samples were separated in Tris-HEPES-
SDS electrophoresis buffer at a constant voltage of 150 volts for 40 minutes, alongside a protein marker 
(Fermentas: PAGE RulerPlus). When a greater degree of separation was required, proteins were 
separated using 15% polyacrylamide gels which were run in Tris-glycine-SDS electrophoresis buffer at 
a constant current of 30 mA for 1 hour. Proteins were stained with GelCode Blue Reagent (Thermo 
Fisher Scientific) as per manufacturer’s recommendations. The composition of the buffers used for 
SDS-PAGE and Immunoblotting are outlined in Table C1. 
 
C1.4 Immunoblotting 
Immunoblot analysis was performed using gradient polyacrylamide gels. Gels were run as described 
and proteins were electrophoretically transferred to Polyvinylidene Fluoride (PVDF) transfer membranes 
(Immobilon-Millipore) in transfer buffer at 35 mA for 1 hour using a semi-dry blotting system (Bio-Rad 
Laboratories, Hemel Hempstead, UK). Membranes were blocked overnight and extensively washed 
before endogenous HRP was eliminated using SG substrate (Vector Laboratories, Peterborough, UK) 
as per manufacturer’s instructions. Briefly, membranes were incubated with HRP-conjugated goat-anti-
mouse IgM (Southern Biotech, AL, USA) for 40 minutes at room temperature on a platform shaker, 
before incubation with SG substrate for 30 minutes. The SG substrate was then discarded and the 
membranes were rinsed twice in dH2O to stop the reaction. Membranes were further blocked for 1 hour 
and then washed. Primary monoclonal antibodies or sera were added and blots incubated overnight. 
After overnight incubation membranes were washed and probed with HRP-conjugated goat-anti-mouse 
IgG or IgM secondary antibodies (Southern Biotech, AL, USA). Membranes were washed before 
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developing using Supersignal Chemiluminescense (Thermo Fisher Scientific, USA). All washing, 
blocking, and probing steps were carried out in wash buffer (Table C1). Blocking was done in 20% (w/v) 
skimmed milk powder (Marvel, UK) whilst antibodies were added in a solution containing 5% (w/v) 
skimmed milk powder. Overnight incubation of membranes were at 4°C under gentle agitation whilst 
shorter incubations were for 2 hours at room temperature and under gentle agitation.  
 
C2  Isolation of Purified Porins for Immunisation (Described in 2.2.3) 
Purified porins from ST (strain ATCC 9993) or STm (strain ATCC 14028) were extracted by Dr. Cristina-
Gil Cruz through repeated extraction with SDS. In brief, ST or STm were incubated in minimal salts 
medium (MAM) containing 0.1% yeast extract, 0.5% glucose and 0.1% MgSO4 at 37°C with aeration 
(200 rpm) until late log phase (ODλ600nm of 1). Cells were then diluted 1:10 in 1.5 L MAM and further 
incubated until late log phase.  
 
Cells were harvested at 6000 x g for 15 minutes at 4°C and washed in wash buffer. Cells were then re-
suspended in wash buffer and disrupted using a French pressure cell at 20, 000 psi. Un-broken cells 
were removed at 6000 x g for 20 minutes at 4°C and the lysate was spun at 30, 000 x g for 40 minutes 
at 4°C. The resulting envelope fraction was re-suspended in 100 ml solubilisation buffer and incubated 
for 2 hours with aeration (120 rpm) at 37°C. The soluble inner membrane fraction was then separated 
from the insoluble outer membrane (OM) by centrifugation at 30, 000 x g for 45 minutes at 4°C. This 
extraction step was performed twice. Pelleted cells (OM envelope) were re-suspended in Nikaido buffer 
and incubated for 1 hour at 37°C with aeration (120 rpm) before centrifugation at 30, 000 x g for 1 hour 
at 20°C. The resulting supernatant isolated after this third extraction contained the OM fraction. The 
composition of all the buffers used for the purification of OMPs is outlined in Appendix A. 
 
Final purification was achieved by FPLC gel filtration on a Sephacryl S-200 column with Nikaido’s 
purification buffer. Fractions with an optical density at λ280 nm of >0.2 were pooled and extensively 
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dialysed against PBS containing 0.1% (w/v) SDS. Purity was assessed by SDS-PAGE and protein 
concentration using the BCA assay (Thermo Fisher Scientific). The LAL assay showed LPS 
contamination to be 0.06 EU/480 µg protein. Protein identity was confirmed by trypsin digest and 
Quadrupole Time of Flight (QTOF) mass spectrometry at the School of Biosciences Functional 
Proteomics Unit (University of Birmingham). Protein was stored at -80ºC. 
 
C3 Biophysical Assessment 
C3.1 Analytical Ultracentrifugation (AUC) 
Porins were structurally assessed by sedimentation velocity using analytical ultracentrifugation (AUC) to 
assess whether they adopted an oligomeric conformation through monitoring their rate of movement in 
response to centrifugal forces. In brief, purified porins were extensively dialysed in conjunction with Dr. 
Karina-Tveen Jensen against PBS (pH 7.4) containing 0.1% SDS at 20°C. After dialyses the porins 
were subjected to sedimentation velocity by Drs. Karina-Tveen Jensen and Tim Dafforn. AUC 
sedimentation velocity was performed at 37°C using PBS (pH 7.4) containing 0.1% SDS (buffer 
reference) with a ProteomeLab XL-I analytical ultracentrifuge protein characterisation system (Beckman 
Coulter). The protein sample and reference buffer were centrifuged at 20,000 rpm in a Ti-50 rotor and 
absorbance measured at 280 nm. The data was analysed using the software Sedit (Schuck, 2000). 
 
C3.2 Circular Dichroism (CD)  
Purified porins were assessed using circular dichroism (CD) spectroscopy to assess whether they were 
folded. Porins were extensively dialysed in conjunction with Dr. Karine-Tveen Jensen as with AUC 
assessment. Far UV CD measurements were performed on a JASCO J-715 spectropolarimeter with a 1 
mm path length cell, 2 nm bandwidth, 1 nm increments, 100 nm/min scanning speed and a 2 second 
response time by Drs. Karina-Tveen Jensen and Tim Dafforn. The scanning mode was continuous. 
Twenty scans were averaged and the resulting spectrum was corrected for buffer contribution. Data was 
interpreted using standard methods (Kelly et al., 2005).  
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SDS Sample Buffer (6X) 
500 mM Tris HCl (pH 6.8) 
12%  (w/v) SDS 
25%  (v/v) Glycerol 
5mM EDTA 






Electrophoresis buffer  
100 mM Tris Base (pH 8.3) 
100 mM HEPES (electrophoresis grade) 
3 mM SDS 
  
Electrophoresis of  





20% (w/v) Sucrose 
1.5 M Tris Base (pH 8.8) 
Acrylamide 
10% (w/v) SDS 
10% (v/v) APS (Ammonium Persulphate) 
N, N, N’, N’ N- tetramethylethylenediamine (TEMED) 
1.25   ml 
1.25   ml 
2400  µl 
50      µl 
12.5   µl  
5        µl 
 
 







0.3 M Tris HCl (pH 6.8) 
Acrylamide 
10% (w/v) SDS 
10% (v/v) APS (Ammonium Persulphate) 
N, N, N’, N’ N- tetramethylethylenediamine (TEMED)   
944    µl 
789    µl 
267    µl 
40      µl 
10      µl 
2.1     µl 
 
 
Preparation of one 4% 
Stacking Gel 
 
10X Tris-Glycine-SDS  
Electrophoresis buffer  
250 mM Tris Base (pH 8.3) 
1.92 M Glycine (electrophoresis grade) 
1.0% (w/v) SDS 
  





25 mM Tris HCl (pH 8.3) 
150 mM Glycine 
20% (v/v) Methanol 
0.1% (w/v) SDS 
  
Transfer of gels to PVDF 
membrane 
 
Wash buffer  
 
100 mM Tris Base (pH 7.5) 
1.0 M NaCl 
1.0% (v/v) Tween 20 
 Washing, blocking and 
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